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SUMMARY
A series of 52 primary human bronchial carcinomas was studied 
karyotypically using G-banded metaphase preparations after short 
term culture of solid tumour material removed at operation.
All the tumours studied exhibited multiple gross chromosomal
abnormalities, both numerical and structural. There was a clear
indication of non-random involvement of the different chromosomes
*
in these abnormalities, differential participation appearing to be 
related to chromosome length and particuarly evident for the longer 
chromosomes. Chromosomes 1,3,5»7> and 8 contributed more to 
marker chromosomes and to extra chromosomal material, and 
chromosomes 2,if and 6 were involved less, than the?rest of the 
chromosomes. Material from chromosome 15 was found to be missing 
from cells more frequently than that from any of the other 
chromosomes.
In discussion of these results, the value of modal chromosome 
number as an index of chromosomal abnormality is questioned.
The implications of the findings for theories of the significance 
of chromosomal abnormality in the aetiology and progression of 
tumours are discussed, with particular emphasis on the stemline 
concept and on processes of clonal selection in tumours.
No significant differences were apparent amongst the results 
obtained for the different histological groups of carcinomas, or 
from patients of different ages, or between the two sexes.
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Section I 
INTRODUCTION
1.1. Historical background
Cancerous tissues, whether benign or malignant, are dependent 
upon cell division and multiplication for their growth.
Chromosomal anomalies have been known to be associated with cancer 
since the end of the nineteenth century. Arnold (1879) was the 
first to describe cell division in human tumours, and he observed 
cells which were multinucleate. He proposed that these cells 
were the result of multiple division of the nucleus independent 
of any cytoplasmic control.
Hansemann, who was the first person to study cell division 
systematically in malignant tumour tissue, gave cytological 
descriptions of a number of human tumours (Hansemann 1890). He 
stressed the presence of many abnormalities in malignant tissue
1
during cell proliferation, particularly the fact that some cells 
had unusually large numbers of chromosomes and others unusually 
small numbers, and proposed that the variable numbers of chromosomes 
contained by the cells were the results of abnormal spindle 
formation during cell division causing an unequal distribution 
of chromosomes between the daughter cells. Hansemann also 
suggested that the abnormal numbers of chromosomes present in 
these cells would upset the balance, which otherwise would have 
existed, between the nucleus and the cytoplasm, and that this 
unbalanced state is an aetiological factor for "neoplasia'1. He 
used the term "neoplasia" to indicate the deviation of cancerous 
growth from the normal pattern of differentiated tissues. He also 
suggested that the presence of chromosome aberrations could be 
used as a diagnostic criterion for the state of malignancy. 
Krompecher (1902) studied 330 human cancers and found the 
occurrence of multipolar spindles to be very common in the
dividing cells of these tissues, thus supporting the views of 
Hansemann.
Also in 1902, Boveri showed that if a sea urchin egg was 
fertilised by two spermatozoa, a tetrapolar spindle was formed 
during the first cleavage division, the centrioles having been 
introduced into the cytoplasm of the egg by the spermatozoa. 
Consequently, the triploid complement of chromosomes were 
distributed unequally to the four daughter cells in almost all 
instances. The resultant abnormal cells tended to form themselves 
into groups which lacked the regular arrangement of cells 
characteristic of normal tissues (Boveri 1902). Hansemann*s 
idea of the role of a disturbed balance between nucleus and 
cytoplasm in the proliferation of malignant cells was further 
elaborated by Boveri (1912). From his observations Boveri 
inferred that the mitotic anomalies and lack of cellular 
organisation into a differentiated tissue were causally related, 
and indicated that this situation was similar to that found in 
proliferating tumour tissue. These findings led Boveri to put 
forward his theory of the origin of malignancy (Boveri 1914).
The essence of his conception was that malignant growth 
originated in those cells which had acquired an abnormal chromatin 
constitution as a result of abnormal mitosis, the significant 
factor being the unbalanced chromatin constitution rather than 
the way in which this originated. Boveri!s idea was that an 
original property of the cell is a tendency to proliferate 
continuously, and that this property is inhibited due to 
environmental control in the multicellular organism; changes in 
nuclear constitution could be responsible for a breakdown of this 
inhibitory mechanism, and the cell would then function 
independently of the surrounding tissues. He thought of a
tumour mass, comprising different cell types with variations in 
chromosomal make up, as being a collection of individual tumours 
rather than one tumour which had originated from a single stem 
cell and undergone a process of progression and diversification.
Winge (1 92 7) provided cytological evidence which supported 
Boveri*s theory on the origin of malignant tumours when he 
demonstrated that certain plant tumours comprised cells which 
contained more than the normal number of chromosomes, and a few 
years later (Winge 1930) using tar-induced tumours he reported 
that a large proportion of the tumour cells had double the 
number of chromosomes of normal mouse cells. He conceived the 
idea of cellular heterogeneity of tumour tissue and proposed 
that the aetiology and development of tumours was the result of 
a selective process operating within the heterogeneous cell
1
population.
Based partly on the already proven observation that ionising
s'
radiation and X-rays were capable of inducing gene mutations, 
without necessarily causing noticeable chromosomal aberrations, 
and also caused carcinomas and sarcomas in humans, Bauer wrote 
two reports concerning carcinogenesis and gene mutations (Bauer 
1928a,1928b). He suggested that changes in the genetic material 
responsible for initiating carcinogenesis were not necessarily 
discernible as chromosome aberrations and would most likely take 
place at gene level. So, according to Bauer's theory, in the 
majority of cases the chromosome abnormalities observed in cancer 
cells would be consequent upon the basic event of gene mutation. 
This could be considered an elaboration rather than a 
contradiction of Boveri's theory of the origin of malignancy, 
though strictly speaking, the chromosome abnormalities were 
considered to be a causal factor in carcinogenesis by Boveri,
but a consequential occurrence by Bauer. Whether chromosome 
abnormalities are a causal or consequential occurrence in 
carcinogenesis has not been resolved today.
Various mitotic anomalies have been observed in both human 
tumours and experimentally induced animal tumours. Any one or 
a combination of these could be responsible for the formation of 
cells with abnormal chromosome complements. Some of these 
anomalies were studied by Koller (19^ -7) • Stickiness of 
chromosomes is a common abnormality in tumour cells, and can 
result in clumping at metaphase or in the formation of ’'bridges11 
between the poles of the mitotic spindle. Non-disjunction, the 
failure of a pair of daughter chromosome^ to separate at anaphase 
can be caused by sticky chromosomes and results in an unequal 
distribution of chromosomes between the daughter nuclei.
i
Lagging of chromosomes results in a loss of chromosomes which 
may remain outside the mitotic spindle and form micronuclei in 
the cytoplasm. Multipolar spindle formation results in an 
abnormal, unbalanced distribution of chromosomes into several 
nuclei which are often linked by chromosome "bridges". 
Occasionally binucleate cells are formed when a cell membrane 
fails to develop between daughter nuclei. The anomalies 
mentioned above were attributed by Koller to disturbances in the 
cytoplasmic control systems caused by metabolic breakdown product 
which are particularly prevalent in necrotic regions of tumours. 
The susceptibility of cancer cells to such environmental 
influences indicated to Koller that they are metabolically 
unstable. So Roller1s idea reinforced Bauer's theory that the 
chromosomal changes were secondary to the metabolic instability.
I .2.Development of Techniques
Before the 1950's there were no accurate chromosomal analyses 
performed on mammalian cells. The reason for this was the lack 
of adequate techniques in preparing the chromosomes so that they 
could be accurately counted. Hsu (1952) observed the effect of 
the treatment of cultured cells with hypotonic solutions prior 
to fixation. The differences in tonicity causes swelling of the 
cell, and so the chromosomes are more spread out. The combination 
of hypotonic treatment and air drying, following the use of 
colchicine, must be regarded as one of the most important 
discoveries in cytogenetic technique, and is still widely used 
today. Both Tjio and Levan (1956) and Ford and Hamerton (1956) 
adapted, from plant cytogenetics (Gavaudan et al 1937)> the 
techniques of using colchicine to prevent spindle formation 
during mitosis and thus promote the accumulation of metaphase 
chromosomes. Using these techniques the exact chromosome number 
of man was shown to be /f6 (Tjio and Levan 1956), when it had 
previously been thought to be Zf8.
Since the implementation of these techniques much information 
regarding the chromosome constitution of animal tumours has been 
collected and analysed. Most tumours studied have abnormal 
chromosome complements and show a wide range of variation both 
between tumours and within the same tumour. These anomalies 
involve both changes in chromosome number and chromosome
structure. Some tumours are pseudodiploid in that although the
\
number of chromosomes present is the same as is found in normal 
tissues, on analysis the karyotype shows structural rearrangements 
when compared with the normal tissue of origin.
Ascites cells from experimental animals were the first
mammalian cells in which chromosome observations yielded results 
which were technically comparable with the best preparations 
obtained from higher plants, insects and amphibians. The study 
of chromosomes in animal ascites tumours was soon supplemented 
with results from human malignant effusions. Since ascites 
tumours are generally old metastatic tumours, in which the 
chromosomal constitution could have changed considerably since 
the primary oncogenic process, cytogeneticists working in the 
cancer field became directed towards other materials.
Consequently many chemically induced tumours and tumours caused 
by viruses were transplanted and studied in experimental animals.
Work with human tumours is more difficult than with other 
animal tumours. The aetiology of the tumours is usually uncertain 
and even similar histological types may include many different
i
aetiologic entities. If different aetiological agents are 
responsible for producing different chromosome abnormalities 
then histological tumour types will be characterised by a 
confusing mixture of several chromosome patterns. A major problem 
with human tumours is that early stages in the malignant process 
are rarely available and, in general, samples of tumour tissue 
for chromosome study can only be obtained in connection with or 
subsequent to the clinical treatment. Also genetic and 
environmental factors which can be controlled in experimental 
tumours are generally unkown variables in human tumours.
A major breakthrough was achieved in cancer cytogenetics with 
the introduction of chromosome banding techniques in the early 
seventies. In 1970 Caspersson and his colleagues demonstrated 
a longitudinal differentiation of human chromosomes by observing 
the differential binding of alkylating fluorochromes using an 
ultra-violet light source (Caspersson et al 1970). Subsequently,
banding techniques based on protease digestion (Seabright 1971»
Wang and Fedoroff 1972), denaturation with hydrochloric acid and 
barium hydroxide followed by renaturation (Sumner 1972), 
suppression of fluorescence of dyes bound to regions containing 
bromodeoxyuridine (Latt 1973) and amraoniacal silver staining 
(Howell e_t al 1975 > Goodpasture and Bloom 1975) > rendered possible 
the analysis of G-bands, constitutive heterochromatin, sister 
chromatid exchanges and nucleolar organiser regions respectively. 
These and other banding techniques have made possible the detection 
of minor structural chromosomal abnormalities and so cells with a 
pseudodiploid chromosome complement may be differentiated from 
cells with a normal karyotype even in the absence of distinct 
marker chromosomes (Shaw and Chen 197*f» Muller and Stalder 1976). 
However, since good quality metaphase spreads are essential for 
satisfactory banding patterns to be obtained, and because these 
are more readily achieved using cells in suspension, haematological 
malignant diseases have provided the great majority of material 
for work on chromosome banding in human malignancies. Relatively 
few types of human solid tumours have been submitted to chromosome 
banding analysis.
1.3.Nature of chromosome aberrations in tumours
Structural abnormalities of one or more chromosomes are often 
a feature of tumours, such a structurally abnormal chromosome 
being referred to as a marker chromosome. Markers may be easily 
recognisable, particularly if they are of a large size or with 
more distally placed centromeres than normal chromosomes of a 
similar size, or if they are dicentric or ring chromosomes.
They are often present in a large number of metaphases in tumours
and can sometimes be identified in interphase nuclei in routine 
histological and cytological material. If the long arms are 
larger than the total length of the largest normal chromosome, 
then they can produce clearly visible nuclear protrusions (Atkin 
and Baker 196^ -, Brandao and Atkin 1 96 8). The presence of one or 
more marker chromosomes common to most of the cells in a given 
tumour is usually strongly held to suggest a clonal growth pattern, 
and much of the associated cytogenetic variability can be related 
to secondary sub-populations derived from the initial neoplastic 
clone.
The most well known marker chromosome is the Philadelphia 
chromosome (Ph1) which was discovered by Nowell and Hungerford 
(i9 6 0) in cells from patients with chronic myeloid leukaemia (CML). 
Using chromosome banding techniques the Phf chromosome has been
1
identified as a deleted number 22 chromosome (O'Riordan et^  al 1971). 
The deleted portion of the number 22 chromosome is often 
translocated onto another chromosome, usually a number 9* The Ph1 
marker chromosome has been found in over 90% of reported cases of 
typical CML (de Nava 1 9 6 9) and is usually present in every 
metaphase observed in the bone marrow of these Ph* positive 
patients (Trujillo and Ohno 1963, Whang _et al 1963)* Its presence 
is usually the only visible chromosome abnormality in the 
leukaemic cells in the chronic stage of CML. The Ph* chromosome 
is often used as a diagnostic criterion for CML. In the blastic 
phase, however, additional changes are evident (Kemp ert al 196*f, 
Lawler 1967). These are more varied but are still non.-random in 
that three particular changes are relatively common, these being
(1) duplication of Ph*, (2) an extra number 8 chromosome, (3) an 
isochromosome for the long arms of a number 17 chromosome (Atkin 
1975, Levan and Mitelman 1975). So, in the chronic stage the
leukaemic cell population seems monoclonal, whereas one or more 
new clones, each characterised by a new chromosomal change, arise 
at the time of acute transformation. These progressive changes 
represent clonal evolution and indicate a phase of increased 
malignancy in the leukaemic cells.
The karyotypes of tumour cells are also generally characterised 
by deviations from the normal diploid chromosome number of the 
species. These deviations are present in the form of aneuploidy 
and heteroploidy in a heterogeneous cell population. The number 
of chromosomes present in the highest observed proportion of cells 
in a tumour is termed the modal number, with the remaining cells 
showing different chromosome variants. If cells with the modal 
chromosome number also have identical karyotypes, thus indicating 
that they are descended from a common ancestral cell, then these 
cells are held to represent the "stemline11 of the tumour, and are 
assumed to be the most significant cells in the tumour cell 
population. The concept of the "stemline" of a tumour as 
comprising a dominant sub-population of similar cells, within 
the heterogeneous tumour cell population, undergoing a selective 
process of evolutionary change as the tumour progresses was first 
introduced by Winge (1930) when studying tar induced mouse tumours 
A tumour can have one or more "stemlines" contributing to its 
growth, each having a characteristic chromosome constitution which 
however, is capable of change, especially in response to 
environmental variations. It follows that the modal number of 
a tumour may change if cells with a new chromosome constitution, 
numerically, have a greater proliferative capacity than the cells 
with the existing modal number. Variations in the "stemline" will 
thus occur as the tumour progresses.
Chromosome changes, consistent with a clonal pattern of growth,
in tumours have been observed throughout the development of solid 
tumours from early preinvasive lesions to frank malignancy, 
definite sub-populations having been shown to exist in all stages 
of development, with apparently normal chromosome complements; 
this situation being less common in frank malignancies (Atkin 197k)• 
With the use of present banding techniques some of these apparently 
normal karyotypes might have been shown to have had previously 
undetectable structural rearrangements. The cytogenetically 
abnormal cell clones observed late in the course of neoplastic 
disease tend to deviate further from normal than those found in 
earlier lesions. Following the introduction of screening 
vprogrammes for the detection of exfoliated cervical cells in smears, 
dysplasia and carcinoma in situ have become well recognised as 
symptomless lesions which are believed in many cases to precede 
carcinoma of the cervix (Spriggs 1972). Aneuploidy was first 
demonstrated in material from premalignant lesions of the cervix 
uteri by Spriggs ejt al (1962b) and the presence of clones with 
markers was indicated. However, markers have only been found in 
a minority of pre-invasive cervical lesions though they are common 
in microinvasive carcinoma (Granberg 1971» Spriggs et al 1971).
In a study of carcinomas of the urinary bladder Spooner and Cooper 
(1972) showed that all well differentiated and moderately well 
differentiated carcinomas studied were near diploid whereas only
9
20% of poorly differentiated carcinomas were near diploid, the 
remainder being distributed through a range from triploid to 
hypertetraploid. Findings of an increased deviation from the 
diploid karyotype associated with more advanced stages of malignancy 
led Levan (1956) and Hauschka (I96I) to postulate concepts of 
tumour progression associated with sequential alterations in 
chromosomal pattern. Nowell (1974) summarised clonal evolution in
neoplasia as follows:
(1) Most tumours, by the time they reach macroscopic size, have 
chromosome abnormalities that indicate a clonal pattern of 
neoplastic growth, A few neoplasms being exceptional in 
that alterations of karyotype may not be obvious,
(2) The time of appearance of cell clones that are identifiable 
cytogenetically may be individually variable, but they have 
been observed at all stages of tumour development,
(3) Chromosome abnormalities usually progress in parallel with 
other neoplastic characteristics, evolving towards more 
deviant karyotypes as the tumours become more malignant,
(Zf) These observations suggest (a) that most neoplasms are 
unicellular in origin; (b) that they develop through an 
evolutionary process, with sequential selection of more
i
neoplastic variants and more aneuploid karyotypes; and (c) 
that the fully developed human malignancy is, therefore, 
usually seen in an irreversible and individualised state,
I ,Zf.Aetiological factors in chromosome aberrations
According to the chromosomal theory of carcinogenesis (Lejeune 
1965> de Grouchy and de Nava 1968, Levan 1969> Bishun 197^) 
chromosome aberrations are the common pathway by which carcinogenic 
factors induce malignancy. These factors can be either external 
or internal. External factors include such things as oncogenic 
viruses, chemical carcinogens and ionising radiation, all of which 
are also known to be capable of producing chromosome damage. 
Internal factors are less obvious and more complex and include 
such things as congenital chromosome abnormalities and certain 
genetic diseases.
I .If. i.External factors
a. Radiation
Clones of abnormal cells, presumably arising from radiation 
induced translocations and non-disjunctions, have been described in 
lymphocytes of Thorotrast treated patients (Court-Brown et al 1967* 
Visfeldt £t al 1975); in the bone marrow of patients treated with 
radioactive phosphorus for polycythaemia rubra vera (Lawler et aJL 
1970, Visfeldt et al 1973); in lymphocytes and bone marrow cells 
of individuals exposed to irradiation following atomic-bomb 
explosions (Ishihara and Kumatori 1967; Awa 197^ f» Kamada and Uchino 
1976); and in lymphocytes of patients treated with radiation for 
ankylosing spondylitis (Buckton et aJL 1978).
1
b. Chemicals1 1 ■' — 1  - ■
Chemicals which cause chromosome damage have been reviewed 
by Shaw (1970). Strong evidence for in vivo induction of 
chromosome aberrations by chemicals is limited to relatively few 
compounds. Benzene causes chromosome breaks and also induces 
leukaemia (Tough et al 1970, Forni et al 1971, Atkin 1976). Vinyl 
chloride has been shown to induce chromosome aberrations in vivo, 
and epidemiological studies have established the carcinogenic 
properties of this compound (Ducatman ert al 1975? Funes-Cravioto 
et al 1975, Purchase et al 1975). Evidence for mutagenic activity 
of compounds used in hair dyes has been demonstrated in bacteria 
(Searle et al 1975) and later with chromosome damage in humans 
(Kirkland £t al 1 9 7 8). Cytotoxic drugs used in chemotherapeutic 
treatment of patients have also been shown to induce chromosome 
aberrations (Stacher ejt al 197*f, Lawler and Walden 1978).
c. Viruses
There is considerable evidence for viral induced chromosome 
damage (Nichols 1970, Stich and Yohn 1970, Harnden 197kt 
McDougall ei; al 1974). The DNA viruses comprise several different 
groups which are oncogenic (e.g. adenoviruses, herpesviruses, 
papoviruses and poxviruses). These viruses along with the oncogenic 
RNA viruses (e.g. Rous sarcoma virus) produce chromosome damage 
characterised by chromosome gaps, breaks and rearrangements, 
whereas the non-oncogenic RNA viruses (e.g. measles, mumps, rubella) 
produce damage characterised by fragmentation without any evidence 
of rearrangements.
I.A»ii»Internal factors
i
a. Chromosomal anomalies
It has been shown that there is an association between the 
occurrence of congenital chromosome abnormalities and the 
development of malignancy (Lejeune 1$G3, de Grouchy, and de. Nava
1968)• Acute leukaemia has been shown to have an increased 
incidence of at least ten times the normal frequency in 
individuals trisomic for chromosome number 21 compared with 
normal individuals (Krivit and Good 1957j Holland £t al 1962,
Cawein et al 1965> Conen and Erkman 1966, Demayo et al 1967)
Miller 1970, Gericke et al 1977). Similarly, the occurrence of- 
malignancy in the gonads of certain individuals with gonadal 
dysgenesis and a karyotype involving an XY cell line- with mosaicism 
or structural abnormalities of the Y chromosome is relatively 
high (Frasier et al 1964) Hayak and Yunis 1975) Maikova et al 1975). 
Males with Klinefelter1s syndrome and two or more X chromosomes 
are more likely than normal males to develop carcinoma of the
breast (Jackson e_t al 1965, Harnden e_t al 1971).
Retinoblastoma is a rare malignant eye tumour which either 
appears spontaneously or occurs in genetically predisposed persons 
(Knudson 1971, Knudson et al 1976). Of the latter group, some are 
apparently inherited in an autosomal dominant mode with about 80%  
penetrance and the others are associated with a deletion of the 
long arms of a number 13 chromosome (Lele et al 1963? Taylor 1970, 
Howard et al 197k, Francke 1 97 6).
b. Chromosomal breakage syndromes
In this group of diseases, which are associated with an 
increased risk of malignancy compared with the general population, 
the cytogenetic findings consist of a fragile chromosomal morphology 
in cultured lymphocytes and fibroblasts and occasionally in 
uncultured marrow cells (German et al 1965,1966, de Grouchy 1 9 6 6, 
German 1972, de Grouchy £t al 1972). The chromosomal instability^ 1
is manifested by breaks and rearrangements in metaphase spreads, 
and distorted nuclei and the formation of micronuclei at telophase 
and interphase. The most well known examples of such disorders 
are ataxia telangiectasia (Taylor et al 1975,1976); Fanconi!s 
anaemia (Swift 1971, Schroeder and German 197k)\ Bloom's syndrome 
(German et_ al 1977), and xeroderma pigmentosum (Cleaver and Bootsma 
1975).
These are Mendelian recessive disorders, the phenotypic 
expressions of which are discrete, but elsewhere in the population
other genes could exist, with no obvious phenotypic expression,
\
which are also responsible for chromosome breakage, so causing a 
predisposition to carcinogenesis in the carriers of these genes.
This could account for a high incidence of carcinogenesis in 
certain families. Tokuhata and Lilienfeld (1963,1963a ) in two
separate studies found 2..1+ and 2.7 times more lung cancer among 
first degree relatives of patients with lung cancer than among 
relatives of controls. The familial factors were more evident 
among non smokers than among smokers and conversely, the effect 
of smoking was less evident among case relatives than among control 
relatives. The familial and smoking effects were synergistic.
The familial influences could be environmental or genetic, but 
are probably an interaction of both (Tokuhata 1976). De Grouchy 
(1967) has also shown that there is a permanent background of 
chromosome rearrangements in normal somatic cells.
I.*f.iii. Inferences for clonal development
It would appear therefore, that chromosome rearrangements
1
occur with a frequency and a degree of specificity that is 
dependent upon the aetiological factor and the type of tissue 
involved. The resultant abnormal cells will usually fail to 
survive, but occasionally, when the chromosome rearrangement 
produces a cell for which the environment is more favourable 
then this cell could be the starting point of a new clone of cells. 
This new clone need not be malignant immediately but could 
selectively evolve until malignancy is achieved. Generally, 
during tumour progression, there are changes of chromosome number 
which usually tend towards an increase, the original noticeable 
change often being the gain of a single chromosome. Although
some relationship between the degree of chromosome abnormality
\
and tumour progression can usually be demonstrated, attempts to 
correlate specific biochemical alterations with certain chromosome 
changes have largely been unsuccessful in malignant cell 
populations, perhaps because the chromosomes were not always
correctly identified in prebanding studies. Many enzyme studies 
have been extensively carried out on transplantable and primary 
animal tumours, but no particular metabolic alteration has.been 
found to be associated with any specific cytogenetic change 
demonstrated in these tumours (Nowell £t al 1967j Hori and Sasaki
1969)• There is a well established association between the Ph1 
chromosome and reduced leukocyte alkaline phosphatase in the 
neoplastic granulocytes of chronic granulocytic leukaemia, but 
even this is not present in certain patients (Nowell 1965* 
Sandberg and Hossfeld 1970).
I .5.Technical considerations
I.5*i-Evidence for the use of culture techniques in karyotyping
1
solid tumours
Certain technical problems are encountered when trying to 
study the chromosomes of neoplastic tissues and it is usually 
impossible to obtain satisfactory chromosome preparations from 
every tumour studied. This is particularly so when using the 
new banding techniques, for which good quality metaphase spreads 
are essential in order to give results which are readily 
analysable. This type of problem is especially relevant to the 
study of solid tumours. Although tumours are often thought to 
comprise rapidly proliferating cells, this is not necessarily 
the case, and a major problem can be the lack of sufficient
numbers of dividing cells to give adequate results from direct
\
preparations. The type of tissue, degree of differentiation and 
the amount of fibrous tissue present can all affect the spreading 
and morphology of the chromosomes in the metaphase spreads. As a 
consequence, much of the published data has been concerned with
cells which are relatively easy to obtain, and where these problems 
are minimal (e.g. in the leukaemias and malignant effusions). By 
using culture techniques it is often possible to obtain larger 
numbers of divisions than could be obtained from direct 
preparations but when studying the chromosomes of tumours it has 
often been thought preferable to use uncultured material as there 
is always the possibility of chromosome changes occurring in vitro 
if the tumour cells are cultured, or of the cells being studied 
originating from some non-malignant cells which were present in 
the tumour. If short-term culture rather than long-term culture 
is used, then these problems are reduced. Atkin (1974) found it 
advantageous to use both direct preparations and short-term culture 
techniques for lymphomas and malignant testicular tumours. He 
employed varying culture periods up to 96 hours and found that 
the results obtained were generally comparable with those from 
the direct preparations. Kotler and Lubs (1967) using solid 
primary tumours from various sites concluded that short-term 
culture methods were extremely useful for karyotyping. They 
compared direct preparations with two short-term culture techniques 
and found a larger proportion of mitoses, which were also of 
better morphology, with both short-term culture methods than with 
the direct preparations. In one case, a marker chromosome was 
identified in both the direct preparations and the cultured tissue.
Several workers have demonstrated that normal fibroblast-like
f
cells in vitro tend to retain a diploid chromosome complement
(Chu and Giles 1959> Makino et al 1962). Puck and his associates
'\
maintained fibroblast-like cells, of normal human tissue origin, 
in culture for 3-9 months. Except for a small proportion of 
polyploid cells, chromosome analyses showed a chromosome number 
of 46 only (Tjio and Puck 1958). Hayflick and Moorhead (1961)
karyotyped 13 strains of cultured foetal cells and found that the 
degree of aneuploidy was low and could have been due to artefact. 
According to Hayflick (1965)> during the period of active growth 
in culture of human fibroblasts the diploid karyotype of the cells 
appears to be stable. Aberrations, including the formation of 
aneuploid cells, occur during the degenerative phase of normal 
cell' cultures. This situation was further demonstrated by Saksela 
and Moorhead (1963)* It follows that the chromosome constitution, 
at least of normal human fibroblasts, is remarkably stable even in 
long-term culture.
Many human cell lines originating from tumour tissue have been 
established in culture. Study of these cell lines at various 
times during continuous culture in vitro, involving numerous 
passages shows the majority to possess generally stable karyotypes 
(Moore and Sandberg 19^> Moorhead 1965j Ishii and Nishimura 1966, 
Rigby and Franks 1970, Peterson £t al 1970, Duran-Troise and 
Dehustig 1972, Plata et al 1973)*
I.5»ii»Problem of normal cells
Cell identification is a major problem when preparing 
cultures from solid tumours, because the tumour comprises a 
mixed cell population and it is therefore difficult to determine 
accurately from which cells in the tumour tissue the cultured 
cells have developed. Solid tumours contain varying amounts of 
connective tissue, tumours of the bronchus tending to be 
particularly fibrous, and this tissue often gives rise to the 
development of fibroblasts in the culture vessel. These 
fibroblasts sometimes have preferential growth properties to 
any epithelial cells which may have developed in culture from
the tumour tissue and so study of the latter is considerably 
hindered. Even if obvious epithelial cells develop in the 
culture, one cannot say with certainty that they have originated 
from malignant tumour cells, when there are probably normal 
epithelial cells also present within the tissue that has been 
used. The presence of aneuploidy in cells cultured from a tumour 
found in an otherwise chromosomally normal individual would be 
highly suggestive that the cells have originated from malignant 
tumour cells. Using high quality banding, some tumours have 
been found which have apparently normal chromosomes, but these 
are extremely few (Mitelman jet al 1975, Mitelman et al 1976, 
Fleischman and Prigogina. 1977)• If small but consistent 
karyotypic anomalies are found, then chromosome analysis should 
be carried out on some other tissue of the individual, using for 
example lymphocyte culture or normal fibroblast culture, in order 
to ascertain whether or not there was already some innate 
aberration present.
1.6.Tumours of the lung
The number of lung tumours which have been karyotyped is 
relatively small, but none have been reported with normal 
karyotypes. Most chromosome studies on bronchial tumours have 
been carried out on biopsies, pleural effusions and tumour tissue 
removed at operation. In the earlier of these studies, accurate
analysis was generally impossible because of the poor quality of
\
the preparations, and so, often, only modal chromosome numbers 
were determined, and some marker chromosomes noted when present. 
Ising and Levan reported, from observations on a pleural effusion, 
a poorly differentiated highly invasive carcinoma of the lung
with a modal chromosome number of 75 and a prominent ring marker 
chromosome which was present in almost all of the cells analysed 
(Levan 1956, Ising and Levan 1957). Spriggs et al (1962) 
analysed cells, with respect to chromosome number, from a brain* 
metastasis of a carcinoma of the lung, and from a primary oat cell 
carcinoma of the lung. These tumours had modal chromosome numbers 
of 35 and 70-90 respectively, but the presence of.markers was not 
mentioned. In the same paper two lung tumours with modal 
chromosome numbers of 75 and 80 were reported. The results were 
obtained using cells from pleural effusions. A high modal 
chromosome number and the presence of marker chromosomes was also 
demonstrated by Ishihara e_t al (1963) in cells from a pleural 
effusion in a patient with bronchial carcinoma. Davidson and 
Bulkin (1966) reported a long acrocentric marker chromosome in 
all well spread metapha'ses from a pleural effusion in a patient 
with metastasising bronchogenic carcinoma. The metaphases had 
varying chromosome numbers, with a modal number of /f8. Long 
acrocentric markers were also reported by Benedict et _al (1971) 
in each of four bronchial tumours, but again these were in unbanded 
preparations of cells from malignant effusions so they were not 
necessarily karyotyped accurately. Kotler and Lubs (1967) 
reported a modal chromosome number of 7 2, with marker chromosomes 
in 80% of cells analysed, in cultured cells from a primary lung 
tumour. These represented the first reported karyotypes from 
primary lung cancer, but the results were from 10 cells only. Of
seven bronchogenic carcinomas studied by Falor _et al (1 9 6 9) using
\
bronchoscopic biopsy material, two tumours yielded no metaphase 
spreads, two others yielded many spreads but all except one of 
them were of poor quality and unsuitable even for counting, and 
the remaining three tumours exhibited a modal chromosome number
above 60 with the presence of marker chromosomes. An attempt by 
the authors to place the extra chromosomes into groups, seems 
rather futile as the preparations were unbanded and so the 
chromosomes were not identified specifically.
Some of the more recent studies have utilised some of the now 
widely accepted banding techniques for chromosomal analysis, and 
this has enabled missing, extra, and marker chromosomes to' be 
identified more accurately. Kakati et al (1975) analysed 
effusions from two lung tumours using three different banding 
techniques. One of the tumours had a modal chromosome number of 
about 60 and the other of about 85• Both of the tumours had many 
marker chromosomes, most-of; which were unidentifiable, and there . 
were three markers which were common to both of the tumours.
These were (1) a number 1 chromosome with deleted long arms,
(2) a chromosome involving a translocation with a break point at 
qll in a number 3 chromosome, and (3) a chromosome involving a 
translocation with a break point at qll in a number 21 chromosome.
It should be mentioned however, that both patients had received 
courses of both radiotherapy and chemotherapy prior to the effusions 
being obtained and this would probably have increased the likelihood 
of the observations differing from the chromosome constitution of 
the primary tumours.
Pickthall (1976) reported a metastatic bronchial carcinoma with 
a modal chromosome number of 60. C and G-banded preparations 
showed that trisomy of chromosomes 1,2,3,4,5,10,12,20 and 21 was 
a constant feature in the analysed cells, and a predominant group 
of metaphases (designated the stemline of the tumour) were observed 
with 5 common markers involving chromosomes 5 ,6 ,7 ,1 0 ,1 1 ,1 4  and 18.
A primary bronchial carcinoma with a modal chromosome number of 47 
was described by Sonta £t al (1977), the only abnormality in all
the analysed modal cells being an extra chromosome number 2 .
A series of malignant human effusions reported by Korsgaard 
(19 7 9) included 89 effusions from patients with lung carcinomas. 
Although several banding methods were employed, and the presence 
of numerous markers was mentioned, the composition of the markers 
was not reported, presumably because the main aim of the author 
was .to demonstrate the diagnostic significance of cytogenetic 
analyses. The modal numbers covered the range 47 to 7 8 , though 
some cells were found with as many as 121 chromosomes. At the 
other extreme, many cells were reported with a hypodiploid 
chromosome number, some with only 23 chromosomes. It is difficult 
to believe that a human cell would remain viable with such few 
chromosomes unless large marker chromosomes were involved. Perhaps 
the cells observed with these low chromosome numbers were artefacts
1
due to burst metaphase spreads. ‘
A comparison of these results and the observations presented 
in this study could be misleading in that some results were 
obtained from primary tumours, some from metastases and others 
from pleural effusions or ascitic fluid. Also, some of the 
patients had received radiotherapy and/or chemotherapy prior to 
the cytogenetic analysis. Consequently, the results cannot be 
assumed to represent the cytogenetic constitutions of the primary 
tumours in all cases.
1.7. Involvement of specific chromosomes in aberrations
Few studies have been reported, on bronchial carcinomas, using 
chromosome banding techniques and so it is difficult to say with 
certainty whether or not specific chromosomes are more likely to 
be involved in anomalies than others. In the two cases of
metastatic bronchial carcinoma reported by Kakati et aj. (1 9 7 6) 
three common marker chromosomes were found, these being: an 
isochromosome for the long arms of a number 16 chromosome, a 
terminal deletion of the long arms of a number 1 chromosome, and 
a translocation involving a number 21 chromosome and another 
unidentified chromosome. None of these was present in the tumour 
studied by Pickthall (1 9 7 6).
Mitelman and Levan have reviewed the relevant literature on 
human tumour material at various sites and observed that there 
was a definite clustering of the abnormalities around specific 
chromosomes (Levan and Mitelman 1975 > Mitelman and Levan 1976, 
Mitelman and Levan 1978). Their first review was based on 129 
reported cases of human neoplasms and the karyotypic anomalies 
involved specific chromosomes, these being numbers 8,9j1^j20,21 
and 22. In a later study, using much more material, the results 
from a total of 287 cases of human neoplasms were used and 
chromosome number 7 was the only additional chromosome involved 
in any karyotypic aberrations. As more data were collected, more 
chromosomes were found to be involved in aberrations but the overall 
aberrations still tended to cluster to specific chromosomes. In 
their most recent survey (Mitelman and Levan 1978) data from 856 
cases of human neoplasms were used. The neoplasms were divided 
into 15 classes comprising mainly myeloproliferative and 
lymphoproliferative disorders (only k3 carcinomas were included 
and only 12 of these were primary tumours), which overall involved
aberrations relating to only 12 of the 2Zf chromosomes, eight of
\
these chromosomes being involved in at least three classes of 
disease. The eight most involved chromosomes were numbers 1,3j5 j7» 
8,9,1/f and 22. Only a small proportion of the data is concerned 
with solid tumours, most of the information coming from studies
of the myeloproliferative disorders and leukaemias. This is 
because it is much easier to obtain good quality metaphase spreads, 
which are essential for banded preparations, from the tissues 
involved in these latter diseases than from solid tumour material. 
However, there is no reason to presuppose that future results 
from similar work, on tumours not yet studied, will disagree with 
the results so far obtained, though it may be expected that those 
chromosomes most commonly involved in aberrations in one group of 
neoplasms, e.g. the leukaemias, may differ from those most commonly 
involved with another group e.g. carcinomas. From the data so far 
available the various types of leukaemia appear to be mostly 
associated with abnormalities of chromosomes numbers 8,9,17,21 
and 22, whereas carcinomas are mostly involved with abnormalities 
of chromosomes numbers 1,3,5,7 and 8 (Mitelman and Levan 1978).
If the chromosome ctianges which occur in human tumours are 
studied more closely, it becomes apparent that different chromosomes 
are preferentially involved in different types of change. For 
example; Levan and Mitelman (1977) examined the changes in the 
most commonly affected chromosomes in patients with acute myeloid 
leukaemia. They found that anomalies involving chromosomes 
numbers 5 and 7 were usually concerned with a loss of chromosomal 
material (In 186 cases, of the 31 aberrations involving chromosome 
number 5, 42% were deletions and 32% were monosomies; and of the 
36 aberrations involving chromosome number 7, 33% were deletions 
and 56% were monosomies), whereas those involving chromosomes
numbers 8 and 9 were usually trisomic or involved in translocations
\
(In the 186 cases, of the 82 aberrations involving chromosome 
number 8, 32% were translocations and 56% were trisomic; and of 
the 35 aberrations involving chromosome number 9, 34% were 
translocations and Af9% were trisomic). Chromosome number 21
showed approximately equal occurrences of monosomy and trisomy. 
Chromosome number 1 was found to be involved in structural 
aberrations in each of 14 consecutive cervical carcinomas (Atkin 
and Baker 1977a )» in 7 of 13 bladder carcinomas (Atkin and Baker 
1977b), in 9 of 14 ovarian carcinomas (Atkin and Pickthall 1977) 
and in each of 7 cell lines established from breast carcinomas 
(Jones Cruciger ert al 1976).
Non-random changes in karyotypes have also been noted in 
experimental tumours, chiefly in rodents, such as dimethylbenz- 
anthracene induced rat carcinomas and sarcomas (Levan et al. 1974«
it
Ahlstrom 1974), Rous sarcoma virus induced rat sarcomas, benz pyrene 
and methylcholanthrene induced rat sarcomas (Levan and Levan 1975), 
and in spontaneous leukaemia in mice (Dofuku £t al 1975)* Studies 
carried out before the development of chromosome banding techniques 
are summarised by Mitelman ^t al (1972) and Rowley (1974)* These 
results tend to suggest that the clustering effect of the karyotypic 
anomalies to a few chromosomes is a general characteristic of 
tumours of other species as well as of man. Another important 
outcome of these studies is the discovery that tumours which are 
histologically similar, or even indistinguishabletend to have 
different karyotypic patterns depending upon the carcinogen 
(Kurita et aj. 1968, Rees 1969, Mitelman and G. Levan 1972,
Ahlstrom 197if).
1.8. Future studies
\
Until recently, cytogenetic analyses were performed using 
contracted midmetaphase banded chromosomes. Yunis (1976), by 
reducing the period of exposure of the cells to colcemid in culture 
techniques, produced elongated midmetaphase chromosomes with more
chromosome bands per haploid set of chromosomes than in the 
contracted state. Improved culture techniques of both normal 
and malignant tissues have been developed for chromosome analysis 
(Lasfargues 1975? Leibovitz 1975 > Kusyk ejt al 1979> Wake e_t al 1 98 1), 
and these allow for the examination of the chromosomes in early 
metaphase or late prophase. Such techniques,- using brief colcemid 
exposure and cell synchronisation induced with, for example, 
methotrexate or thymidine block, increase the number of mitoses 
which can be analysed. Bromodeoxy uridine and actinomycin D have 
also been employed to partially inhibit chromosome condensation 
(Yunis and Chandler 1977* Yunis et al 1978, Viegas-Pequignot 
and Dutrillaux 1978). Such preparations allow for the analysis 
of chromosomes with 550-850 bands per haploid set as opposed to 
approximately 300 from the use of earlier techniques. These new 
techniques are already being used in the cytogenetic studies of 
neoplasms (Yunis and Ramsay 1978, Riccardo et al 1978, Manolova 
et al 19799 Yunis and Ramsay 1980); and helped in the discovery 
of new chromosomal syndromes such as the aniridia-Wilm*s tumour 
syndrome association with lip deletion, and 15q deletion as a 
cause of the Prader-Willi syndrome. Clearly, minute chromosome 
defects which were previously not apparent are being uncovered 
using these new techniques. Francke _et al (1977)* and Chandler . 
et al (1978,1979) have used these techniques to localise specific 
genes to chromosomal bands. There is now an internationally 
accepted system of nomenclature for high resolution banding in 
human cytogenetics (ISCN(l98l)).
\
1.9. The present project
Malignant epithelial tumours are the most common human
malignancies and, at least with regard to mortality, carcinomas 
of the lung are probably the most significant of these (Trends in 
mortality 1978, Epstein and Swartz 1981). However, only a 
relatively small amount of work on the cytogenetics of lung tumours 
had been reported. With the development of chromosome banding 
techniques there was an increased interest in cancer cytogenetics 
and a number of specific chromosomal anomalies have been 
discovered in various different types of tumour. In view of these 
findings, and the relative sparsity of cytogenetic reports on 
lung tumours, it seemed worthwhile to carry out a detailed 
chromosomal analysis of a series of this type of tumour.
\
\
Section II 
EXPERIMENTAL
II.1 Preliminary experimental approach
A major problem in the study of carcinoma of the bronchus is 
that diagnosis is often made at a late stage of- malignancy thus 
making it dfficult to examine the early changes involved in this 
type of neoplasia.
A relatively new method used for obtaining material for 
cytological examination from the proximal part of the bronchial 
tree employs a sterile flexible brush, made from an inert material, 
on the end of a metal rod. The brush is admitted to the bronchus, 
via a bronchoscope, under general anaesthesia and detaches 
epithelial cells from the bronchial mucosa as it is rubbed against 
the latter. The cellular material is collected on the brush and 
processed as required. This method produces adequate material for 
cytological analysis,'in many cases without the need for taking 
biopsies.
It was initially thought that the material obtained from these 
brushes could be used to carry out cytogenetic studies of human 
bronchial epithelia with a view to obtaining an insight into the 
cytogenetic aspects of malignant transformation by studying 
material from normal, metaplastic and malignant bronchial mucosae. 
In practise however, a number of problems were encountered. The 
quantity of material obtained using the brushes was small, and 
although a reasonable proportion of the cells were viable (using 
trypan blue as an indicator, viability varied from specimen to
specimen within the range of 20% to 85% of the cells., but usually
\
\
around 65%) an almost negligible number of cells were seen to be 
in mitosis. Therefore, in order to obtain information about the 
karyotype of the tiasue to be studied it was concluded that the 
tissue would have to be cultured. Several culture methods were
attempted, but all proved to be unproductive for cytogenetic studies. 
If karyotyping is to be carried out, a large number of cells must 
be dividing at such a rate that many of them can be arrested during 
metaphase at the same time. This situation was not reached. Although 
the cells obtained from the brushes often adhered to the surface 
of the culture vessel and started to divide, the division rate 
was insufficient for accurate chromosomal analysis to be possible. 
Also., the multiplication of the cells appeared to cease after about 
10 to 1/f days in culture, after which time a static situation often 
persisted for several months. By this time the cells could have 
undergone changes during culture and so would not give a true 
representation of their in vivo characteristics. In view of this 
possibility, the cells were then discarded.
It was then decided to use tumour material removed at operation 
to study human bronchial tumours cytogenetically.
II.2 Materials
The tissue studied consisted of pieces of lung tumours cut 
from whole tumours which had been removed from 52 patients at 
operation. The operations were performed under general 
anaesthesia and involved the removal of a whole lung or the lobe 
containing the tumour. The patients were referred over a 30 month 
period from 1977 to 1979> to St. Helier Hospital Carshalton, for 
thoracotomy after the diagnosis of a lung tumour following either
bronchoscopic examination or diagnostic X-ray examination. None
\
of the patients had undergone either chemotherapy or radiotherapy 
prior to operation, and all of the patients were smokers. In one 
of the cases the lung tumour tissue was obtained post mortem, at 
which time metastases were also obtained from two other sources.
3*f of the 52 patients were male, 18 were female and their ages 
varied from 3k years to 75 years.(see appendix A).
Details of laboratory reagents used are given in appendix B.
II.3 Methods
The fresh lung tissue containing the tumour was transported 
to the pathology laboratory, in a sterile container, as soon as 
possible after removal from the patient. On arrival at the 
pathology laboratory the tissue was immediately examined 
macroscopically and a slice approximately 1mm thick of the tumour 
was placed in chilled tissue culture medium whilst the remainder 
was placed in k0% v/v formalin prior to histological analysis.
The approximate dimensions of the tumours varied between l.^cms 
and lOcms in diameter, 'and the size of the slices varied accordingly. 
The slices of tumour tissue in the tissue culture medium were then 
transported to the cytogenetic laboratory where they were prepared 
for cytogenetic analysis.
The specimens for cytogenetic studies were usually processed 
within 3 or A hours of removal from the patients. Four specimens 
however were left in tissue culture medium at A°C overnight before 
being processed.
Any obviously necrotic tissue was removed from the slice of 
tumour, and the remaining tissue was divided into two approximately 
equal pieces using sterile instruments and adopting an aseptic
technique. One of the pieces was cultured and the other was used
\
for direct preparations (in the sense of culture for a period of 
up to one hour).
Figure 11,1; Flow diagram showing the sequence of events in the 
processing of the tumour tissue
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II.3.1- Pilot study
a.Direct preparations
The tissue was transferred to culture medium containing 
colchicine at a concentration of 0.3ngm ml~^ where it was finely 
minced, using scissors, for approximately two minutes, the precise 
time depending upon the consistency of the tissue. The fine 
suspension obtained was triturated several times with a Pasteur 
pipette in order to further separate and suspend the cells. 
Approximately half of the cells were left in the above medium at 
37°C for 30 minutes and the remainder of the cells were left for 
60 minutes before being centrifuged at lOOg in a M.S.E. "super- 
minor" centrifuge for 10 minutes.
Colchicine prevents spindle formation during cell division 
and so any cells, in the medium containing colchicine, which 
otherwise would have passed through metaphase are halted at this 
stage of mitosis. This is a method of collecting more metaphase 
spreads than would be possible if mitosis proceeded normally.
At metaphase the chromosomes are suitably contracted to allow 
for an adequate cytogenetic analysis, but with longer periods of 
exposure to colchicine the chromosomes become excessively contracted.
After centrifugation the supernatant was removed and the cell - 
pellet resuspended in a hypotonic KC1 solution (pre-warmed to 37°C) 
for 10 minutes. The hypotonicity of the KC1 causes the cells to
swell, enhancing the spreading of the metaphase plates when the
\
slides are prepared. The cell suspension was recentrifuged as 
before and the supernatant removed to leave a cell.pellet in the 
bottom of the centrifuge, tube. This pellet was resuspended, using 
a "whirlimixer", whilst chilled, freshly prepared fixative was
added drop by drop until 1ml had been added. This careful fixation 
helps to prevent the aggregation of cells which would result in 
incomplete fixation and in turn to poor quality metaphase spreads. 
More fixative was then added to make the cell suspension up to 8ml. 
The cell suspension was again recentrifuged at lOOg for 10 minutes 
and this fixing procedure was repeated twice, the cell pellet being 
finally resuspended in enough fixative to give a cell suspension 
which appeared slightly cloudy. This suspension was used to prepare 
the microscope slides.
Clean microscope slides were breathed on to allow a film of 
condensation to form on them,then three drops of the cell 
suspension were dropped at different points on each slide from a 
height of about six inches. When the drops had stopped spreading 
out, fresh fixative was dropped onto the slide in the same places 
as the cell suspension had been dropped. This addition of fixative 
after the cells have been dropped onto the slide enhances the 
quality of the fixing of the metaphase spreads. The slides were 
then allowed to dry at room temperature. Initially only one or 
two slides were prepared so that they could be examined using a 
X10 phase contrast objective to see if the metaphase plates were 
suitably spread and fixed, and if not, the material left was used 
to make more slides whilst varying the technique slightly. To 
improve fixing the fixative in the tubes was changed a few more 
times and sometimes the cell suspension was stored overnight at 
-20°C. To aid spreading, some of the slides were blown dry with
warm air from a hairdryer. The slides were stored at room
\
temperature prior to banding.
b.Cultured preparations
The piece of tumour was finely minced in a small amount of
tissue culture medium, using sterile scissors, for approximately 
two minutes; by which time a thick suspension of individual cells 
along with small aggregates of cells had been obtained. The 
suspension was made up to 9ml with tissue culture medium and 
divided equally between three plastic tissue culture flasks. The 
flasks were then qbsexved" daily using an inverted microscope with 
phase contrast illumination to assess the adherence of the cells 
to the bottom of the culture vessel, and the degree of 
proliferation.
The culture medium was replaced with fresh medium after 4 days 
in culture and then on every subsequent 3rd day. Often there were 
still many cells and tissue fragments still in suspension in the 
medium which was being replaced at the first medium change and so 
this medium was placed in a new tissue culture flask to allow the 
cells more time to adhere and commence growth. Some cells usually 
adhered to the growing surface and started to multiply within 2 day
The primary cultures were harvested when the number of attached 
cells in the culture vessel was equivalent to approximately ^ of 
the number of cells required for a confluent monolayer culture.
Both individual cells and small tissue fragments settled and 
adhered to the growing surface, the latter resulting in more 
compact growing cell.populations than the clones produced by the 
former. When the cultures were considered to be ready for 
harvesting the culture medium was replaced with fresh medium.
This changing of the culture medium stimulated many of the cells
in the culture to enter a cycle of cell division with a division
\ %
wave peak at approximately 24 hours. 22 hours after changing 
the medium in the cultures, colchicine was added to give a final 
concentration of 0.3ngm ml~^. After a further 4‘£ hours the 
medium from the culture vessel was decanted into a siliconised
centrifuge.tube, the culture vessel was rinsed out with P.B.S. 
and then the cells adhering to the growing surface were detached 
with the use of a trypsin solution pre-warmed to 37°C. Under an 
inverted microscope, the cells were observed coming off the 
growing surface, and when all the cells had detached the cell 
suspension was added to the medium in the centrifuge tube. The 
cell suspension was then treated in the same way as the cell 
suspension in the direct preparations, with the same methods of 
hypotonic treatment, fixation, and slide preparation.
For the pilot study cells were harvested at varying culture 
periods up to a maximum of approximately four weeks. At the time 
of the first harvest for each of these cases one of the cultures 
was subcultured. Using aseptic techniques and sterile materials 
throughout, the cells were detached from the growing surface using 
trypsin, centrifuged at' lOOg for 10 minutes and the cell pellet 
resuspended in fresh tissue culture medium. The resultant cell 
suspension was divided between 3 new culture flasks, half into 
one and one quarter into each of the others. The medium in each 
flask was then made up to 3ml* Cells began to attach to the growing 
surface within 2 hours. (Subculturing stimulates the cells to 
commence cell division and so after approximately 22-2A hours a 
division wave occurs in the culture). Colchicine was added to the 
flask containing the most cells 22 hours after subculturing and 
the culture was harvested by the usual method. The remaining 
two cultures were allowed to proliferate until cells in the flasks
were covering approximately 30% of the growing surface and then
\
they were subcultured and one flask was harvested as before.
This procedure was.repeated for a total of 3 passages. Because of 
the variation in viability and the rate of proliferation the 
periods between subculturing varied for each of the six cases.
The first cells to adhere to the growing surface and divide 
in the primary cultures were epithelial type cells. These were 
sometimes followed by fibroblast-like cells presumably from 
stromal cells present in the original tumour tissue. These 
fibroblast-like cells were extremely few in number in the direct 
preparations and posed no problem. In some of the later passaged 
cultures however they tended to proliferate at a greater rate than 
the epithelial-like cells and if the cultures had been passaged 
normally the fibroblast-like cells would probably have developed 
into the predominant cell type in the culture. -This could have 
resulted in harvesting large numbers of cells of normal stromal 
origin as opposed to cells of malignant epithelial origin.
Because of this possibility, where large clones of fibroblast 
cells were present trypsinisation was reduced to a minimum (as the 
epithelial cells detached before the fibroblasts) and the 
epithelial-type cells were scraped from the growing surface with 
a rubber "policeman11 before many of the fibroblasts had detached.
c.Chromosome preparations
The chromosome preparations were G-banded using a 
modification of the method used by Seabright (1971j1972). The 
air dried slides were treated with a 0.1% w/v trypsin solution 
for 10 seconds, rinsed in tap-water then stained in Giemsa for 
two minutes. The slides were again rinsed in tap-water, temporarily 
mounted in tap-water and observed microscopically using a X100 oil
immersion objective (numerical aperture 1:30) with bright field
\
illumination to assess the degree of banding. (There is 
considerable variation in the degree of banding produced from 
case to case and even between different areas of the same slide. 
Consequently, each slide may need to be subjected to a different
length of time in trypsin compared with'other elides and so each 
slide needs to be treated separately). If the chromosomes were 
overbanded after 10 seconds in trypsin, then the next slide of 
that case was left in trypsin for a shorter period. If the 
chromosomes were underbanded then the next slide was given 
a longer treatment period or the original slide was destained with 
methanol-acetic acid and then given further treatment in trypsin. 
When the chromosomes were satisfactorily banded the slides were 
mounted in DPX.
Slides from each case were systematically scanned for metaphase 
spreads and the chromosome number was counted for 20 metaphases 
for each case from the direct preparations. Sometimes more than 
10 slides were scanned in order to find 20 metaphases. For a 
comparison of the chromosome variations over the differing culture 
periods 50 spreads were analysed for chromosome number at each 
harvesting. Where the numbers of spreads counted are less than 
these numbers, the reason is that the material was exhausted.
II.3»ii-Main study
The six cases comprising the pilot study were also included 
in the main study.
The cultures were initiated from the specimens of tumour tissue 
in the same way as those in the pilot study, and were harvested 
when the number of attached cells in the culture flask was
equivalent to approximately_£ of the number of cells- required for
\
a confluent monolayer culture, before any subculturing. The 
harvesting and chromosome preparation techniques were identical to 
those used in the pilot study.
Slides from each case were systematically scanned for metaphase
spreads and the chromosome number was counted for 100 metaphases 
for each case. (In a few cases the material was exhausted before 
100 metaphases of suitable quality had been observed, and this is 
indicated in the results section. Only twice was the number of 
metaphases counted less than 90). At the same time as the slides 
were examined and metaphase spreads analysed for chromosome number 
any spreads which were suitably banded were karyotyped by visual 
inspection down the microscope. Any extra or missing chromosomes 
compared with the normal human karyotype were noted and where 
possible the marker chromosomes present were examined in order to 
try and determine their composition with respect to whole or parts 
of normal chromosomes. 2 0 -3 0 metaphase spreads were karyotyped 
for each case, but some of the markers were not identifiable.
As an aid to karyotyping, a representative sample of the
i
metaphase spreads from each case were photographed using a Zeiss 
photomicroscope with bright field illumination, a X100 oil immersion 
objective with a numerical aperture of 1:30, and Ilford 35mm PanF 
film. 25cms x 20cms enlargements were printed from the negatives, 
and these were cut out for karyotyping. Karyotypic analysis was 
carried out with reference to HAn International System for Human 
Cytogenetic Nomenclature (1978)” (ISCN(1978)).
Section III
RESULTS AND INTERPRETATION
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Figure III. Showing typical metaphase spread obtained in the study.
This is from case 49, and the markers arrowed are described
in figure III.51 on page 148
III.l. Pilot study
Ill.l.i. Aim
This section comprises the results from the first six 
cases investigated in the total study. The aim of the pilot study 
was to determine whether or not short-term culturing of the tumour 
tissue resulted in any significant change in karyotype, by 
karyotyping each case after varying culture periods up to 
approximately four weeks (see section III.3*i»)*
Ill.l.ii. Results
Histograms of number of cells plotted against chromosome 
number for each of the culture periods of each of the six cases 
are shown in figs.III.1-6. In direct preparations 20 cells were 
counted, and in the cultured preparations 50 cells were counted 
for each case, except for the 28 day culture of case I, where for 
technical reasons only cells were counted.
Ill.l.iii. Interpretation of results
A superficial study of the histograms shown in figs.III. 
1-6 suggests that the pattern of distribution of the tumour cells 
when examined for chromosome number is similar for each of the 
different culture periods. This appears to be true for each of 
the six cases studied. Within each case, the variation in modal 
number is small; if there is any variation at all. The distribution 
of cells around this modal value is symmetrical, although some 
skewness is imposed by a few cells with approximately twice the
Figures III.1-6, Histograms showing distribution of cells with respect 
to chromosome number after various culture periods for 
cases 1-6 respectively. The culture period is 
indicated on each histogram
Figure III.1
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modal number of chromosomes. Some of the cells having the higher 
chromosome numbers were difficult to analyse accurately because of 
multiple overlaps of the chromosomes, and other technical imperfections.
In order to make a more accurate comparison of any variation in 
the distribution patterns occurring during the culturing of the 
tumour cells, the means, standard deviations and variances, with 
respect to chromosome number, of the. cell populations were 
determined for each harvesting of each case. The respective values 
are shown in tables III.1-6. In calculating the means, standard 
deviations, and variances, the spreads which appeared to have 
double the modal chromosome complement were ommitted. These 
spreads represented only a relatively minor proportion of the 
spreads harvested from the tumour cell population, and they appeared 
to be only polyploid versions of cells whose chromosome number was 
around the modal value. It was considered that therefore, they 
did not represent significantly different types of cell with respect 
to chromosome constitution, and would only introduce bias into the 
statistical comparisons for the present purpose if they were 
included. The data provide no evidence of any change in the 
proportions of such cells with change in culture period.
a. Modal number
There is only a small degree of variation in modal 
number within any one case of the six tumours studied. In two of 
the cases (case 1 and case 3) the value is consistent throughout 
the complete culture period studied. In three of the other cases 
(cases 2,4 and 5) the differences in modal number within any one 
case were two or less, and no constant increase or decrease in 
modal number with increasing culture period was apparent. In case 
6 one of the harvests- gave a modal number of 42 whereas the other
Tables III*1-6.______showing the modal numbers, means, standard
deviations and variances at various culture periods for cases 
1-6 respectively.
Table III.i. Case I
Time in Modal No. Mean Standard Variance
culture Deviation
r-1 hr. 62 63.118 7.516 56.483
10 days. 62 63-870 6.163 37.983
16 days 62 65.489 11.169 124.756
21 days 62 63.045 8.755 76.649
28 days 62 65.070 10.282 105.720
1.96x standard error for first harvest =3*573
‘ Table III.2 Case 2
Time in Modal No. Mean Standard Variance
culture *■ Deviation.
J-l hr. 72 7 2 .1 1 1 1.491 2.222
12 days. 72 70.702 4.059 16.475
17 days. 72 71.347 3.257 1 0 .6 0 6
22 days. 70 70.239 , 5.934 35.208
27 days. 72 71.667 - 3.097 9-589
1.96x standard error for first harvest =0^688
Table III. 5^. 
Time in 
culture 
7-1 hr.
9 days 
14 days 
19 days 
25 days
Case 3 
Modal No.
58
58
58
58
58
Mean
62.000
60.311
60.391
59.851
58.432
Standard
Deviation
8.210
4.866
4.669
6 .0 7 9
3-216
Variance
67.412
23.674
21.799
36.956
10.344
1.96x standard error for first harvest =3*793
Table III.4. Case 4
Time in Modal No. Mean Standard Variance
culture Deviation.
7-1 hr. 63/65 64.150 6.167 38.029
14 days 65 65.000 3.758 14.125
19 days 63/64/65 63.760 3.772 14.227
24 days 63 63.915 4.916 24.167
28 days 65 63.479 4-557 20.766
1.96x standard error for first harvest =2.705
Table III .5.. Case 5 
Time in Modal No. Mean Standard Variance
culture Deviation.
£-1 hr. 47/48 51-053 6.876 47.275
11 days. • 47/48 4 8 .667 2.604 6.780
15 days. hi 50.614 5.248 27.545
20 days. 47 51-213 7.581 57.475
22f days. 48 50.622 5.773 33.331
1.96x standard error for first harvest =3-093
Table III .. 6. Case 6 .
Time in Modal No. Mean Standard Variai
culture Deviation.
i-1 hr. 46 4 4 .8 9 5 2.885 8 .3 2 2
12 days. 46 45.745 5.084 2 5 .8 4 6
17 days. 42 "45.689 4.342 18.856
22 days. r46 47.644 5.461 2 9 .8 2 5
27 days. 46 45-256- 4.489' 20.147
1.96x standard error for first harvest =1 .2 9 5
four each gave values of 46. If the histogram for this harvest is 
examined, it is apparent that although a high proportion of 
metaphase spreads with a chromosome number of 42 were counted the 
distribution of spreads counted is similar to those for each of the 
other harvests in this case. In fact, the mean is higher than that 
for two of the other harvests.
The histograms (figs.III.1-6) illustrate the heterogeneity of 
the tumour cell populations being studied. Technical problems 
which exist in trying to study the chromosome constitution of 
tumours limit the number of direct observations which are possible 
from a given cell population. Because of these limitations, only 
a relatively small sample of the whole population can be looked at, 
and coupled with the heterogeneous nature of the cell population 
could account for the small variations in modal number 
encountered in some of the six cases during the total culture 
periods studied.
b. Mean
As with the modal numbers, the variation in the means 
throughout the total culture periods is small. There is no 
consistent increase or decrease in the mean chromosome number 
with increasing culture period. The values appear to move up or 
down randomly. Again, these variations are probably attributable 
to a combination of the restricted sampling and the heterogeneity 
of the cell populations.
Working at a 95% level of certainty the sample means should 
fall within + I .96 standard errors of the true mean. In order to 
compare statistically the variation in the means throughout the 
total culture period for each case, the value for 1.96 multiplied 
by the standard error was calculated for the results from the
first harvest (direct preparations) in each case. These values 
are indicated in tables III.1-6. For cases 1,3*4 and 5 the means 
from all the harvests fall within the range + 1.96 standard errors 
of the mean of the first harvest in their respective cases. The 
results for case 2 suggest a significant variation in the means, 
but the reason for this is apparent when the histograms in fig.Ill .2 
are examined. The low value obtained for the standard error in the 
first harvest of case 2 is attributable to the fact that there is 
very little spread around the modal value, though there are two 
apparently polyploid cells (N.B. These two cells are omitted from 
the statistical comparison). In case 6, all the means except that 
for the 22 day harvest are within + 1.96 multiplied by the standard 
error of the results from the first harvest in this case.
Examination of the histograms in fig.III.6 shows that for the 
22 day harvest there is a skew to the right of the modal value in 
comparison to the results from the other harvests. Consequently, 
there is an increase in the mean obtained for this harvest.
However, there is not a constant increase in the mean which moves 
consecutively up and down with each harvest.
The results from the first harvests are obtained from only 
20 cells whereas those from the subsequent harvest are obtained 
from 50 cells (only 45 cells in the final harvest in case 1).
This was because of the technical difficulties in obtaining metaphase 
spreads of suitable quality from the direct preparations. 20 cells 
is a smaller sample than one would ideally use to study such a 
heterogeneous cell population, but even so, these few results for 
cases 2 and 6 are the only ones where a significant variation is 
indicated, and an inspection of the histograms figs.III.2 and 6 
makes the reason for this clear.
c. Standard deviation and variance
No constant pattern of variation in the standard deviations 
is apparent. In some cases it decreases after the first harvest 
then increases some time later in culture whereas in other cases 
it increases first then decreases later. The variance ratio test 
was applied to te.st such differences. The first and final harvests 
were compared to see if there was a significant change in the standard 
deviation over the whole culture period. The first and second 
harvests were compared because, if there was no significant 
chromosomal change before the second harvest, then this would be 
the stage at which the tumours would be examined during the main 
study (i.e. before any subculturing of the tumour cell population).
The variance ratio values are shown in table III'..7. The most 
obviously significant values are those for case 2, where the 
standard deviation in the results from the first harvest is relatively 
small (1.491). The only other variance ratios which approach this 
level of significance are those in case 3 for the first and final 
harvests, and in case 5 lor the first and second harvests.
The histograms in fig.III.3 indicate that there is little spread 
around the modal value in the results from the final harvest 
(except for some polyploid cells which are omitted from the 
statistical analysis), and a similar observation can be made for 
the results from the second harvest in case 5*
A low level of spread around the modal value suggests a less 
heterogeneous cell population than if there was a high level of 
spread. However, in the cases studied here which have results 
from individual harvests showing a low level of spread around the 
modal value, the heterogeneous nature of the cell population is 
illustrated in the results from the other harvests of the same 
cases, all of these showing a much higher level of spread.
Table III.7. Variance ratios for the first and second and first and 
final harvests for each of tha cases 1-6
Case
1
1
2
2
■3
3
4
4
5
5
6 
6
Harvests Variance ratio
1st & 2nd 1.487
1st & final 1.872
1st & 2nd 7.414
ist & final 4.315
1st & 2nd 2.848
1st & final 6.517
1st & 2nd 2.692
1st & final 1.831
1st & 2nd . 6.973
1st & final 1.418
1st & 2nd 3.106
1st & final 2.421
Probability 
10-20%
5%
0.1%
0.1%
0.1-1%
0.1%
0.1-1%
5-10%
0.1%
10-20%
0.1-1%
1-5%
d. Marker chromosomes
Although few of the chromosome ..preparations obtained using 
the direct technique were satisfactorily banded, some common 
markers could be identified with confidence for each case at all 
harvests throughout the entire culture period. The criteria used 
were length of chromosome, and the position of the centromere.
Some markers are difficult to recognise in an unbanded state if 
they are of a similar size and relative arm length to some of the 
normal chromosomes, but unusually large and unusually small marker 
chromosomes are relatively easy to recognise.
Other markers were found in the cells analysed from one harvest 
but not in those from another harvest from the same case, but the 
numbers were small. Such a variation was also found amongst cells 
from one harvest of one case. There was no evidence of any major 
losses or gains in marker chromosomes during the total culture 
period studied.
e. Conclusions
With respect to chromosome number, there is no consistent 
pattern of variation which is evident during a culture period of 
up to 28 days and involving three passages. Although changes are 
apparent, sometimes an increase in value is involved, and 
sometimes a decrease. There are a few variations which appear 
to be significant statistically (e.g. variance ratio test in case 2) 
but even these do not follow a regular pattern, and only occur 
because the heterogeneous nature of the tumour cell populations 
is not fully illustrated by the results from the harvests which 
give these values. Results from other harvests of the same case 
do however illustrate a much higher degree of heterogeneity.
It seems reasonable therefore to assume that there is no
consistent or significant change in chromosome number during 
short-term tissue culture of human lung tumour tissue.
The presence of common marker chromosomes in the metaphase 
spreads obtained from each harvest carried out during the whole 
of the culture period also suggests that there is no fundamental 
change in chromosome constitution during these culture periods 
although a low level of chromosome reorganisation continues.
This was noted for each of the six cases.
It was therefore decided to study the chromosomes of lung tumours 
using tumour tissue in short-term culture prior to any subculturing. 
By obtaining results from 100 metaphase spreads, sampling errors 
encountered in using a smaller number of results would be reduced.
III.2. Main study
The results in this section include those for the six cases 
in the pilot study.
III.2.i. Analysis with respect to chromosome number
A summary of the distribution of metaphase spreads with 
respect to chromosome number is given in table III.8 for each of 
the 52 cases studied. Where possible 100 metaphase spreads were 
analysed for chromosome number in each case, but in only two cases 
was the number analysed less than 90 (82 in case 36 and 72 in case 
For most of the cases there were some spreads with chromosome 
numbers so high that the chromosomes could not be counted 
accurately (e.g. 12 spreads for case 15 had a chromosome number 
somewhere between 130 and 150). These spreads are omitted from 
table III.8. A representative sample of six distributions is 
shown in histogram form in figs.III.7-12.
Generally the results follow a similar pattern of quasi-normal 
distribution with the degrees of spread around a modal value 
varying from case to case. Occasionally there is a second minor 
peak, at around double the chromosome number of thejmodal value, 
represented by polyploid versions of the metaphase spreads around 
the modal value. Most cases have a group of cells which are 
polyploid relative to cells in the main group of the distribution, 
occasionally forming a minor peak at around double the chromosome 
number of the modal value, and their high chromosome numbers make 
accurate analysis difficult. Some cases have single cells outside 
the main distribution pattern but these are extremely few in number
The tumour cell populations in most of the cases studied are
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hyperdiploid, only five (cases 6,11,13j20 and 31) having a modal 
chromosome number below if6• (The modal chromosome numbers are 
underlined in table III.8). The modal numbers range from Ifl to 88 
and there is no heavy clustering around specific values, although 
there is a small peak around 62 (see histogram fig.Ill.13).
The most striking observation, regarding chromosome number, of 
the human lung tumours studied is that, although they usually have 
considerably more than chromosomes, in a few cases the modal 
numbers are less than A6, suggesting that these cells are thriving 
with a less than normal chromosome complement. Analysis of 
banded preparations should demonstrate whether or not these cases 
are deficient with respect to specific chromosomes, or if 
rearrangements have occurred which have reduced the chroinosome 
number but not the total amount of chromosomal material.
III.2.ii. Analysis of banded preparations
From the banded preparations it was possible to karyotype 
accurately metaphase spreads from between 20 and 30 divisions in 
each case. Some of the marker chromosomes were not identifiable, 
but where possible their derivations were recorded along with the 
number of extra or missing whole normal chromosomes compared with 
the normal human karyotype. In each case the heterogeneous nature 
of the tumour cell populations was clearly illustrated by the fact 
that most of the cells analysed in each case had different 
karyotypes, but it also became evident that there were small groups 
of cells having identical but abnormal karyotypes.
Taking each case separately, where two or more cells were found 
with identical karyotypes they were assumed to represent a clone.
A clone is usually defined as a population of cells derived from a
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single progenitor cell (ISCN 1978). Using this definition a clone 
is not necessarily homogeneous, as cells with a similar though not 
identical karyotype could have arisen from a single ancestral cell. 
Here the term clone will only be used to represent a group of at 
least two cells with karyotypes identical both in respect of 
chromosome number and banding pattern, so that they can be assumed 
to be commonly derived although some other cells not included 
could also have had the same ancestor. In some cases more than 
one clone was found. The clone comprising the highest number of 
cells found by analysis to be identical will be referred to as the 
main clone, and any other clones with a smaller number of identical 
cells as sub-clone 1, sub-clone 2, etc. This does not imply that 
the main clone in any case is exerting more influence in the tumour 
cell population than the other clones, or that further clones are 
not present in the cell'population. This' terminology.-is an 
operational one, and is used for ease of reference. The tumour 
cell populations are made up of millions of cells, so it is a 
relatively small sample which is being analysed; it is unreasonable 
therefore to assume that the main clones as found, are the most 
important cells in the tumour.
As an example, a histogram of the chromosome analysis for 
case 3k showing the relative proportions of cells comprising the 
main clone, sub-clones, cells in which banded karyotypes were 
analysed, and cells in which only chromosome numbers were 
ascertained is shown in fig.III.14. Because of technical 
difficulties in the preparation of the tumour material it was 
only possible to obtain banded chromosome spreads suitable for 
complete analysis in 20-30 cells for each case. If more cells 
had been analysed more clones would probably have been found.
Also, a different main clone might have been found.
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In fig.III.14> if more cells had been analysed from the columns 
with 50 chromosomes and 54 chromosomes it is possible that a clone 
represented by more cells than that in the column with 52 chromosomes 
(the main clone found) could have emerged. Clearly, the relative 
importance of the different clones in the tumour cell population 
cannot be demonstrated using such a relatively small sample. Also 
evident from fig.Ill.14 is that the modal number is not necessarily 
the same as the chromosome number found in the main clone. In some 
cases most of the cells, having the modal number of chromosomes, 
which were analysed using banded preparations had different 
karyotypes. It follows that the modal number of a particular 
tumour cell population is not necessarily a very useful piece of 
information.
Of the samples analysed, some cases were found only to have a 
main clone, the remaining cells of the sample having karyotypes 
different from each other and from that of the main clone: other 
cases had up to three sub-clones as well as the main clone and 
other cells with individual karyotypes.
However, all cases produced similar patterns to that illustrated
i
in fig.III.14 (for case 34)> with the clones, particularly the 
sub-clones, being represented by a- relatively small proportion 
of the cells which had been analysed for chromosome number, and 
the main clone as found, often occurring in a different column 
from that represented by the modal number.
a. Analysis of main clones
In order to establish whether or not there were any common 
features in the chromosome constitution of the different cases, 
the karyotypes of the main clone found in the cultures from each 
case were tabulated together (table III.9). In the construction
of this table the normal karyotype of 46XX or 46XY was taken as a 
base, and where a whole recognisably normal chromosome was extra to 
or missing from this normal base this is indicated in the table by 
+ or - respectively (2 extra or missing chromosomes are indicated 
by double signs ++, or —  etc.). When marker chromosomes were 
found in the karyotypes, they were designated a letter (A,B,C, etc.) 
It must be mentioned that marker A in case 1 is not the same as 
marker A in any of the other cases; the markers in each case were 
assigned letters in the order in which they were discovered.
Where these letters are duplicated in a line of the table this 
means that two identical marker chromosomes of that type were 
present. When all or some of the constituent parts of markers 
were identifiable the letters signifying the marker chromosomes 
are placed in the appropriate columns of the table. Some of the 
marker chromosomes found were totally unidentifiable and these 
are omitted from table III.9 but listed separately in table III.10. 
Where a marker was made up of parts of two or more normal 
chromosomes, the letter signifying the marker is entered in each 
of the relevant columns in the table. A summary of information 
regarding extra and missing chromosomes and chromosomes involved 
in markers is given at the foot of the table. In discussing the 
results from table III.9 the sex chromosomes will be ignored 
because (a) their involvement is extremely small (In the total of 
52 cases the X chromosome was found to be involved in only one 
marker chromosome, and the Y chromosome was found to be missing 
in only one of the main clones. No other anomaly involving the 
sex chromosomes was found.), and (b) the cases comprise both 
male and female patients so an analysis of the sex chromosomes 
would be difficult from grouped results.
The row of the table showing the number of main clones with at
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TABLE III.10, List of the unidentified marker chromosomes opservea in tne 
main clones analysed for each of the cases
CASE UNIDENTIFIED CASE UNIDENTIFIED
MARKERS MARKERS
1 EF 29 CCFF
2 DDDDFF 30 EEEE
3 31
4 CC 32 DDDDF
5 33 DEEEEF
6 C 34
7 35 CC
8 CCCEFF 36 DDDDF
11 37 CC
12 38 CCCE
13 40 DDE
14 A 41 CEE
15 BEEE 42 CFF
16 43 CCFGGG
17 CCDDDDFG 44
18 45 CCD
19 CCCCHHJ 46 CEE
20 47 CFFFGG
21 CH 48 E
22 CCFGG 49 EEE
23 FFFFG 50 DE
24 52 EEEEFF
25 CCCHHH 53 EEEEF
26 J 54 CC
27 A 55 ADEFFFF
28 DE 56 DEEE
N.B. The marker chromosomes were designated lestters in order of their 
discovery and so the markers designated A in the different cases 
are not identical. However, markers haying the same letter 
within individual cases are considered to be identical.
least one extra chromosome, for each of the 24 different chromosomes 
clearly illustrates that the involvement of the different 
chromosomes is not random, the percentage involvement varying 
considerably.
Of the 22 autosomes, for some chromosomes the percentage 
involvement is above average (chromosomes numbers 1,3,5j7>8,19>
20 and 22 are found to be present as extras in 22-35 of the 52 
main clones studied with chromosomes numbers 5>7 and 8 
significantly occupying the upper regions of this range by being 
involved in more than 59% of the main clones (see fig.III.15) •
Eleven of the autosomes are found to be present as extra 
chromosomes in 13-18 of the main clones. These are chromosomes 
numbers 2,9,10,11,12,13,14,16,17,18 and 21. This second group 
of chromosomes can be distinguished as showing average involvement 
in extra chromosomes (25-35%). The remaining chromosomes 
(numbers 4»6 and 15) can be considered as forming a third group 
with a relatively small degree of involvement in extra chromosomes. 
This group however does not form such a closely knit group as the 
other two, but as can be seen in the table they are all involved 
in less than 22% of the main clones (which is less than the other 
19 autosomes), particularly chromosome number 6 which was found 
to be extra in only 6 of the 52 main clones analysed (chromosomes 
15 and 4 were involved in 9 and 11 of the main clones respectively).
The row in table III.9 showing the number of main clones with 
at least two extra chromosomes of a specific type follows a 
similar pattern to that for one extra chromosome, with chromosomes 
5,7,8 and 20 occurring considerably more often than the other 
chromosomes, and chromosomes 4>6,11 and 15 less often. The data 
in the at least 2 extra row are also included in the at least 1 
extra row. The row showing cases with at least 3 extra chromosomes
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contains insufficient numbers for any worthwhile comparison.
Karyotypes with missing whole chromosomes are shown to be less 
numerous than those with extra chromosomes, though the individual 
chromosomes still appear to be involved in a non-random fashion. 
This is demonstrated by the figures in the row representing at 
least 1 missing chromosome, towards the bottom of table III.9* 
Unlike the analysis for involvement in extra chromosomes the 
different chromosomes do not fall into distinct groups, but the 
degree of involvement in missing chromosomes covers a range from 
0-16 of the 52.main clones studied. Chromosomes 15j20 and 22 are 
lost in 16,13 and 15 cases respectively, which is considerably 
more than the other chromosomes. At the other end of the range 
chromosomes If and 8 were not found to be lost in the main clones
in any of the cases studied, and chromosomes 2 and 6 were only
lost in 1 and 2 cases respectively.
Variation in the involvement of the different chromosomes is 
also illustrated if the results for extra and lost chromosomes 
are compared. Chromosome..number 8 is involved as an extra 
chromosome more than any of the other chromosomes, whereas it is 
never involved as a lost chromosome. Chromosome 15 on the other 
hand gives an opposite picture in that it is involved as a lost 
chromosome more than any other chromosome, and yet is involved 
only in a minor degree as an extra chromosome. Chromosomes 20 
and 22 are heavily involved as extra in some cases and also as 
lost chromosomes in other cases.
The row in table III.9 showing the number of different markers
in which each chromosome is involved does not represent the number 
of cases (e.g. where chromosome 1 is involved in the formation of 
two distinct markers in a particular case this is scored twice at 
the foot of the column for chromosome 1. Duplicated markers are
only scored once). Again, this row shows non-random involvement 
of the individual chromosomes to a considerable degree. The number 
of times each of the 22 autosomes was involved in the formation of 
a different marker chromosome, found in the analysis of the main 
clones, covers the range O-i+1. Chromosomes 1,3>5>7 and 8 were 
found to be involved in the formation of 39>**1 >29*29 anc* ^  
different markers respectively. At the other end of the range, 
the remaining chromosomes were each only involved 5 times or 
fewer in the formation of different markers, and chromosomes 6 
and 19 were not found to be involved at all. So the different 
chromosomes seemed to form these two distinct groups with respect 
to involvement in marker chromosomes, with no chromosomes occupying 
the middle region of the range.
A possible factor affecting the non-random involvement of 
different chromosomes in these anomalies is their variation in 
size. The smaller chromosomes might be expected to be involved 
in the numerical anomalies more than the larger chromosomes in 
that they could be more easily left out of daughter nuclei, after 
cell division, due to lagging. The left out chromosomes could
i •
then be easily dragged into the other daughter nucleus creating 
an imbalance. The smaller mass of certain chromosomes could be 
advantageous to this process.
By contrast, in the formation of the marker chromosomes the 
longer chromosomes might be expected to be involved more, simply 
because of their relative length they stand a greater chance of 
undergoing breakages, which are essential to these rearrangements.
In an endeavour to establish whether or not there was any 
straightforward relationship between relative length and the 
above abnormalities, scatter diagrams were constructed for 
relative chromosome length and contribution to extra, missing
and marker chromosomes respectively (figs.III.16,17 and 18).
The values for relative chromosome length used were those given 
by Lubs et al (Paris Conference 1971).
Fig.III.16 is constructed from the values given in the row 
showing the number of main clones in which at least one extra 
chromosome of a specific type was found, in table III.9* The 
actual values for numbers of main clones were converted to a 
percentage of the total of 52 cases studied in the construction 
of the scatter diagram. The points are well spread and do not 
suggest a definite relationship between chromosome length and 
involvement in extra chromosomes. The correlation coefficient 
is 0.011 which is not significant. The addition of a regression 
line calculated from all of the points shows that there is 
virtually no correlation between relative chromosome length and 
degree of involvement as extra whole chromosomes. The dashed 
lines on the scatter diagrams represent the 95% confidence limits, 
and it is evident that many of the points are outside these limits. 
This feature is particularly noticeable for the points for 
chromosomes 5>7 and 8 above these limits and those for chromosomes 
6 and 15 below the limits.
Fig.III.17 is constructed from the values (converted to 
percentages of 52) given in the row of table III.9 for numbers of 
main clones with at least one missing whole chromosome for each 
of the 22 autosomes. As hypothesised, an inverse relationship 
between involvement as missing chromosomes and chromosome length 
is clearly indicated (correlation coefficient=-0.662;p<0.001).
The addition of a regression line, calculated using all points, 
with 95% limits shows most of the points to fall inside or near 
to these limits. A few chromosomes however are shown to depart 
from this main trend. These are chromosomes 3 and 15 which are
Figures III.16-55. Scatter diagrams of extra, missing, and marker
chromosomes plotted against relative chromosome
length
Figure III.16. Involvement in extra chromosomes for the main clones. 
Figure III.17. Involvement in missing chromosomes for the main clones
Figure III.18. Involvement in marker chromosomes for the main clones
Figure III.19. As fig;; III. 18, but divided into 3 groups.
Figure III.2Q. As fig. III.16, but with markers included.
Figure III.21. As fig. III. 17* but with markers included..
Figure III.22. Involvement in extra chromosomes for the sub-clones.
Figure III.23. Involvement in missing chromosomes for the sub-clones,
Figure III.24. Involvement in marker chromosomes for the sub-clones.
Figure III.25. As fig. III.24, but divided into 3 groups.
Figure III.26. As fig. III.22, but with markers included.
Figure III.27. As fig. III.23, but with markers included.
Figure III.28. Involvement in extra chromosomes for total cells.
Figure III.29. Involvementt in missing chromosomes for total cells.
Figure III.30. Involvement in marker chromosomes for total cells.
Figure III.31. As fig. III.30, but divided into 3 groups.
Figure III.32. As fig. III.28, but with markers included.
Figure III.33. As fig. III.29, but with markers included.
The chromosome corresponding to each point is indicated near the point 
The dashed lines represent the 95% confidence limits.
The correlation coefficients, regression coefficients, and residual 
variances used in the construction of the diagrams are given in 
appendix C.
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involved in missing chromosomes much more than their relative 
length would suggest and chromosome 8 which is involved much less 
than its relative length would suggest, the criterion for this 
conclusion being that the points for each of these three chromosomes 
is well outside the 95% confidence limits in the scatter diagram 
(fig.III.17).
Towards the bottom of table III.9 there is a row showing the 
total number of times each chromosome was involved in the formation 
of different marker chromosomes in the 52 main clones studied, for 
each of the different chromosomes. A summation of these totals 
for the 22 autosomes gives a value of 208. (The X chromosome 
was also found to be involved in the formation of one marker).
The values from this row of table III.9 were converted to 
percentages of 208 (i.e. The value for each autosome was 
expressed as a percentage of the total involvement in recognisable 
marker formation of all of the autosomes) before being used to 
construct a scatter diagram of involvement in markers plotted 
against relative chromosome length. This scatter diagram is 
shown in fig.III.18.
As hypothesised, it shows a distinct positive relationship 
between involvement in markers and chromosome length (correlation 
coefficients.607;P^O.005), though there is a considerable degree 
of spread amongst the points for the longer chromosomes. A 
regression line with 95% confidence limits was calculated from 
the values for all points, and these are also shown in fig.III.18.
It is noticeable that all points except those for the longer 
chromosomes fall within or near to the 95% confidence limits. . 
Chromosomes numbers 2,if and 6 are shown to be involved in marker 
chromosomes less than one would expect according to their lengths 
(they are involved in the formation of only 5>1 and 0 markers
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respectively) and are well below the 95% confidence limits. The
points for chromosomes 1,3,5,7 and 8 on the other hand are above
the 93% confidence limits, suggesting that these chromosomes are
involved in markers considerably more than one would expect, even
allowing for any increased involvement due to their high relative
chromosome length. Each of the chromosomes 1,3,5,7 and 8 has been
found to be involved in marker chromosomes at least five times
\
more than any of the other chromosomes. The overall picture 
from this scatter diagram (fig.Ill,18) therefore is that the 
points for the different chromosomes form three distinct groups: 
(a) those for chromosomes 2,Zf and 6, (b) those for chromosomes 
1>3,5,7 and 8, and (c) those for chromosomes 9-22 inclusive.
Because of this apparent formation into three distinct groups 
the scatter diagram was reconstructed using the same values as 
for fig.III.18, but regression lines with 95% confidence limits 
were calculated and plotted for the three groups separately 
(fig.Ill.19). Each of the three groups maintains a positive 
relationship between chromosome length and involvement in marker 
chromosomes, but clear differences in the degree of involvement 
of the different groups is obvious. Also, a significant 
correlation between chromosome length and involvement in marker 
chromosomes is indicated within each of the groups. In the 
group comprising the points for chromosomes 2,/* and 6 all the 
points are within the 95% confidence limits and the correlation 
coefficient is 0.9999 (p<0.001). Similarly, in the group 
comprising the points for chromosomes 1,3,5,7 and 8 all the points 
are within the 95% confidence limits and although the correlation 
coefficient is not as high as for the previously mentioned group, 
it is still highly significant (correlation coefficient=0.8^2; 
p<0.001). In the third group (that comprising the points for
chromosomes 9-22) some of the points (those for chromosomes 13,16 
19 and 20) are outside the 95% confidence limits but they are not 
far outside. The correlation coefficient (0.390) is still highly 
significant (p<0.003) though not as high as in the other two groups. 
This scatter diagram (fig.III.19) shows chromosomes 1,3,5,7 and 8 
to be involved in markers much more than chromosomes 2,1f and 6. 
Assuming that there is a linear level of involvement related to 
chromosome length and indicated by the group of chromosomes of 
numbers 9-22, then chromosomes 1,3,5,7 and 8 are involved more 
than would be expected and chromosomes 2,if and 6 are involved 
less than would be expected. Even if the relationship is 
non-linear, there is a clear disparity in the level of 
involvement shown by the two groups representing the longer 
chromosomes•
If the markers are taken into consideration in analysing the 
results for extra and missing chromosomes then the picture is 
altered somewhat. This is shown by studying the figures in the 
rows XM and MM at the base of the table III.9; XM showing the 
number of cases in which a whole chromosome or a substantial 
part of a chromosome in the form of a marker is present as 
extra in the main clone, and MM showing the number of cases 
where a v/hole chromosome equivalent is missing, when the portions 
of chromosomes making up the markers are included for the main 
clones. This part of the analysis therefore is concerned with 
the total chromosomal material present in the karyotypes of each 
main clone with respect to the total chromosomal material present 
in the normal karyotype, but not necessarily with the way in 
which it is arranged within the karyotype. So, for example, if 
only one normal number 3 chromosome is present but most of a 
number 3 chromosome exists in a marker then a number 3 chromosome
would not be considered as missing. Similarly if with inclusion 
of the markers, more than the diploid equivalent of chromosomal 
material for a specific chromosome is present in the karyotype 
then this chromosome would be considered as being involved as 
an extra chromosome. This approach therefore should give a more 
accurate assessment of the involvement of specific chromosomes in 
extra or missing chromosomal material (compared with the normal 
human karyotype) than the study of only whole, normal, extra or 
missing chromosomes.
The values given in rows XM and MM of table III.9 were 
converted to percentages of 52 (total number of main clones studied) 
and used to construct scatter diagrams of chromosome involvement 
in extra and missing chromosomes respectively, plotted against 
relative chromosome length, in a manner similar to that for 
the scatter diagrams (figs.III.16 and 17) previously discussed.
Fig.III.20 is a scatter diagram of chromosome involvement in 
extra chromosomal material when the marker chromosomes have been 
included plotted against relative chromosome length. As far as 
the presence of extra whole or substantial portions of specific 
chromosomes is concerned, the additional consideration of marker 
chromosomes considerably accentuates the involvement of chromosomes 
1>3>5>7 and 8, and the non-involvement of chromosome 6. As with 
fig.III.16, in fig.III.1 9, the points for the different chromosomes 
again suggest the presence of three distinct groups, and so 
separate regression lines have been calculated and plotted for 
each of the three groups, and incorporated into the scatter 
diagram (fig.Ill.20). The group comprising the points for 
chromosomes 1,3,5,7 and 8 shows a highly significant inverse 
relationship between involvement in extra chromosomal material 
and chromosome length (correlation coefficient=-0.888;p<0.001),
for these chromosomes, all points being within the 95% confidence 
limits. This relationship is opposite to that for the same group 
of chromosomes for involvement in markers, where a positive 
relationship between involvement in markers and chromosome 
length was shown earlier (fig.Ill.19)• This suggests that the 
division into three groups in fig.Ill.20 is not wholly 
accountable for by the introduction of a consideration of the 
markers in the extra chromosomal material. The group comprising 
the points for chromosomes 9-22 also shows a significant inverse 
relationship between involvement in extra chromosomal material 
and chromosome length (correlation coefficient=-0.545; p<0.01) •
All the points except those for chromosome 15 and 20 are within
v
the 95% confidence limits. The point for chromosome 15 is well 
below the 95% confidence limits suggesting that the involvement 
of this chromosome in extra chromosomal material is less than 
would be expected according to its length. Similarly the point 
for chromosome 20 is above the 95% confidence limits suggesting 
that this chromosome is involved in extra chromosomal material 
more than would be expected according to its length. Were it 
not for these two points the correlation would have been much 
more significant. The 95% confidence limits for these two gx'oups 
are well separated, further suggesting a significant difference 
in their degree of involvement in extra chromosomal material.
The third group (that for points for chromosomes 2,4 and 6) 
unlike the other two groups shows a positive relationship between 
involvement in extra chromosomal material and chromosome length, 
and again this correlation is highly significant (correlation 
coefficient=0.896;p<0.001). An outstanding feature is that the 
degree of involvement of the chromosomes in this group in extra 
chromosomal material is considerably less than that for the other
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longer chromosomes.
Fig.III.21 is a scatter diagram of chromosome involvement in 
missing chromosomal material when the markers have been included, 
plotted against relative chromosome length. Inclusion of the 
markers results in a considerable reduction in the number of 
main clones found with missing chromosomal material..For chromosomes 
2>3j*f>5>7 and 8 no main clones were found with a whole chromosome 
equivalent missing, and for chromosomes 1,6,10 and 11 only one or 
two main clones were found with a whole chromosome equivalent 
missing. Chromosome involvement in missing chromosomes is 
considerably less than that in extra chromosomes (compare the 
values in the rows XM and MM in table III.9) and so, perhaps 
because of this size of sample a division into groups is not 
demonstrated in fig.III.21. However, taking all points into 
consideration a regression line with 95% confidence limits was 
calculated and plotted and indicates a highly significant inverse 
relationship between involvement in missing chromosomal material, 
after consideration of the markers, with chromosome length 
(correlation coefficient=-0.780;p<0.001)• This correlation is 
greater than that found before inclusion of the markers 
(c.f. fig.III.17; correlation coefficient=-0.662). A comparison 
of figs.III.17 and III.21 also shows that inclusion of the marker 
chromosomes results in a reduction in the number of main clones 
exhibiting missing whole chromosome equivalents. These reductions 
however are largely restricted to the longer chromosomes. This 
presumably is because fewer markers were identified which were 
made up of chromosomal material from the smaller chromosomes.
This could be because of a difficulty in identifying segments 
of these chromosomes accurately. Many markers were found whose 
aetiology could not be decided (table III.10) and it is conceivable
that some of them contained portions of these smaller chromosomes. 
Inclusion of the markers has resulted in the point for chromosome 
3 being relocated from well outside the 95% confidence limits to 
a point almost on the regression line. The point for chromosome 
15 however remains well above the 95% confidence limits indicating 
an involvement in missing chromosomal material greater than one 
would expect according to its length, even when marker chromosomes 
are included in the analysis. Chromosome 15 did not depart from 
the main trend when involvement in marker chromosomes was analysed 
(fig.III.18 and 19), thus suggesting that this increased level 
of involvement in missing chromosomal material is a significant 
feature. After inclusion of marker chromosomes, no main clones 
were found with whole chromosome equivalents missing of any of 
chromosomes 2,3,*f>5,7 and 8 (fig.Ill.21). The points for 
chromosomes 2,3 and if are still within the 95% confidence limits, 
but the points for chromosomes 5j7 and 8 are below these limits.
An examination of the scatter diagrams for chromosome involvement 
in marker chromosomes (figs.III.18 and 19) shows chromosomes 5>7 
and 8 to belong to the group showing a high level of involvement 
in marker chromosomes. This could be the reason why these 
chromosomes are shown not to occur in the main clones as missing 
whole chromosome equivalents, or it could be that cells having 
these chromosomes missing have a reduced viability compared with 
other cells.
These results demonstrated that in the main clones of the 
human lung tumours studied there is a positive relationship 
between chromosome length and involvement in markers, an inverse 
relationship between chromosome length and involvement in extra 
chromosomes and missing chromosomes, and also that the chromosome. . 
involvement in these abnormalities is non-random even when allowing
for the differences in chromosome lengths. In order to determine 
whether or not these findings were restricted to the main clones 
rather than being a general feature of the tumour cell populations, 
a similar analysis was carried out on the data collected for the 
sub-clones.
b. Analysis of sub-clones
In this analysis the data collected for all the sub-clones 
found within the 52 cases studied is incorporated, all main clones 
being omitted. Only A2 of the 52 cases exhibited sub-clones as 
defined in this study but as some of the cases had more than one 
sub-clone the data are collected from a total of 6k sub-clones.
The karyotypes found for all of the 6k sub-clones are tabulated 
(table III.11) in a similar way to those for the main clones, the 
unidentifiable markers being listed separately (table III.12).
The numbers of unidentifiable markers were comparable for main 
clones and sub-clones. They averaged out at l.i+8 and 1.56 
unidentifiable markers per clone for the main clones and sub-clones 
respectively. The row of table III.11 showing the numbers of 
sub-clones with at least one extra chromosome (for each of the 
different chromosomes) clearly illustrates that the involvement 
of the different chromosomes is not random. As was found in the 
main clones, chromosomes 5>7 and 8 are each involved in extra 
chromosomes in at least 59% of the 6k sub-clones found (in k3yk3 
and 38 of the sub-clones respectively; see table III.11). Also, 
similar to the findings in the analysis of the main clones, 
chromosome number 6 is the chromosome which is least involved in 
extra chromosomes in the sub-clones, being involved in only 5 (7#8l%) 
of the 6k sub-clones.
The row in table III.11 showing the number of sub-clones with
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TABLE III.12. List of the unidentified marker chromosomes observed in all 
the sub clones analysed for each of the cases
CASE SUB CLONE UNIDENTIFIED CASE SUB CLONE UNIDENTIFIED
MARKERS MARKERS
1 1 FG 26 1 JJP
2 1 DDDDFFF 27 1 A
3 1 27 2 AEE
3 2 E 28 1 EFFFF
3 3 29 1 CC
4 1 CC 30 1 EEGG
4 2 CC 30 2 EEGG
5 1 32 1 DDDDF
5 2 CCEE 33 1 EEEEEH
6 1 D 33 2 EEEEJ
7 1 HH 34 1 D
8 1 CCCEFFF 34 2 E
12 1 F 34 3 FF
13 1 35 1 CC
13 2 EEFF 35 2
14 1 AD 37 1 CCCCF
17 1 CCCDDDDFJJK 37 2
17 2 CCCDDDDDDJJLM 38 1 CCC
18 1 D 40 1 DD
18 2 40 2 DDDDH
20 1 41 1 EEG
20 2 DE 41 2 CEEE
21 1 CH 44 1 D
22 1 CCGGJ 44 2 EEFF
23 1 FFFJ 45 1 CC
24 1 DDDGHH 45 2 GH
24 2 46 1 CEE
25 1 CCCHHHJJL 46 2 EE
52 1 EEEH 47 1 GGH
53 1 EEEEGGG 48 1 FFFF
54 1 CCG 48 2 FFFFG
56 1 FEE 50 1 E
N.B. The marker chromosomes were designated letters in order of their 
discovery and so the markers designated A in: the different cases 
are not identical. However, markers having the same letter within 
individual cases are considered to be identical.
at least two extra chromosomes of a specific type follows a 
similar pattern to that for one extra chromosome, with chromosomes
5,7,8 and 20 being involved considerably more often than the 
other chromosomes (as was found in the analysis of the main 
clones; table III.9), chromosomes 4,6,11,14 and 15 were not 
found to be involved as two extra chromosomes in any of the 
sub-clones found. This is also similar to the findings in the 
main clones where these chromosomes were rarely found to be 
involved as two extra chromosomes. As with the main clones, the 
row in table III.11 showing cases with at least three extra 
chromosomes contains insufficient numbers for any worthwhile 
comparison.
Karyotypes with missing whole chromosomes are shown to be less 
numerous than those with extra chromosomes, but the individual 
chromosomes still appear to be involved in a non-random fashion. 
This is demonstrated by the figures in the row representing at 
least one missing chromosome, towards the bottom of table III.11. 
The degree of involvement in missing chromosomes covers a range 
from 0-22 of the 64 sub-clones found. Chromosomes 14,15,20,21 
and 22 are lost in 20,22,18,17 and 17 sub-clones respectively 
(This is similar to the findings for the main clones where 
chromosomes 15,20 and 22 were the chromosomes most often involved 
in missing chromosomes)* As with the main clones, chromosomes 4 
and 8 were the only chromosomes which were not found to be lost 
in any of the sub-clones.
The row in table III.11 showing the number of different markers
\
in which each chromosome is involved also indicates a non-random 
involvement of the different chromosomes to a considerable degree. 
The number of times each of the 22 autosomes was involved in the 
formation of a different marker chromosome, as found in the
analysis of the sub-clones covers the range 0-46. Chromosomes 
3>5,7 and 8 were found to be involved in the formation of 
46,39,29,21 and 30 different markers respectively. Apart from 
chromosome number 10, which was involved 10 times, the remaining 
chromosomes were each only involved 6 times or fewer in the 
formation of different markers, and chromosomes 4 ,6  and 19 were 
not found to be involved at all. These findings are similar to 
those for the main clones, with the same chromosomes showing a 
high level of involvement in marker formation in both the main 
clones and the sub-clones.
Scatter diagrams of relative chromosome length and contribution 
to extra, missing and marker chromosomes were constructed.
Fig.III.22 is constructed from the values given in the row showing 
the number of sub-clones in which at least one extra chromosome of 
a specific type was found, in table III.11. The actual values in 
the table were converted to a percentage of the total of the 64
s '
sub-clones studied, in the construction of the scatter diagram.
The points are well spread and do not suggest a definite relationship 
between chromosome length and involvement in extra chromosomes, 
and the addition of a regression line calculated from all of the 
points shows that there is no significant correlation (correlation 
coefficients.075) • These findings are in agreement with those 
for the main clones, and it is also noticeable that many of the 
points are outside the 95% confidence, limits (represented by 
dashed lines in fig.III.22). As with the main clones, the points
for chromosomes 5,7 and 8 are well above these 95% confidence
\
limits. Below the limits however, the points for chromosomes 
6,10,12 and 14 are most noticeable in the sub-clones (fig.III.22) 
but those for chromosomes 6, and 15 in the main clones (fig.Ill.16).
Fig.III.23 is constructed from the values (converted to percentages
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of 6k) given in the row of table III.11 for numbers of sub-clones 
with at least one missing whole chromosome, for each of the 22 
autosomes. As hypothesised for and confirmed in the main clones, 
a significant inverse relationship between involvement in missing 
chromosomes and chromosome length is clearly indicated (correlation 
coefficient=-0.657;P<0.001). The addition of a regression line, 
calculated using all points shows, most, of the points to fall within 
or near to the 95% confidence limits. A few chromosomes however 
do seem to depart from this main trend. These are chromosomes 
Ik and 13 which are involved in missing chromosomes more than 
their relative length would suggest (c.f. chromosomes 3 and 15 in 
the main clones), and chromosomes 8,11 and 18 which are involved 
less than their relative lengths would suggest (in the main clones 
the involvement of chromosomes 11 and 18 is slightly more, though 
they are still below the 95% confidence limits).
Towards the bottom of table III.11 there is a row showing the 
total number of times each of the different chromosomes was 
involved in the formation of different marker chromosomes. A 
summation of these totals for the 22 autosomes gives a value of 
210. The values in this row were converted to percentages of 210 
before being used to plot a scatter diagram of involvement in 
markers in the sub-clones against relative chromosome length.
This scatter diagram is shown in fig.III.2Zf, the overall picture 
being similar to that for the main clones (fig.Ill.18) . As 
hypothesised, a distinct positive correlation between involvement
in the formation of markers in the sub-clones and chromosome
\
length is indicated (correlation coefficients.593;P<0.005)> though 
there is a considerable degree of spread amongst the points for 
the longer chromosomes, which appear to be split into two well 
separated groups. A regression line, calculated using data from
all points, with 95% confidence limits shows the points for the 
longer chromosomes to lie outside these limits. Chromosomes 2,Zf 
and 6 are shown to be involved in marker chromosomes considerably 
less than one would expect according to their chromosome lengths 
(they are involved in only 2,0 and 0 different markers respectively) 
and the points for these chromosomes are well below the 95% 
confidence limits. The points for chromosomes 1,3,5*7 and 8 
however are all above the 95% confidence limits, suggesting that 
these chromosomes are involved in markers more often than one 
would expect, even allowing for their probably increased 
involvement due to their high relative chromosome length values. 
Although the point for chromosome 9 is below the 95% confidence 
limits for both the main clones and the sub-clones, the level of 
involvement is less in the sub-clones. However, as in the main 
clones, the chromosomes appear to be divided into three distinct 
groups: (a) chromosomes 2,A and 6, (b) chromosomes 1,3,5,7 and 8, 
and (c) chromosomes 9-22.
Therefore, the scatter diagram was reconstructed using the same 
values as for fig.III.2Zf, but regression lines with 95% confidence 
limits were calculated for the three groups separately (fig.Ill.2 3 ). 
Each of the three groups maintains a significant correlation 
between involvement in markers and chromosome length, though the 
correlation for group (c) in the sub-clones (correlation coefficient 
=O.Zf38; p<0.05) is not as significant as for the same group in the 
main clones (correlation coefficient=0.590;p<0.005). In all three 
groups all points in each group are within the 95% confidence 
limits, and the groups comprising the longer chromosomes show 
highly significant correlations between involvement in markers in 
the sub-clones and chromosome length. For chromosomes 2,Zf and 6 
together the correlation coefficient is 0.98Zf (p<0.001) and for
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the group comprising chromosomes 1,3,5,7 and 8 the correlation 
coefficient is 0.883 (p<0.001). So, as with the analysis of the 
main clones, the most outstanding feature in fig.III. 25 is the high 
level of involvement in marker formation in the sub-clones of 
chromosomes 1,3j5 >7 and 8, and the low level of involvement of 
chromosomes 2,if and 6.
If the markers are included in analysing the results for extra 
and missing chromosomes the effect is similar to that observed in 
the analysis of the data for the main clones. As for table III.9 
for the main clones, the rows XM and MM at the base of table III.11 
show the numbers of sub-clones in which a whole chromosome or 
substantial part of a chromosome in the form of a marker-is extra, , 
and the number of sub-clones in which a whole chromosome equivalent 
is missing when the portions of chromosomes making up the markers 
are included respectively. The values in rows XM and MM of table 
III.11 were converted to percentages of 6^ (total number of 
sub-clones studied) and used to plot scatter diagrams of chromosome 
involvement in extra and missing chromosomal material against 
relative chromosome length.
Fig.III.26 is a scatter diagram of chromosomal involvement in 
extra chromosomal material when the marker chromosomes have been 
included plotted against relative chromosomal length. As with the 
study of the main clones, the inclusion of the marker chromosomes 
accentuates the involvement of chromosomes 1 ,3>5»7 and 8 in extra 
chromosomal material, and suggests the presence of three distinct 
groups each with a different degree of involvement, but the level 
of involvement within each group is still related to chromosome 
length. Separate regression lines with 95% confidence limits were 
calculated and plotted for each of the three groups (fig.Ill.26) • 
The group comprising chromosomes 1 ,3»5>7 and 8 shows an inverse
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relationship between chromosome involvement and chromosome length 
(correlation coefficient=-0.435;p<0.05)- Though this correlation 
is not as high as with the main clones, all of the points are 
within the 95% confidence limits for this group, and are well 
separated from both of the other groups. The group comprising 
the chromosomes 9-22 also shows an inverse relationship between 
chromosome involvement in extra chromosomal material and chromosome 
length (correlation coefficient=-0.6l*f; p<0.005) • This is a more 
significant correlation than for the same group of chromosomes in 
the main clones, even though there are more points outside the 
93% confidence limits than in the main clone study. In the main 
clone study the points for chromosome 13 was below the 95% 
confidence limits and the point for chromosome 20 was above. In 
the sub-clones (fig.III.26) the corresponding points are in a 
similar position, but also the points for chromosomes lif and 16 
are below the 95% confidence limits. This suggests a lower level 
of involvement in extra chromosomal material, in the sub-clones, 
than one would expect according to their chromosome length for 
chromosomes lkjl3 and 16 and a higher level for chromosome 20.
As with the main clone study, chromosomes 2 ,k and 6, unlike the 
other two groups, show a positive relationship between involvement 
in extra chromosomal material and chromosome length (correlation 
coefficients.877;p<0.001) • It is noticeable that the involvement 
of this group is considerably less than that for the other longer 
chromosomes.
Fig.Ill.27 is a scatter diagram of chromosome involvement in 
missing chromosomal material, when the markers have been included, 
plotted against relative chromosome length. A regression line 
calculated using data for all points shows a highly significant 
inverse relationship between chromosome involvement in missing
chromosomal material and chromosome length (correlation coefficient 
=-0.716;p^O.001) with most of the points being within the 95% 
confidence limits. This correlation is greater than that found 
before inclusion of the markers (c.f. fig.III.2 3 , correlation 
coefficient=-0.657)• A comparison of figs.III.23 and III.27 shows 
that inclusion of the marker chromosomes results in a reduction 
in the number of sub-clones exhibiting missing whole chromosome 
equivalents, this reduction largely being restricted to the longer 
chromosomes. Chromosomes Zf,7 and 8 were not found to be involved 
in missing chromosomal material in the sub-clones (This finding 
was also present in the main clones (fig.III.21) where chromosomes 
2,3 and 5 also lacked involvement). Even after inclusion of the 
markers, the point for chromosome 15 remains well above the 95% 
confidence limits, indicating a significantly higher level of 
involvement in missing chromosomes in the sub-clones than one 
would expect according to the length of the chromosome (fig.Ill.27)• 
This was also found in the main clones (fig.Ill.21). The points 
for chromosome lif are above the 95% confidence limits for both 
the main clones and the sub-clones, but a higher level of 
involvement is indicated in the sub-clones. This level of 
involvement, however is not as great as that for chromosome 15 in 
either the main clones or the sub-clones. The same points are 
present below the 95% confidence limits in both the main clones 
(fig.III.21) and the sub-clones (fig.III.27)• These are for 
chromosomes 7,8,10,11 and 18. The levels of involvement are
comparable in both the main clones and the sub-clones, except for
\
chromosome 11 which shows a lower level of involvement in the 
sub-clones than in the main clones.
As the separate analyses for the main clones and the sub-clones 
yielded very similar results with a common pattern it would have
been reasonable to combine these results. However, the logical 
step seemed to be to extend the analysis to cover all of the cells 
karyotyped from all of the 52 cases in order to ascertain whether 
or not this pattern was a general feature of all the cells in the 
52 tumour cell populations. An analysis of the single cells 
(i.e. cells not constituting a clone as defined for this study) 
was started but the results proved to be similar to those found in 
the main clones and in the sub-clones, so the results from all of 
the cells in the clones were added to the results from the single 
cells and it is only this combined data which is presented in the 
next section.
c. Analysis of all cells from each case
In this analysis the data collected from every analysed 
banded metaphase spread in each of the 52 cases studied is 
incorporated.
Between 20 and 30 cells were analysed for each case making a 
total of l,3Zf7 analysed banded karyotypes. When plotting the 
frequency diagrams for chromosome involvement in extra and missing 
chromosomes instead of using relative chromosome length and 
percentage of the 52 cases with the appropriate anomaly as the 
co-ordinates, the percentage of total cells (100#c= 13k7) which 
showed the appropriate anomaly was plotted against the relative 
chromosome length. For the marker chromosomes a unit "cell-marker11 
was created. One cell-marker was represented by one marker in one
cell. If the same marker was found in 5 cells then this would
\
represent 5 cell-markers. If three different markers were found 
in each of 5 cells then this would represent 15 cell-markers and 
so on. When two identical markers were found in the same cell 
however, only one of them was scored. As a result of this
standardisation, a total of 4 ,9 1 2 cell-markers were found, and in 
the frequency diagrams for chromosome involvement in marker 
chromosomes the involvement of each chromosome expressed as the 
percentage of total cell-markers involving the relevant chromosome 
for each of the 22 autosomes was plotted against the relative 
chromosome length. Unidentifiable markers were omitted from the 
analysis•
To make a similar table to those for the main clones and 
sub-clones (tables III.9 and III.11 respectively) representing 
the karyotypes of all of the cells analysed would require more 
than 1 ,3 5 0 rows, and so only information showing the totals of 
the columns for each of the 22 autosomes is given in table III.13* 
This table corresponds to the rows towards the bottom of tables
III.9 and III.1 1.
The row of table III.13 showing the numbers of cells with at 
least one extra chromosome (for each of the different autosomes) 
again clearly shows that the involvement of the different 
chromosomes is non-random. Chromosomes 5,7 and 8 are eacji involved 
in extra chromosomes in at least 64% of the total cells studied 
(in 930, 867 and 870 of the 1,367 cells respectively. See table 
III.13)* Also, as with the main clone and sub-clone analyses, 
chromosome 6 is the chromosome which is least involved in extra 
chromosomes, being involved in only 106 (7 *87%) of the total cells. 
Karyotypes with missing whole chromosomes are again shown to be 
less numerous than those with extra chromosomes, and the 
chromosomes show non-random involvement. This is demonstrated by 
the row in the table ill . 13 representing cells with at least one 
missing chromosome of a specific type. The degree of involvement 
in missing chromosomes covers a range from 0 -5 2 3 of the total cells 
analysed. Chromosome 15 is again the chromosome most often lost
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(523 (38.83%) of total cells, the next most involved chromosome 
being chromosome 20 which is lost in 351 (26.06%) of the total 
cells studied). As with the main clones and sub-clones, 
chromosome 8 was not found to be missing in any of the cells 
studied. Chromosome 4 was only found to be missing in 2 of the 
1,347 cells.
The row in table III.13 showing the numbers of different 
markers in which each chromosome is involved again indicates a 
considerable degree of non-random involvement. The number of 
times each of the 22 autosomes was found to be involved in the 
formation of a different marker chromosome in the total 1,347 
cells analysed covers the range 0-1095* A total of 4912 !,cell- 
marker11 units were found. Again, chromosomes 1,3,5,7 and 8 were 
involved in the formation of most of these markers being involved 
in 978 (19.91%), 1095 (22.29%), 684 (13*93%), 626 '(12.74%) and 
597 (12.15%) markers respectively. Chromosome number 19 was not 
found to be involved at all in the markers, and chromosome 6 was 
found to be involved in the formation of only 1 marker. Apart 
from chromosomes 1,3,5,7 and 8, involvement in markers for each 
of the different chromosomes was found in less than 3% of the 
markers analysed.
As in the analysis of main clones and sub-clones, scatter 
diagrams of contribution to extra, missing and marker chromosomes 
plotted against relative chromosome length were drawn. Fig.III.28 
is constructed from the values given in the row showing the number
of cells where at least one extra chromosome of a specific type
\
was found, in table III.13. The actual values in the table were 
converted to percentages of 1,347 (total number of cells analysed) 
before being used. The points are well spread, with chromosomes
5,7 and 8 showing a relatively high level of involvement in extra
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chromosomes, and chromosomes 6 and 15 showing a relatively low 
level of involvement. The points for these chromosomes are well 
outside the 95% limits of a regression line calculated using data 
for all points, whereas the remaining points are within or near 
to these limits. No significant correlation between involvement 
in extra chromosomes and chromosome length is indicated 1 
(correlation coefficient =-0.003). These results are similar to 
those found in both the main clone analysis and the sub-clone 
analysis.
Fig.Ill.29 is constructed from the values (converted to 
percentages of 1,34-7) given in the row of table III.13 for numbers 
of cells with at least one missing whole chromosome, for each of 
the 22 autosomes. A significant inverse relationship between 
involvement in missing chromosomes and chromosome length is 
indicated by the regression line calculated using data for all 
points in the scatter diagram (correlation coefficient=-0.628; 
p<0.005). The most noticeable points lying outside the 95% 
confidence limits of the regression line are.those, for chromosomes 
3 and 15 above the limits (suggesting a higher level of involvement 
in missing chromosomes than one would expect according to their 
chromosome lengths) and those for chromosomes 8 and 18 below the 
limits (suggesting a lower level of involvement than one would 
expect according to their chromosome lengths).
In table III.13 there is a row showing the total number of 
times each of the different autosomes was involved in the formation 
of a marker chromosome. A summation of these totals gives a value 
of 4-912. The values in this row were converted to percentages of 
4912 before being used to plot a scatter diagram of involvement in 
markers against relative chromosome length. The scatter diagram 
is shown in fig.III.30. A positive correlation is indicated
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between involvement in markers and chromosome length (correlation 
coefficient=0.621;p<0.005), though the points for the longer 
chromosomes (1-8) are all clearly outside the 95% confidence limits 
of a regression line calculated using data for all chromosomes.
The points for the longer chromosomes are again split into two 
distinct groups, those for chromosomes 1,3,5,7 and 8 being above 
the 95% confidence limits (suggesting a higher level of involvement 
in markers than one would expect according to their chromosome 
lengths), and those for chromosomes 2,if and 6 being below the 
95% confidence limits (suggesting a lower level of involvement in 
markers than one would expect according to their chromosome lengths).
A scatter diagram (fig.Ill.31) was reconstructed using the same 
points as in fig.Ill.30 but regression lines with 95% confidence 
limits were calculated and plotted for the three groups separately 
as in the main clone and sub-clone analyses ((a) chromosomes 2,if 
and 6, (b) chromosomes 1,3,5,7 and 8 and (c) chromosomes 9-22 
inclusive). Each of the three groups maintains a significant 
positive correlation between involvement in markers and chromosome 
length, but the level of involvement between the three groups 
clearly differs. The correlation coefficient for the group 
comprising chromosomes 2,if and 6 is 0.990(p<0.001), that for the 
group comprising chromosomes 1,3,5)7 and 8 is 0 .805(p<0.001), and 
that that for chromosomes 9-22 is 0.730(p<0.001). Once again the 
most outstanding feature in fig.Ill.31 is the high level of 
involvement in markers of chromosomes 1,3,5,7 and 8 compared with 
the low level of involvement of chromosomes 2,if and 6.
If the markers are included in analysing the results for extra 
and missing chromosomes the effect is similar to that observed in 
both the analysis of the main clones and the analysis of the 
sub-clones. The rows XM and MM in table III.13 show the numbers
of cells in which a whole chromosome or a substantial part of a 
chromosome in the form of a marker is extra, and the number of cells 
in which a whole chromosome equivalent is missing when the portions 
of chromosomes making up the markers are included, respectively.
The values in rows XM and MM of table III.13 were converted to 
percentages of 13^7 (total number of cells analysed) and used to 
plot scatter diagrams of chromosome; involvement in extra and 
missing chromosomal material against relative chromosome length.
Fig.Ill.32 is a scatter diagram of chromosome involvement in 
extra chromosomal material when the marker chromosomes have been 
included, plotted against relative chromosome length. The high 
level of involvement of chromosomes 1 ,3 ,5 ,7  and 8 is again 
accentuated, and a division into groups is apparent. Separate 
regression lines were calculated and plotted with 95% confidence 
limits (fig.III.3 2 ) for each of the three groups, *as with the main 
clone and sub-clone analyses. The group comprising chromosomes
1 ,3 ,5 ,7  and 8 shows a significant inverse relationship between 
chromosome involvement in extra chromosomal material and chromosome 
length (correlation coefficient=-0.?56;p<0.001) when markers have 
been included. All points are within the 95% confidence limits 
and are well separated from the points in the other two groups.
The group comprising chromosomes 9-22 also shows an inverse 
relationship between chromosome involvement in extra chromosomal 
material and chromosome length (correlation coefficient=-0.631;P<0.005). 
This is a similar correlation to that found in the main clone and 
sub-clone studies, and in each study the point for chromosome 15 
is well below the 95% confidence limits and the point for 
chromosome 20 is above the limits. Again, chromosomes 2,if and 6 
show a highly significant positive relationship between involvement 
in extra chromosomal material and chromosome length ■
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(correlation coefficient=0.83*fJP<0,001), and their level of 
involvement is considerably less than that of the longer chromosomes.
Fig.III.33 is s scatter diagram of chromosome involvement in 
missing chromosomal material, when the markers have been included, 
plotted against relative chromosome length. A regression line 
calculated using data for all points shows a highly significant 
inverse relationship between chromosome involvement in missing 
chromosomal material and chromosomal length (correlation coefficient 
=-0.711;p^O.OOl) with most of the points being within the 95% 
confidence limits. Inclusion of the markers has resulted in a 
reduction in the number of cells with whole chromosome equivalents 
missing (compare fig.III.33 with fig.III.29). This is particularly 
noticeable for chromosome 3 which is well above the 95% confidence 
limits in fig.III.2 9 , but after inclusion of the markers the point 
for chromosome 3 is on the regression line. The point for 
chromosome 15 is well above the 95% confidence limits in both 
figs.Ill,29 and III.33, indicating a significantly higher level 
of involvement of this chromosome in missing chromosomal material 
than one would expect according to its length. . Below the 95% 
confidence limits the points for chromosomes 7*8,10,11 and 18 
occupy similar positions to those in the main clone and sub-clone 
studies and are not far outside the 95% confidence limits. The 
points for chromosomes 7 a&d 8 are probably the most significant 
of these as they show non-involvement in this analysis.
d. Sex chromosomes
As mentioned earlier, data concerning the sex chromosomes 
was not included in the stastical comparisons of the involvement 
of the different chromosomes in the abnormalities encountered in 
the study. It seems worthwhile to mention however that the degree
of involvement of the sex chromosomes in the various anomalies was 
found to be relatively small compared with that of most of the 
autosomes. In the total of 52 main clones studied the X chromosome 
was found to be involved in the formation of only one marker and 
the Y chromosome was found to be missing in one case. No other 
anomaly involving the sex chromosomes was found in the main clones. 
In the total 1,3k7 cells analysed in this study an X chromosome 
was found to be extra, missing or involved in the formation of a 
marker chromosome in 11,9 and 2 cells respectively. From table 
III.13 it can be seen that this is considerably less than the 
involvement of the autosomes except for chromosomes k and 8 which 
were found to be missing in 2 and 0 cells respectively, and 
chromosomes 6 and 19 which were found to be involved in only 
1 and 0 different marker chromosomes respectively. It must be 
remembered however that of the 52 tumours studied 3*f were from 
male patients and only 18 were from female patients but even
s '
allowing for the fact that fewer female cells were analysed, the 
involvement of the X chromosome is still considerably less than 
the involvement of the autosomes in these anomalies. A similar 
picture is shown for the Y chromosome for involvement in extra 
and marker chromosomes. In the 1,3^7 cells analysed a Y chromosome 
was never found as an extra chromosome, and was only found to be 
involved in the formation of one marker chromosome. It is possible 
that the Y chromosome was involved in more than one marker but 
could not be identified because of its small size and indistinct 
banding pattern. The Y chromosome was however found to be missing 
in 87 cells, which is more than was found for several of the 
autosomes (see table III.13).
e. Conclusions
In this analysis the data for the total cells were not 
examined first as it was thought that differences could exist 
within the tumour cell population of any individual case and that 
a consideration of the cell population as a whole could mask any 
specific feature which may have been present. Furthermore, for 
this reason, the data from the main clones were analysed first 
followed by an analysis of the sub-clones and then the total cells. 
From the outcome of the results it is evident that such stages in 
the analysis were not necessary. The patterns produced by the
results from the main clones, sub-clones and total cells exhibit
/
a high degree of similarity, thus suggesting that this type of 
pattern is a definite characteristic of the tumour cell 
populations in the cases studied rather than being restricted to 
specific clones.
The correlation between chromosome length and chromosome 
involvement in extra chromosomal material is not apparent unless 
the marker chromosomes are included in the analysis. The modified 
distribution pattern after the markers have been taken into account
i
shows a positive correlation between involvement in extra 
chromosomal material and chromosome length. The significance is 
not high however (correlation coefficient 0.33;p<0.1) and the 
expectation of decreased involvement with increasing length is not 
followed. However, an observation which is consistent is an 
apparent division of the distribution points into three distinct 
groups, and when these groups are separated in the analysis the 
correlations between involvement in extra chromosomal material 
and chromosome length are much more significant.
Group (a) comprising chromosomes 1,3}5>7 and 8 always shows a 
highly significant inverse relationship between chromosome
involvement in extra chromosomal material and chromosome length 
(correlation coefficients: main clones -0.888 (p<0.001), 
sub-clones -0.435 (p<0.05)> total cells -0.756 (p<0.001)). This 
group also shows a much higher level of involvement than the 
remaining chromosomes.
Group (b) comprising chromosomes 2,4 and 6 always shows a highly 
significant positive relationship between involvement in extra 
chromosomal material and chromosome length (correlation coefficients: 
main clones O .896 (p<0.001), sub-clones 0.877 (p<0.001) 
total cells 0.768 (p<0.001)). Another significant feature of this 
group is the low level of involvement compared with group (a).
Group (c) comprising chromosomes 9-22 inclusive always exhibits 
a significant inverse relationship between chromosome involvement 
in extra chromosomal material and chromosome length (correlation 
coefficients: main clones -0.545 (p<0.01), sub-clones -0.614 (p<0.003)» 
total cells -0.631 (p<0.005)* Another significant feature of this
s '
group is that the point for chromosome 13 is always below the 
95% confidence limits thus suggesting a lower level of involvement 
in extra chromosomal material than one would expect according to 
its length, and that the point for chromosome 20 is always above 
the 95% confidence limits thus suggesting a higher level of 
involvement than its length would predict.
In the analyses of missing chromosomal material a highly 
significant inverse relationship between chromosome involvement 
and chromosome length is always obtained both without and including 
the markers for the main clones, sub-clones and total cells. The 
least significant correlation coefficient obtained is -0.628(p<0.005) 
for the total cell analysis before inclusion of the markers(fig.Ill .2 9 ). 
Inclusion of the markers resulted in an increase in the 
significance of the correlation in each analysis. The point for
chromosome 15 is always considerably above the 95% confidence 
limits, and is always more involved in missing chromosomal material 
than any other chromosome, thus suggesting that it is involved 
considerably more than expected according to its length. The points 
for chromosomes 7 and 8 are always below the 95% confidence limits 
and after inclusion of the markers the points fall to a zero level 
of involvement which is below that expected according to their 
lengths. Chromosome 4 was only shown to be involved in missing 
chromosomal material twice in the whole study, but the points for 
this chromosome are still within the 95% confidence limits in the 
scatter diagrams.
In the analyses of involvement in the marker chromosomes found, 
a significant positive relationship between chromosome involvement 
and chromosome length was always obtained. In the analyses for 
the main clones, sub-clones and total cells, before inclusion of 
the markers the least significant correlation coefficient was for 
the sub-clones (correlation coefficient =0.595;p<0.005) • The points 
for chromosomes I,3j5>7 and 8 are always above the 95% confidence 
limits of a regression line calculated using data from allpoints, 
and the points for chromosomes 2,4 and 6 are always below these 
limits, resulting in a considerable difference in the level of 
involvement of these two groups in marker chromosomes. Y/hen the 
three groups are separated in the analysis, a significant positive 
correlation between chromosome involvement in markers and chromosome 
length is maintained within each of the groups. Except for the
group comprising chromosomes 9-22 in the main clones and total cell
\
analyses where some of the points are marginally outside the 95% 
confidence limits, the points are always within the 95% confidence 
limits of their own group. There is some overlap of 95% confidence 
limits of the three groups in the sub-clone analysis, probably
because the points are more spread out than in the other two analyses 
In the other two analyses however, there is no overlap of these 
limits and the three distinct groups are very obvious. This is 
particularly evident in the scatter diagram for the main clones 
(fig.III.19).
It may be concluded that the involvement of the different 
chromosomes in numerical and structural abnormalities of human 
lung tumours as assessed by analysing extra, missing and marker 
chromosomes, is non-random. Consideration of the relative 
chromosome length of the different chromosomes shows that there is 
generally a positive correlation between chromosome length and 
chromosome involvement in markers, and a negative correlation 
between chromosome length and both chromosome involvement in extra 
chromosomes and chromosome involvement in missing chromosomes. 
However, even allowing for the differences in chromosome length, 
chromosome involvement in extra, missing, and marker chromosomes 
is clearly non-random. Chromosomes 1,3,5 >7 and 8 are involved 
significantly more than the other chromosomes in both extra 
chromosomal material and marker chromosomes. Chromosomes 2,if and.6 
are involved significantly less than the other chromosomes in 
these anomalies. Chromosome 15 is involved significantly more in 
missing chromosomes than any of the other chromosomes.
Ill .3. Analysis of break points and chromosome segments in the
marker chromosomes
\
In an attempt to determine whether or not the marker 
chromosomes were formed as a result of random breakage, an analysis 
of the break points for chromosomes 1,3,5»7 and 8 was performed on 
the marker chromosomes found in the main clones.
Chromosomes 1,3,5>7j and 8 only were used as the other chromosomes 
were involved in too few markers to allow for a significant analysis. 
High quality banded preparations are essential in order to determine 
break points, but sometimes it is still not possible to be completely 
accurate. Also, different chromosomes have different sized segments 
between the bands so it is difficult to pin-point the break points. 
Consequently, the break points reported here are confident 
estimations rather than accurate points and could vary slightly 
depending on the banding pattern of the appropriate chromosome.
The break points found in markers in which chromosome 1 was 
involved are illustrated in diagrammatic form in fig.III.3 -^*
The banded pattern of a normal number 1 chromosome is represented 
in numerical form on the left and the break points are shown by 
crosses in the diagram, the solid lines representing the segments 
of chromosome 1 which are present in the relevant marker chromosomes. 
There are a total of 50 break points in fig.Ill.3k and these appear 
to be fairly randomly spread. However, some grouping is evident.
8 (16%) of the break points are in the region of band p22 and
6 (12.%) of the break points are in the region of band p3 2 .
The highest number of points for any of the other bands is k (8%) 
for the region of band q32. It is noticeable that 30 (60%) of the 
break points are in the short arms, and only 19 (38%) in the long 
arms of chromosome 1 .
With regard to the significance of the involvement (or lack of 
involvement) of specific chromosome segments in the markers 
concerned with chromosome 1 , it is difficult to come to any 
conclusions. In the cases studied, with the exceptions of case. .13 
where only one number 1 chromosome is present and no markers
involving chromosome number 1 were found, all of the main clones
have an excess of chromosomal material from chromosome 1 (table III.9)*
Figure III.54. Break points for marker chromosomes involving
chromosome number 1 ,
P
No. of 
breaks
8
2
3
3
3
4
Total 50
23 of the main clones have at least one normal chromosome 1 extra 
compared with the normal human karyotype suggesting that no particular 
region of chromosome 1 is deleterious to the cell population if 
present in excess to the normal quantity. It noticeable in fig.III.34 
that some part of the chromosome distal to band p32 in the short
arms is missing in 2/+ of the 50 markers found. The reason for this
however could be that chromosome 1 usually exhibits only pale 
staining bands in the region distal to band p32 and so this segment 
of the chromosome would be difficult to detect if it was present 
in other marker chromosomes.
Fig.III.35 shows the break points for chromosome 3 in the same 
way as fig.Ill.3k for chromosome 1. There are a total of 3k break 
points in fig.III.35 and most are in the proximal regions of the 
long and short arms. Only 5 points are distal to band q22 in the
long arms, and only 5 points are distal to the band p21 in the
short arms. It is noticeable that breaks were found more often 
in the long arms than the short arms of chromosome 3 
(36(66.67%) in ^he short arms and 18(33*33%) in the long arms).
Of the 36 breaks in the short arms, 14(38.9%) are in the region 
of band p21, suggesting that this region may be more susceptible 
to chromosome breakage than the other regions of the chromosome, 
and 9(25%) are in the region of band pl4. Table III.9 shows that 
22(42.31%) of the main clones found have at least one extra whole 
chromosome 3 compared with the normal human karyotype, suggesting 
that no specific region of this chromosome has a harmful effect on
the cell population when present in excess. As far as missing
\
segments with respect to the normal complement are concerned, it 
is noticeable in fig.III.35 that the part of the short arms distal 
to band p21 is missing in 21(54%) of the markers found involving 
chromosomes 3 in the main clones. However, by inspecting table III.9
THpnrrft III.35. Break points for marker chromosomes involving;
chromosome number 5.
No. of 
breaks
4
1
14
4
9
4
4 
2
2
5
Total 54
999999996
it becomes evident that in most instances these apparent deficiences 
are compensated for by a presence of two normal chromosome 3*s or 
the presence of another marker incorporating this segment along with 
one normal number 3 chromosome. However, in the main clones for 
cases 6,11,30,35 and 47 this deficiency is still present. (This is 
less than 10% of the cases studied).
Fig.Ill.36 shows the break points for chromosome,,5 in the markers 
studied. There are a total of 30 break points and 17(56.7%) occur 
in a segment of the chromosome between the centromere and band ql4 
in the long arms. 8 of these are in the region of band ql3 and 8 
are in the region of the centromere and band qll. No break points 
were recognised in the short arms of chromosome 5* Table III . 9 
shows that 35(67*31%) of the main clones found have at least one 
extra whole number 5 chromosome compared with the normal human 
karyotype, thus suggesting that none of the various segments of 
this chromosome has a harmful effect on the cell population if 
present in excess. 21(72.4%) of the 29 markers involving 
chromosome 5 are deleted of the short arms of this chromosome.
An inspection of table III.9 indicates however that only 3 of the 
main clones found (cases 6 ,3 1 and 35) have an overall deficiency 
compared with the normal human karyotype, of this chromosome 
segment when other markers and normal chromosomes are considered.
Fig.III.37 shows the break points for chromosome 7 in the 
markers studied. There are a total of 39 break points with 35(64%) 
occuring in the short arms of chromosome 7* This suggestion of an
increased level of breakage in the short arms is more significant
\
than the values suggest because the short arms are only half the 
length of the long arms in this chromosome. 13(33%) of the 39 
break points are in the region of the band pl3> suggesting that 
this region of chromosome 7 is more susceptible to breaks than the
tm oiik-r III.36. — - * 1 ^  m i*nr r h r n - o ^ -  involving
— & : rhromosPTne number 5.
No. of 
breaks
Total 30
Figure 111,57. Break points for marker chromosomes involving
nhromosonie number 7
No. of 
breaks
1
9
13
Total 39
remaining regions of the chromosomes, and 9 (23%) are in the region 
of band pl5. Table III.9 shows that 32(61.5*f%) of the main clones 
found have at least one extra whole chromosome number 7 compared 
with the normal human karyotype, thus suggesting that no specific 
region of this chromosome is harmful to the cell if present in 
excess. As far as missing segments with respect to the normal 
chromosome complement is concerned, it is noticeable in fig.Ill.37 
that in 29 markers involving chromosome„7, 13(31*7%) are missing 
the segment between bands pl3 and pl3* However, by inspecting 
table III.9 it is evident that in most cases these apparent 
deficiencies are compensated for by extra normal chromosomes or 
other markers in which the segment is present. The only main clones 
in which the deficiency persists are those in cases Zfif and if5*
Fig.III.38 shows the break points for chromosome.8 in the 
markers studied. There are a total of 32 break points. The long 
arms of chromosome 8 are approximately twice the length of the 
short arms, so the presence of ll(3*f.*f%) break points in the 
short arms, and 21(65*6%) in the long arms does not suggest a 
non-random distribution of break points. However, a closer 
examination of fig.III. 38 suggests that the break points are 
non-random, with 8 (25%) break points occuring in the region of 
bands ql2 and ql3> 7(21.9%) occurring in the region of band q22, 
5 (1 5*6%) each occurring in the regions of bands pll and p21, and 
only 7 break points occurring in chromosomal regions other than 
these. Table III.9 shows that 3^(65*38%) of the main clones found 
have at least one extra whole chromosome number 8 compared with 
the normal'human karyotype, thus suggesting that no specific region 
of this chromosome is harmful to the cell if present in excess.
A part of chromosome 8 in the region of bands q21 and q22 is the 
segment most often missing in the total of 26 markers found
Figure III.58.. Break points for marker chromosomes involving
chromosome number 8
No. of 
breaks
 L
Total 32
(this is missing in 8 (3 0 .8%) of the markers involving chromosome 8). 
However, none of the main clones found were shown to be deficient 
in any chromosomal material, from chromosome 8, compared with that 
in the normal human karyotype.
So, an analysis of the break points in the marker chromosomes 
involving chromosomes 1 , 3 , 5 j 7  and 8  suggests that the breaks do 
not occur randomly over the whole lengths of these chromosomes. 
Consequently, specific chromosome segments are present in (and 
others absent from) more of the markers involving a particular 
chromosome than the other segments making up that chromosome.
There are several explanations which could account for this 
apparently non-random occurrence of break points, and these will 
be discussed later.
III.if. Comparison of different histological types
The histological analysis was carried out by the pathology 
department of St. Helier Hospital, and their reports were made 
available. The histological reports of all the tumours studied 
were examined, and each tumour was placed into one of four 
different histological types. These were (a)‘ adenocarcinomas,
(b) oat and small cell carcinomas, (c) undifferentiated carcinomas, 
and (d) squamous cell and epidermoid carcinomas. The distribution 
of the 32 tumours studied between the different histological types 
is given below.
(a) Adenocarcinomas 6 cases.
(b) Oat and small cell carcinomas k cases.
(c) Undifferentiated carcinomas 13 cases.
(d) Squamous cell and epidermoid carcinomas 29 cases.
Fi
gu
re
 
II
I.
59
. 
Hi
st
og
ra
ms
 
sh
ow
in
g 
di
st
ri
bu
ti
on
 
of 
mo
da
l 
nu
mb
er
s 
fo
r 
ea
ch
 
of 
th
e 
hi
st
ol
og
ic
al
 
ty
pe
s C
o
SM
O
%
o
o
£3
in-^ mc\J t- o
co
LT\ W  r -  O
O
£5M
O
O
<
P=i
PqM
Q
S
no
U
[
s a s e o J o
i n j - n  W  -r o  
j 0 q in n ji
o
M
o
%
o
oM
o
s
QM
cu
«a
►-3
w
o
CO
£3
o
noO’
CO
c
m
00
D oCO
m
n-
o
n-
«n
VO
CD
o  *°
VO 0
2
S3
I I
in 05 
^  *  
o
S
o
m
m
J-
o
-3"
m  m  c\j
In order to compare the modal numbers of these different 
histological types, histograms showing the number of cases with 
specific modal numbers were drawn for each of the histological 
types. These are shown in fig.III.39* In some cases the modal 
number was not restricted to one number (e.g. in case 15 an equal 
number of cells was found with 86 chromosomes and 88 chromosomes) 
and so they were allocated half a unit each in the histograms. 
Inspection of the histograms (fig.III.39) does not indicate a 
significance difference between the different histological types, 
with respect to modal number. The range of modal number covered 
by the different groups show a high degree of similarity, except 
for the oat and small cell carcinoma group (60-72 as compared 
with JfO-82, k2-72 and A4-88 for the adenocarcinomas, undifferentiated 
carcinomas, and squamous cell and epidermoid carcinomas 
respectively). This is probably because there are only k tumours 
in the oat and small cell carcinoma group. However, 3 of these Zf 
tumours have a modal number occupying the middle of the range 
covered by the other groups. If a larger sample had been studied 
the picture would probably have been clarified somewhat.
t
III.5. Comparison of modal numbers in different sexes
Of the 52 tumours studied, were from male patients
and l8(3*f.6%) were from female patients. The modal numbers found 
in the two sexes were compared by constructing histograms of numbers 
of cases with specific modal numbers for males and females 
separately. These are shown in fig.Ill.40. With the size of the 
sample studied here, neither of the histograms shows a peak modal 
number with a specific distribution pattern. The modal numbers 
appear to be randomly distributed within the range of A-l-78 for
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females, and ZfZf-88 for males, with no obvious differences in overall 
pattern between the two histograms. It appears therefore that in 
this study there is no apparent difference between the modal numbers 
of the male tumours and those of the female tumours.
III.6. Analysis of modal number with respect to age
In order to determine whether or not there was any 
correlation between modal number and age of the patient from which 
the tumour was removed, a scatter diagram was plotted of age against 
modal number for each tumour studied (fig.Ill.Zfl). In fig.III.41 
the points which are ringed indicate that two points are superimposed 
and points with a dotted ring around them indicate a modal number 
in a tumour in which two modal numbers were found (i.e. both modal 
numbers are recorded and a dotted ring is placed around them both). 
Most of the points in the scatter diagram are between the ages of 
50 and 70 (only if patients were younger than 50, and if older than 
70) with what appears to be a random distribution of modal numbers 
within the range ifl-88, though there is a slight tail off towards
t-
the limits of the range, particularly the upper limit. A correlation 
coefficient calculated using data from all points of the scatter 
diagram fig.III.ifl gives a value of -0.15 which is not significant, 
thus showing that in this study there is no correlation between 
age of patient and modal chromosome number in human lung tumours.
III.7* Analysis of a metastasis
\
In one of the cases studied, tumour tissue was obtained 
post mortem from what was later reported histologically as being a 
primary lung tumour (adenocarcinoma), a metastasis in a different
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lobe of the same lung, and a metastasis in the heart. Although 
this was the only case in which any metastatic material was obtained 
it was considered worthwhile to study the metastatic material and 
compare the findings with those of the primary tumour.
The distributions of metaphase spreads with respect to chromosome 
number for each of the three tissues are shown in histogram form 
in figs.III.42-44* The three histograms are very similar, each 
resulting in a quasi normal distribution pattern with most of the 
metaphases having a chromosome number within the range 50-65- 
All three histograms have a small group of metaphases with 
chromosome numbers greater than 100. The modal numbers for the 
primary tumour and the two metastases are 58, 54. and 55 respectively
On analysis of banded preparations, three clones were found in 
the primary tumour, and two clones were found in each of the 
metastases. The karyotypes of all the clones found are formulated 
in table III.14 where a formula of 46XX represents the normal (the 
patient was female), and extra and missing chromosomes are denoted 
by + and - respectively. The markers were designated A,B,C etc in 
the order in which they were discovered. Marker A is the same
i-
chromosome throughout, as is marker B and so on (i.e. the chromosome 
designated A in the primary tumour main clone is identical to the 
chromosome designated A in any of the other clones in this case).
The formulae display a high degree of similarity. The common 
features being: one extra of each of chromosomes 5>7 and 8, 
two extra number 20 chromosomes, one each of marker chromosomes 
A and B, and two marker chromosome E's.
\
These findings suggest that all the clones found are closely 
related. Inspection of table III.14 shows that the main clone 
found in the metastasis of the.lung is identical karyotypically to 
one of the sub-clones found in the primary tumour. This suggests
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that a cell which was previously a member of this sub-clone (34XX) 
in the primary tumour broke away from the primary tumour and travelled 
to a different site in the lung where it became the progenitor cell 
of the lung metastasis. The sub-clone 58XX in the lung metastasis 
presumably has developed from the main clone during a process of 
clonal evolution, and still retains the abnormal features of the 
main clone but has acquired an extra number 3 chromosome, an 
additional number 7 chromosome, an additional E marker chromosome 
and a new 6 marker chromosome.
The origin of the heart metastasis is not as clear. Itfs main 
clone has a D marker chromosome and so presumably was derived from 
one of the clones with a D marker chromosome in the primary tumour.
It seems less likely that the main clone acquired the D marker 
chromosome in the heart after being derived from a cell not having 
this marker. Sub-clone 59XX in the primary tumour has no 
chromosome number 22 and as both clones found in the heart metastasis
s'
have two normal number 22 chromosomes it seems unlikely that either 
of them developed from this sub-clone. Therefore, the suggestion is 
that a cell broke away from the main clone of the primary tumour,
i
lodged in the heart and developed into a metastasis. During this 
clonal development, the main clone found in the heart metastasis 
resulted, followed by the sub-clone 58XX.
Although this is only a single instance of an analysis of both 
primary and metastatic lung tumour material and so cannot be 
presumed to be representative of lung tumours generally, the results 
do indicate a. close: relationship between, the primary tumour and the 
metastases, and there is a clear suggestion of a continued clonal 
evolution during the metastatic process.
The results presented in this study are from 52 cases of 
bronchial carcinoma. However, 66 tumour specimens from different 
patients were received but 14(21.2%) failed to grow in culture. 
The reasons for this are not apparent (except for two specimens 
which were heavily contaminated with a fungus). None of the 
patients had undergone either chemotherapy or radiotherapy prior 
to removal of the tumour. The specimens which failed to grow 
were not restricted to any particular histological group, and the 
relative numbers in each group are given in table III.14.
There is an indication therefore of limitations in the culture 
techniques.
Table III. 14.
Specimens which failed to grow, divided into different histological 
groups
Histological type 
of carcinoma
Number of cases 
with results
Number which 
did not grow
Epidermoid and 
squamous cell
29(43-9%) 8(12.1%)
Undifferentiated
Oat and small cell
13(19-7%)
4(6.0%)
3(4-5%)
2(3-0%)
Adenocarcinoma 6(9-1%) 1(1.5*
Total 52 14
N.B. The percentages quoted are from a total of 66.
f isurea ruutugrapna i rom a represemaxive sample 01 cases
showing the marker chromosomes found
Figure III.45. Case 4
1 B 22 A C
1 = Normal number 1 chromosome.
B = Number 1 chromosome with the short arms deleted.
22 = Normal number 22 chromosome.
A = Isochromosome for the long arms of chromosome 22.
C = An unidentifiable marker chromosome.
Figure 111.46. Case 8
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A = Number 1 chromosome with most of the short arms deleted.
1 = Normal number 1 chromosome.
B = Number 1 chromosome with most of the long arms of a number 5 chromosome
translocated onto the terminal part of its long arms.
5 = Normal number 5 chromosome.
3 = Normal number 3 chromosome.
D = Number 3 chromosome with deleted long arms and deleted short arms.
18 = Normal number 18 chromosome.
E = An unidentifiable marker chromosome.
C = An unidentifiable marker chromosome.
F = An unidentifiable marker chromosome.
Figure III.47. Case 18
* I
B 13
1 = Normal number chromosome,
C = Number 1 chromosome with deleted short arms,
3 = Normal number 3 chromosome,
B = Number 3 chromosome with deleted long arms and deleted short arms,
13 = Normal number 13 chromosome,
A = Number 13 chromosome with the long arms of a number 7 chromosome 
translocated onto its short arms,
7 = Normal number 7 chromosome.
Figure 111,48. Case 22
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3 = Normal number 3 chromosome.
B = Number 3 chromosome with a pericentric inversion(break points p14 and q25).
5 = Normal number 5 chromosome.
A = Number 5 chromosome with the long arms of a number 5 chromosome
translocated onto the terminal part of its long arms.
7 = Normal number 7 chromosome.
E = Number 7 chromosome with deleted short arms.
1 = Normal number 1 chromosome.
D = Number 1 chromosome with deleted long arms and deleted short arms.
F = An unidentifiable marker chromosome.
G = An unidentifiable marker chromosome.
Figure III.49. Case 34
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1 = Normal number 1 chromosome.
B = Number 1 chromosome with an unidentifiable banded segment
translocated onto the terminal part of its short arms.
8 = Normal number 8 chromosome.
A = Number 8 chromosome with two extra bands on the terminal part
of its long arms.
Figure III.50. Case 41
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1 = Normal number 1 chromosome.
A = Number 1 chromosome with deleted short arms.
3 = Normal number 3 chromosome.
B = Number 3 chromosome with half its short arms deleted.
10 = Normal number 10 chromosome.
G = Number 10 chromosome with an additional band on the terminal part
of its long arms.
H = An unidentifiable marker chromosome.
E = An unidentifiable marker chromosome.
Figure III.51 . Case 49
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F = Number 2 chromosome with an additional segment translocated onto the 
terminal part of its long arms.
2 = Normal number 2 chromosome.
7 = Normal number 7 chromosome.
B = Number 7 chromosome with deleted short arms.
16 = Normal number 16 chromosome.
D = Number 16 chromosome with an additional segment translocated onto
its long arms.
E = An unidentifiable marker chromosome.
Figure III.52. Case 55
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7" = Normal number 7 chromosome.
B = Number 7 chromosome with its short arms replaced by the short arms 
of a number 8 chromosome.
8 = Normal number 8 chromosome.
13 = Normal number 13 chromosome.
C = Number 13 chromosome with deleted long arms.
A = An unidentifiable marker chromosome.
E = An unidentifiable marker chromosome.
Section IV 
DISCUSSION.
IV .1. Chromosome number
The quasi normal distribution patterns for chromosome number 
suggest that there is a predominant cell type, with respect to 
chromosome number, within each of the human lung tumours studied. 
Even though only 100 cells were analysed from the millions of cells 
which make up each tumour, the high degree of similarity in the 
distribution patterns of all the cases studied suggests that the 
results give a true representation of the cells in each of the 
tumours, at least with respect to chromosome number.
There is a possibility of bias entering the study through 
culturing. Tumours comprise a heterogenous cell population and 
so it is possible that certain karyotypes are more advantageous 
to the cell than other different karyotypes. Consequently there 
could be an active process of selection with respect to survival 
and proliferation of karyotypically different cells. Culture 
conditions are not identical to the in vivo conditions which the 
tumour cells experience and so it is unlikely that the selective 
pressures will be the same. Therefore, it is possible that 
karyotypes having the greatest selective advantage in vivo are 
different from karyotypes having the greatest selective advantage 
in culture. It follows, that the longer the culture period is, 
the greater the chance that the cultured cells will be significantly 
different from the in vivo tumour cells. Ideally therefore, when 
examining tumour material cytogenetically, direct preparations 
should be used. However, because of technical limitations in 
obtaining adequate numbers of good quality metaphase spreads, 
short-term culture techniques are sometimes employed.
The pilot study reported here indicates that there is no 
significant karyotypic change, at least with respect to chromosome
number, in the tumour cells during culture periods up to one month 
and involving If passages. As the results of the main study are 
from cells cultured for less than two weeks without subculturing, 
it seems reasonable to assume that they are an accurate indication 
of the in vivo tumour cells. In retrospect, it would have been 
preferable to have carried out a complete analysis on banded 
preparations in the pilot study in order to have been certain that 
the similarity of the cultured cells was as great as the results 
from unbanded preparations suggested. It Is possible that 
chromosomal changes, noticeable only in banded preparations, could 
have occurred in culture. The results of the main study indicate 
that there is a high degree of similarity between the cultured cells 
of individual cases, and all of the cells have a grossly abnormal 
karyotype compared with the normal human karyotype. The metaphase 
spreads analysed for each tumour came from cultures containing 
several clones (each of which had arisen from a cell from the 
in vivo tumour tissue) and it seems extremely unlikely that the 
same anomalies have originated in several different clones in the 
short-term culture periods employed. It is much more likely that 
the anomalies were present in the in vivo tumour cells and that 
the results reported are representative of these cells. This 
assumption is supported by the fact that direct preparations showed 
grossly abnormal chromosome numbers in the pilot study, indicating 
that some chromosome anomalies are certainly present in the in vivo 
tumour cells, and also by the demonstration of identical marker 
chromosomes which were persistent throughout the total culture 
periods involving four passages and were also present in the direct 
preparations.
The modal numbers of the 52 cases studied varied considerably, 
but most of them were hyperdiploid. The number of chromosomes in
an unbanded karyotype may be held to indicate the total amount of 
genetic material present in the cell: previous observations that 
tumour cells are characterised by hyperdiploid chromosome numbers 
are consistent with observstions on the elevated DNA content of the 
tumour cells (Atkin and Richards 1956, Atkin et al 1966, Greisen 
1971, Dixon and Stead 1977). However, without banding, different 
chromosomes of the normal karyotype (particularly numbers 6-12) 
are difficult to identify, and some marker chromosomes being of 
similar dimensions to some normal chromosomes are indistinguishable 
from them on morphological criteria alone. If chromosome breakage 
and rejoining has occurred, the number of chromosomes present could 
vary without necessarily implying a change in the total amount of 
chromosomal material, and it may equally be difficult to distinguish 
between cells having the same number of chromosomes but constituted 
differently.
It follows therefore that the chromosome number of an individual 
tumour cell, and hence the modal chromosome number of a tumour 
cell population, gives information of little significance. Unbanded 
studies can provide relative evidence of total chromosome length, 
but such an estimate would be less accurate as an indication of 
the total amount of genetic material present than direct DNA 
measurement. Moreover, it does not permit the confident assignment 
of extra chromosomal material to an origin in a particular 
chromosome of the normal set.
Of the 52 cases studied, 5 were found to have a hypodiploid 
modal number, and only 370 cells out of a total of 5>115 examined 
in the total study were found to be hypodiploid. Hypodiploid cells 
are found but rarely In the study of human cells, it being 
generally assumed that the state is prejudicial to the viability 
of the cell. In the present series however, hypodiploidy of
chromosome number cannot by itself be taken to imply a deficiency 
of genetic material. Translocation or fusions could result in a 
decrease in chromosome number without a loss of chromosomal 
material, and if combined with duplications and/or non-disjunction 
an excess of chromosomal material could exist within a hypodiploid 
cell. Whether or not there is in these cells a deficiency of 
chromosomal material can only be determined from a study of banded 
chromosome preparations.
IV.2. Banded preparations
A clear finding of this study has been the observation that 
cells having the same chromosome number do not necessarily have 
identical karyotypes, and therefore do not necessarily contain the 
same genetic information. It has been shown that the modal class 
of chromosome numbers in each tumour contains several different 
karyotypes, distinguishable by chromosomal banding. On the 
assumption that cells with identical karyotypes have common and 
recent ancestry, the cells constituting the largest group with 
identical karyotypes in each modal class have been designated a 
"clone” : smaller numbers of cells with other common karyotypes 
have been designated nsub clones” . It has been found possible to 
apply a similar analysis and nomenclature to classes of chromosome 
number other than the modal one in each tumour cell population.
Because of the technical limitations in the study of the 
chromosomes in human lung tumours, the samples studied are 
relatively small compared with the total number of cells present 
in the tumours. Therefore, the relative significance of the 
various karyotypically different sub-populations of cells in each 
tumour is not necessarily reflected by the proportions of the
different clones found in the analyses. It Is conceivable that if 
a larger sample had been studied more clones (as defined in this 
study) would have been discovered in many of the tumours, and also 
that the relative numbers comprising each clone could have been 
different. It must not be assumed therefore that the cells in the 
main clone are the dominant cells of the whole tumour cell 
population, exerting more influence than the remaining cells. 
However, irrespective of whether or not the results described, 
accurately represent the karyotypes of the tumour cell populations 
sampled, it is clearly inappropriate to regard the cells 
constituting the modal number class as constituting a group of 
cells predominating in the tumour by virtue of a common genetic 
constitution and with a different origin from the cells in the 
non modal classes. The concept of a llstemlineM in tumour 
progression will be discussed further in a subsequent section.
A remarkable degree of similarity between the sub-clones and 
main clone of each tumour studied is demonstrated. Even though 
the chromosome constitutions of all the clones found are grossly 
abnormal compared with the normal human karyotype, the degree of 
heterogeneity within each tumour is not great, thus suggesting 
that the main clone and sub-clones are closely related. For each 
tumour studied several common markers were found in all the 
different clones and also in the remaining cells which were 
analysed. Also, many of the numerical chromosome abnormalities 
were common to all cells analysed for each case. This evidence 
strongly suggests that each tumour cell population has a single 
ancestral cell. This implies that the tumour cell population 
is a clone as defined in ISCN(1978) (a population of cells derived 
from a single progenitor cell) and that the heterogeneous nature 
of the cells is a result of sub-clonal evolution.
IV.3. Marker chromosomes
Chromosome banding techniques have allowed for the 
identification of many of the marker chromosomes present in the 
human lung tumours studied. However, even with the use of these 
techniques some markers were still not identifiable. The results 
reported here indicate that involvement of the different chromosomes 
in marker formation is non-random. It is possible that the 
unidentifiable markers have been formed from the chromosomes which 
appear to be involved in marker formation considerably less than 
the others and that this has resulted in an apparently higher level 
of involvement of the chromosomes comprising the identifiable1 
markers, when the levels of involvement of the two groups are actually 
comparable. This could be the case with the F and G group 
chromosomes which show an apparently low level of involvement in 
marker chromosomes. The chromosomes of these groups could be 
difficult to recognise in markers because of ( a) their small size 
(b) their lack of prominent bands. However, this argument could 
not be applied to the larger chromosomes showing a relatively 
small degree of involvement in marker chromosomes (e.g. chromosomes 
if and 6). These chromosomes have banding patterns which are as 
distinct as those for chromosomes 1,3>5>7 and 8 and yet the 
disparity of the involvement in markers of the two groups Is well 
marked.
Although the number of unidentifiable markers found in this 
study seems high, they only represent approximately 1.5 different 
markers per clone studied (1.^8 for the main clones and 1.56 for 
the sub-clones; see p. 91 of results section) as compared with 
3.6 different identified (or partly identified) markers per clone.
Many of tEe unidentifiable markers are small chromosomes, often
smaller than a normal G group chromosome, with no distinguishing 
bands, but stained homogeneously over the whole length of the 
chromosome. Some of the marker chromosomes were relatively long 
and contained many bands, but the band sequences could not be 
Identified as originating from specific chromosomal regions.
These long markers are probably the results of complex 
rearrangements involving more than two chromosomes, or may involve 
breakages and rejoinings at positions within an otherwise easily 
recognisable banding sequence. In routine clinical cytogenetics 
one is dealing with karyotypes which deviate only slightly from 
the normal pattern. In attempting to identify unbalanced 
translocations in a patient one is often able to study the same 
translocation in a balanced form in a relative of the patient.
This allows for a much easier identification of chromosome 
segments involved in the translocation. Solid tumours, particularly 
carcinomas exhibit much more complex karyotypic rearrangements 
than the leukaemias (Mitelman and Levan 1978) and so they are 
considerably more difficult to analyse accurately. Consequently, 
there is a relative scarcity of reported karyotypic analyses of 
carcinomas compared with those of leukaemias and other 
myeloproliferative disorders,
IV.A. Chromosome breakage in formation of markers
Before a marker chromosome can be formed, chromosome breakage 
must occur. It follows that the resultant markers will be 
dependent upon the points at which chromosome breakage occurs, and 
the translocation of chromosome segments resulting from the breaks.
The results presented in this study on the break points found 
In markers involving chromosomes 1,3>5>7 and 8 at first sight
indicate that the break points are specific* Perhaps there are 
11 fragile sites” which are more susceptible to breakage than the 
rest of the chromosome. There could be more of these sites on 
chromosomes 1,3*5*7 and 8 than on the other chromosomes; or there 
could be a differential ”fragility” , the sites on chromosomes 
^>3*5*7 and 8 being more ”fragile” than the sites on the other 
chromosomes, to account for the preponderance of markers involving 
these chromosomes. On the other hand, the break points could be 
occurring randomly, but because of technical limitations in 
analysing the banded chromosomes it appears as though non-random 
breakage is occurring. Certain break points could be difficult to 
detect if they occurred within chromosome segments which were not 
banded noticeably. With solid tumours, and as demonstrated in the 
lung tumours studied here the chromosome markers are often the 
result of complex rearrangements and rearrangements involving 
small segments and so they are considerably more difficult to 
identify than simple translocations such as is involved In the 
Philadelphia chromosome In chronic myeloid leukaemia. Some markers 
probably result from sevefal successive rearrangements and so their 
original banding pattern is lost. The failure to recognise the 
break points in such situations could account for the apparent 
indication of non-random breakage. Another possibility which 
would account for the findings here is that random breakage is 
occurring but a differential viability results depending upon 
positional effects due to the translocations of certain genes or 
combinations of genes, and different interactions between these 
genes. The separation or linkage of specific genes could give a 
cell a selective advantage for proliferation within the given 
environment whereas other combinations could be lethal or at least 
have a low viability. In any event the result is the appearance of
a differential excess of certain chromosome segments, and it is 
probable that the important significant factors are restricted to 
small chromosomal regions within these segments; perhaps to only
a small number of genes. The.importance of small chromosomal 
regions as opposed to specific break points is suggested by reports
of 13q deletions in sporadic bilateral retinoblastoma (Francke 1976), 
where several patients have been reported as having different 
amounts of 13q deleted but the only deleted region showed to be 
common is the band 13qlij.. Similarly in the aniridia-Wilms1 tumour 
association with mental retardation, cases have been reported 7/ith 
varying segments of the short arms of chromosome 11 deleted, but 
the only region deleted in all cases is restricted to the narrow 
band pl3 (Francke £t al 1979). It should be mentioned however, 
that these deletions are not restricted to the tumour cells, but 
are congenital karyotypic anomalies present throughout the affected 
individuals different tissues.
In the lung tumours studied here the results suggest that 
chromosomes 1,3>5>7 and 8 are involved in the markers to a 
considerably greater extent than the remaining chromosomes.
Whether they are preferentially involved in chromosome breakage 
and the consequent formation of marker chromosomes cannot be 
proved or disproved, but the fact that they are present in markers 
more than the other chromosomes could suggest that the presence 
of extra segments of these chromosomes is an important feature of 
the tumour cells. It is noticeable from this study that these 
same chromosomes (1,3>5>7 and 8) are also the chromosomes most 
often involved as extra whole chromosomes, suggesting that the 
markers are not essential as they are not the only mechanism by 
which the cell gains extra genes which are present in these 
chromosomes. Perhaps the markers arise before the extra
chromosomes appear. This argument would then be invalidated and 
the extra normal chromosomes could be an insignificant side effect. 
Studies should be performed on early neoplasms, but in bronchial 
carcinomas diagnosis is usually made when the tumours are in a 
relatively late stage of malignancy, so this is at present not 
possible.
IV.5« Non-random chromosome involvement in abnormalities
The degree of involvement of the sex chromosomes in the 
various anomalies was found to be relatively small compared with 
that of most of the autosomes, and for reasons mentioned in the 
results sections they were not included in the statistical 
comparisons. An exception to the apparent lack of involvement of 
the sex chromosomes is the number of times the Y chromosome was 
found to be missing (in 87 cells of the total cells analysed, which 
is more often than for several of the autosomes; see table III.13)* 
Although lymphocyte cultures were not analysed in order to determine 
the constitutional karyotype of each patient, the fact that in no 
case were all the cells lacking a Y chromosome suggests that the 
Y chromosome was present in the normal cells of the male patients. 
Court-Brown (1967) in population studies showed that older males 
and females tend to lose the Y or an X chromosome respectively, 
and as most of the tumours studied were from patients aged between 
50 and 70 years, this process could account for the cells found to 
be missing the Y chromosome. The greater number of cell divisions 
accumulated within the tumour compared with that in normal cells 
could mimic the ageing process. However, this would not account 
for the low number of cells found with an X chromosome missing.
One might expect that a late replicating inactivated X chromosome
would be more easily lost in tumour cells than in normal cells 
because of the rate of cell division. Perhaps X chromosomes are 
being lost by these means but are also tending to be retained as 
extra chromosomes (in a similar way to many of the autosomes) with 
a net result that there is an apparent lack of participation of 
the X chromosome in the numerical anomalies.
With regard to the autosomes, it appears from the results 
presented in this study that their involvement in both numerical 
and structural chromosomal abnormalities Is clearly non-random.
A differential participation of the chromosomes in abnormalities 
is in agreement with pre-banding studies of Granberg (1971)* in 7 
carcinomas of the cervix, who concluded that there were significant 
gains in C group chromosomes and losses in B,D and G group 
chromosomes, and of Mark (1971) in 50 gliomas. Both Granberg and 
Mark thought that they had without doubt demonstrated the presence 
of specific chromosome changes. Because of the improved precision, 
in establishing chromosome changes, afforded by the development of 
chromosome banding techniques most workers now agree that the data 
from experimental as well as from human material clearly demonstrate 
that the chromosomes are differentially involved in abnormalities 
associated with the development of neoplasia (e.g. Fleischmann et. al 
in malignant lymphomas 1971> Manolov and Manolova In Burkitt 
lymphomas 1971* Mark et al in meningiomas 1972 a and b; see also 
reviews by Atkin 1976, Harnden 1977* Levan et al 1977* Mark 1977* 
Rowley 1977)• Levan and Mitelman have compiled reported data 
which demonstrate clearly that chromosome anomalies in human 
neoplasia tend to cluster to specific chromosomes (Levan and 
Mitelman 1975; Mitelman and Levan 1976; Mitelman and Levan 1978) 
and that a particular chromosome type tends to exhibit the same 
kind of aberration in different cases of one class of neoplasm.
It is noticeable from Mitelman and Levan’s 1978 study that most of 
the data are concerned with chromosome aberrations in 
myeloproliferative disorders. Of the 856 cases included in the 
survey, excluding Philadelphia chromosome positive cases of chronic 
myeloid leukaemia with no additional anomaly, the myeloproliferative 
disorders comprise more than 65%» Carcinomas are grouped together 
and account for only 43 of the 856 cases. Most of these were 
metastatic effusions, only 12 (none of which are bronchial carcinomas) 
being primary tumours. So, even though malignant epithelial tumours 
are the most common malignancies in man, there is a relative 
scarcity of data from banded chromosome.analyses in these tumours.
This is undoubtly because of the greater technical difficulties 
encountered in obtaining good quality banded chromosomes from 
carcinomas compared with those for the myeloproliferative disorders. 
Even though the number of cases of carcinoma is only 43 there is an 
indication of a differential involvement of the chromosomes in the 
aberrations, with chromosomes 1,3,5,7 and 8 being involved in 
these aberrations considerably more than the other chromosomes.
The relatively high level of involvement of chromosomes 1,3,5>7> 
and 8, compared with the other chromosomes, in the aberrations, is 
in agreement with the findings of this study, where the former are 
shown to be involved significantly more than the other chromosomes 
in both extra chromosomal material and marker chromosomes.
However, the significantly low level of involvement of chromosomes 
2,4 and 6 in these anomalies is not indicated in the data from 
Mitelman and Levan’s survey (1978); but perhaps the overall 
picture will alter as more data are collected and added to their 
rather small number of cases. The significantly high incidence 
of-chromosome 15 in a monosomic state in this study cannot be 
compared with Mitelman and Levan’s data which regrettably does
not include separate information on missing chromosomes.
Mitelman and Levan (1978) have grouped the frequencies of 
involvement in numerical and/or structural aberrations together, 
and do not appear to have carried out a detailed numerical 
analysis of the results. Their data could have been more 
convincing if extra chromosomes, missing chromosomes and 
chromosomal rearrangements had been presented separately; and a 
^numerical analysis performed rather than using arbitrary criteria 
for determining ’’selective involvement” of certain chromosomes.
The most obvious physical differences between the different 
chromosomes are their different lengths. Theoretically one might 
expect to find a differential participation of the chromosomes in 
the observed aberrations because of the differences in their 
lengths (see page 78 section Ill.ii.a.). The findings and 
statistical analysis in this study confirm this hypothesis to 
some extent. A highly significant negative correlation was shown
s '
between involvement in chromosome loss and chromosome length, 
and a significant positive correlation was shown between 
involvement in extra chromosomal material and chromosomal length. 
However, this correlation between involvement in extra chromosomal 
material and chromosome length was not demonstrated until the 
markers were included in the analysis. A significant positive 
correlation was also shown between involvement in marker 
chromosomes and chromosome length. These findings are not in 
complete agreement with the findings of Mitelman and Levan (1978) 
who for their collected data only showed a negative correlation 
between chromosome loss and chromosome length, with both chromosome 
gain and structural aberrations showing no correlation, with 
chromosome length. Mitelman and Levan did not present a 
statistical analysis comparing chromosome involvement in the
aberrations and chromosome length, but they did give a correlation 
coefficient (-0.526) significant at the 1% level for chromosome 
length and chromosome loss. A more extensive analysis of their 
data, in a similar way to the analyses presented in this study, 
would perhaps have yielded more important results regarding the 
involvement of specific chromosomes or groups of chromosomes in 
aberrations in relation to chromosome length. It should also be 
remembered that only 43 of the 856 cases in their data were from 
carcinomas, so a direct comparison should be viewed with caution.
It was noticeable that the number of cells found in the total 
study with overall missing chromosomal material, compared with 
the normal human karyotype, was considerably lower than the 
number of cells exhibiting extra chromosomal material. It is 
questionable whether or not these anomalies are a significant 
factor in the aetiology and progression of the malignant process. 
Also, relatively more chromosomes are found to be involved in 
extra chromosomal material than in missing chromosomal material.
This situation is in agreement with chromosomal abnormalities 
found in newborn infants, where the occurrence of hyperdiploidy 
(usually in the form of trisomies) is considerably greater than the 
occurrence of hypodiploidy (e.g. monosomies). It could be that 
the reduced viability is more severe in monosomies than in trisomies, 
and that more monosomies are spontaneously aborted than trisomies, 
but analyses of chromosome abnormalities in spontaneous abortuses 
does not suggest this. 45^0 is the most frequent single anomaly 
demonstrated, accounting for about 20% of the cases. Triploidy 
and tetraploidy account for about 15/o and 3% of cases respectively. 
The trisomies as a group account for about 30% of cases; and 
mosaics and translocations for about 10% (Carr 1965>1967;
Inhorn 1967, Levson and Titus 1970). Only rarely Is autosomal
monosomy found (Kajii et al 1973) • It is possible however, that 
the viability is reduced to such a degree in cases of monosomy 
that they are usually aborted at too early an age to be found in 
abortuses, perhaps even before implantation has occurred.
In this respect, from the results presented in this study it is 
noticeable that chromosomes 7 and 8 were never found to be present 
as a monosomy, and chromosome 4 was only found as a monosomy in 
2 cells out of a total of 1,347 cells analysed. Perhaps there are 
genes on these chromosomes which are essential for the cell to be 
viable.
The chromosome abnormalities found in this study of human lung 
tumours are much more pronounced than in most previously reported 
cytogenetic studies of human malignancies. The abnormalities 
found in the lung tumours are always multiple whereas in other 
studies, particularly of myeloproliferative disorders, there are 
often only single abnormalities: e.g. the Philadelphia chromosome 
in chronic myeloid leukaemia (Mitelman and Levan 1978), the 20q- 
marker chromosome in polycythaemia vera (Reeves et al), the 14q+ 
marker in Burkitt’s lymphoma (Manolov and Manolova 1972).
Whereas it seems reasonable to assume that such specific marker 
chromosomes probably play an important role in the aetiology 
and progression of their related tumours, it is doubtful that all
the chromosome abnormalities found in the lung tumours in this 
study are important factors in the aetiology and progression of 
these tumours, even though they are obviously specific 
abnormalities. It is possible that some of the abnormalities 
are important in these processes however. Alternatively, 
chromosomes 2,4 and 6 showed little involvement in extra, missing 
or marker chromosomes. It could be that the balance of various 
genes in these chromosomes is an Important factor and that most
of the chromosome abnormalities found are insignificant factors 
in the malignant process. Some ideas on the relevance of 
chromosome abnormalities to the neoplastic process will be 
discussed later (section IV.9)*
IV.6. Histological type, sex and age
No obvious differences in the karyotypes for the different 
histological types, sexes or ages was immediately apparent from 
the results obtained in this study and it was not considered that 
a detailed comparison of the different chromosome abnormalities 
could be performed because of the small samples studied, 
particularly in the case of the different histological types, 
where oat cell carcinoma and adenocarcinoma were represented by 
only 4 and 6 cases respectively of the 52 cases studied. However 
a comparison of the modal numbers for the different histological 
types, sexes and ages illustrated no significant differences in 
each category (see sections III.if, III.5 and III.6).
If future similar studies are carried out then the results 
could be pooled in order to give a larger sample and enable a more 
accurate comparison of the chromosome abnormalities found in the 
different groups for each category. However, in such an analysis 
care would have to be taken in classifying the different cases.
Age and sex are straightforward enough, but definite criteria 
would have to be adopted for classifying each of the different 
histological groups. In this study the histological classification 
was based on the hospital pathologist1s report, but some cases are 
difficult to place in a specific histological group with certainty.
IV.7. Concept of stemline
On the basis of chromosome counts in several mouse ascites 
tumours Levan and Hauschka (1953) concluded that the numerically 
largest group of cells comprising members having the same number 
of chromosomes, and adjacent groups (with respect to chromosome 
number), represent the types mainly responsible for growth and 
characterise the principal stemline of each tumour. Makino (1957a) 
from studies of the chromosomes of rat ascites tumours proposed a 
hypothesis which stressed the presence of a stemline (or stemlines) 
of tumour cells in each tumour. The members of a stemline were 
termed stem cells and served as the primary progenitors of the 
growing tumour. It follows from these usages that a stemline 
need not be homogeneous with respect to chromosome constitution, 
and that more than one stemline can coexist within a single tumour.
The stemline of a tumour cell population is now usually defined 
as comprising the cells with the most frequent chromosome 
constitution at the time that it is observed in a direct preparation 
or following short-term culture (ISCN 1978). Presumably, this 
definition is supposed to be concerned with the group of cells 
exerting most influence within the tumour cell population, but is 
restricted to a much narrower band of cells (only cells with 
identical karyotypes) than the term as used by Levan and Hauschka 
(1953)> and Makino (1957a )«
The situation suggested by this more recent definition (ISCN 1978) 
is easily envisaged for tumours whose karyotypes deviate only to a 
small degree from the normal diploid karotype. For example, in 
Philadelphia chromosome positive cases of chronic myeloid leukaemia, 
the Philadelphia chromosome is usually the only chromosome anomaly.
In the acute phase however, further chromosome changes are often
noted (e.g. isochromosome 17q, trisomy 8) and a mosaic pattern of 
karyotype can result. (see fig.IV.1). If, from 50 cells analysed 
20 still have only a Philadelphia chromosome as an abnormality, 25 
have the Philadelphia plus an isochromosome for 17q and the 
remaining 5 cells have trisomy 8 in addition to the two abnormalities 
already mentioned then it seems reasonable to assume that the first 
acquired anomaly was the Philadelphia chromosome followed by the 
isochromosome 17q> followed by the trisomy 8, and so the clone has 
evolved from a stem cell having a Philadelphia chromosome as the only 
anomaly. The cells having this single anomaly would represent the
stemline in the chronic phase of the disease. In the acute phase
/■
however, if the findings were as exampled above, the stemline 
would be represented by cells having an isochromosorae 17q in 
addition to a Philadelphia chromosome. Perhaps, with further 
passage of time cells having a karyotype with a .Philadelphia 
chromosome, an isochromosome 17q and trisomy 8 would become the 
most numerous cell type, and so they would be designated as 
comprising the stemline of the leukaemia. It follows that the 
stemline of a tumour, as understood by this definition, would be 
constantly changing as the tumour progresses.
As most solid tumours are diagnosed in a late stage of malignancy 
(particularly relevant to carcinomas of the lung) and show a 
considerably more marked degree of chromosome abnormality (often 
involving numerous trisomies and complex rearrangements as 
demonstrated for lung tumours in this study), than found in the 
myeloproliferative disorders, it seems reasonable to assume that 
these grossly abnormal karyotypes bear little resemblance to that 
of the original progenitor cell from which the tumour developed.
It is unlikely that many abnormalities occurred at the same time 
early in the development of the tumour. The first anomaly probably
FIGURE 17.1. A diagrammatic representation of the karyotypic development
in Philadelphia chromosome positive chronic myeloid ■ 
leukaemia
ACUTE CRISIS
46 Ph’ i(l7q)46 Ph’
46 Ph1
KARYOTYPE
only involved a single chromosome or translocation between two 
chromosomes and a considerable degree of clonal evolution has 
probably occurred subsequent to neoplastic transformation. It 
follows that the stemlines (as defined above, ISCN 1978) of the 
lung tumours presented in this study are not an accurate 
representation of the karyotypes of the tumour cells which were 
present early in the neoplastic process, though there could well 
be common abnormalities which have been maintained throughout the 
clonal evolution and malignant progression of the tumour.
The karyotypes obtained for the tumour cells of case 30 analysed 
in this study are represented in table IV.1. Although there are 
17 different karyotypes amongst the 27 cells analysed, all of the 
27 cells have several common anomalies, thus suggesting that they 
have developed from a single ancestral cell. When compared with 
the normal human karyotype all 27 cells have 2 extra number 1 
chromosomes, 2 extra number 5 chromosomes, 1 extra number 7 
chromosome, 1 extra number 17 chromosome, 1 chromosome 20 missing 
and the following marker chromosomes: 1 A (a number 8 chromosome 
with deleted short arms and an additional unidentifiable chromosome 
segment), 1 B (a number 7 chromosome with the distal q band replaced 
by the long arms of a number 12 chromosome), 2 G's (a number 3 
chromosome with the distal half of the short arms deleted), and 
2 E*s (unidentifiable small metacentric chromosomes). If these 
27 cells can be regarded as a true sample it would seem reasonable 
to assume that all of the malignant cells in the tumour have 
descended from a cell or cells having these anomalies, but it is 
unlikely that the original progenitor cell of the tumour clone 
suddenly acquired all of these anomalies. It is probable that 
the karyotype of this progenitor cell much more closely resembled 
that of the normal human diploid cell and that through the process
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of clonal evolution cells having karyotypes somewhere between that 
of the original progenitor cell and that showing the common anomalies 
listed above have been lost. In such a situation therefore, it is 
difficult retrospectively to plot a sequence of chromosome changes 
which have occurred, during the progression of the tumour, with a 
significant level of certainty. Suggestions can be made based only 
on the relative proportions of cells found with different karyotypes. 
In the case exampled in table IV.1. the sequence of chromosome 
change is not even clear within the karyotypes found. The 
permutations are too numerous to mention. Case 30 is taken as an 
example, but any of the other cases would have demonstrated the 
same pattern, but involving different chromosomes.
According to the aforementioned definition of stemline (ISCN 1978) 
the stemline for the tumour described in table IV.1. is 
represented by the karyotype given in column 1 of the table, 
assuming that the relative proportions of cells with different 
karyotypes in the tumour cell population is indicated by the 
relative distributions in the sample analysed. Using this 
definition it is possible, and indeed probable with the lung tumours 
studied here, that the stemline is in a state of continual change 
karyotypically as the tumour progresses after the onset of 
malignancy. Taken literally, the stemline of a tumour ought to 
be the common base of cells from which a set of derived forms 
have been made by various modifications to the karyotype, and the 
term stem cell ought to refer to the original progenitor cell of 
the tumour cell population. However, the term stem cell is often 
used loosely to describe a cell of the stemline of a tumour. The 
term stemline is more easily applicable to minimally deviated 
tumours than to solid tumours exhibiting grossly abnormal 
karyotypes. The stemline of a tumour is presumed to indicate the
group of cells,having a common karyotype, exerting most influence 
in the total tumour cell population, but in tumours whose 
sequences of clonal evolution are not apparent because of the 
complexity of the chromosome abnormalities (e.g. in the lung tumours 
analysed In this study) this group of cells is usually difficult 
to Identify. It should be assumed therefore that such a tumour 
comprises a cell population which is made up of several 
sub-populations, the cells within each sub-population having 
identical karyotypes. The tumour should be considered as having 
several stemlines, each represented by one of the sub-populations 
of cells, but no single stemline can be assumed to be contributing 
more to the progression of the total tumour cell population 
than any of the other stemlines unless this can clearly be shown 
to be the case. It should also be understood that the stemlines 
of a tumour may be undergoing continual change as the tumour 
progresses. If this usage of the term stemline was adopted 
universally, then much of the ambiguity which is at present 
attached to the term would be lost.
IV.8. Clonal evolution in neoplasia
That neoplasms frequently develop as a clone from a single 
progenitor cell Is a concept which Is widely accepted and several 
workers since the 1950*s have developed hypotheses of tumours based 
on what Is here called a predominant cell type, that describe 
neoplastic progression In terms of sequential selection of mutant
c
sub-populations derived from a common ancestral cell (Makino 1956b, 
Levan and Biesele 1958, Hauschka 1961, Yosida 1966, de Grouchy and 
de Nava 1968). The suggestion that tumours originate from a single 
cell is not intended to preclude that carcinogens can
simultaneously affect many cells in a tissue. It does however 
suggest, that even though a large number of cells may be affected 
by a carcinogen, the macroscopic tumour that ultimately develops 
usually represents the progeny of a single cell. Presumably, other 
neoplastic or preneoplastic cells in the exposed tissue never 
successfully proliferate or they are destroyed before progressing 
to a fully developed tumour (Stich 1963> Teebor and Becker 1971)*
A few exceptions to this unicellular concept are recognised however. 
For example, in some tumours of viral aetiology adjacent cells 
are infected, and there are certain tumours with a strong 
hereditary basis (e.g. neurofibromatosis) where an inherited gene 
defect presumably involves every cell and greatly increases its 
susceptibility to neoplastic transformation (Linder and Gartler 1965* 
Fialkow 1974).
The normal process of cell renewal in multicellular organisms 
seems to be organised in such a way that the various dividing 
stem cells generally do not compete with each other (Cairns 1975).
For example, studies of X-chromosome mosaicism by Gartler ejt al 
(1971) and Feder (1976) showed that adult human tissues comprise 
a large number of very small families of cells, thus suggesting 
that a process of clonal selection is not in operation. Therefore, 
one of the vital steps in the development of a tumour must be a 
change which allows a stem cell to compete advantageously with its 
neighbouring cells and form a proliferating clone within which 
further natural selection can occur.
It is suggested that there are two possible different patterns 
to represent the chromosomal changes occurring during the clonal 
evolution of a tumour. One shows few branches and is dominated 
by an apical progression; the other is highly branched and 
dominated by a multiple lateral progression. These two different
patterns are represented diagrammatically in fig.IV.2. and IV.3* 
respectively.
In both patterns the process is initiated by a carcinogen 
induced change in a normal progenitor cell resulting in a diploid 
tumour cell, probably with a chromosomal change undetectable by 
available methods. This primary event results in a breakdown in 
the mechanism of controlled cellular division to allow for some 
degree of unrestrained proliferation. This is compatible with 
the suggestion of Boyse (1972) and Pitot et al (1974) that 
initiation usually involves altered gene expression rather than 
structural mutation. So the initial neoplastic cell population 
(represented by 1 in figs. IV.2 and IV.3) need have no detectable 
cytogenetic abnormalities. This does not preclude the possibility 
of this initial event involving a visible chromosome anomaly.
For example, approximately 90% of typical cases of chronic myeloid 
leukaemia are Philadelphia chromosome positive, and so it is not 
unreasonable to suggest that the specific translocation involved 
alters the genetic control of proliferation in the affected cell 
and thus initiates the transformation of a normal marrow cell to 
the progenitor cell of a leukaemic clone. Such a cell possessing 
a Philadelphia chromosome would also be represented by 1 in figs. 
IV.2. and IV.3. (c.f.fig.IV.1).
In the apical pattern of progression as represented in fig.IV.2. 
the clone would develop through a sequence of chromosome changes, 
each change resulting in the initiation of a sub-population of 
cells with a different karyotype from those represented by 2 etc.
A sub-population of cells with one karyotype could be the potential 
precursor of several sub-populations, each having a different 
karyotype (e.g. 4A and 4B in fig.IV.2. will have different 
karyotypes, as will 6A and 6B). In this proposed pattern of
FIGHRB IV.2. Apical pattern of clonal development
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development however, new sub-populations tend to be limited to one 
for each previous sub-population, most of the chromosomally 
different cells proving to be lethal, or having such a low viability 
that they play no part in the proliferation of the tumour, (these 
are represented by shaded circles in figs.IV.2 and IV.3). The 
result is a chain of events which gets longer as the clone evolves, 
with very few side chains. This evolution would result in an 
increase in malignancy and increased likelihood of invasion and 
metastasis. The degree of heterogeneity within the total tumour 
cell population would depend upon the survival rates of the earlier 
sub-populations of cells and the speed with which each sequence 
occurred. It is unlikely that the earlier sub-populations will 
survive for a long time whilst other chromosome changes in the 
sequence are occurring, and where there may be competition between 
cells for metabolic resources in a large tumour mass, especially 
in the highly malignant state of late tumours. If they did one 
would expect to find cells with varying degrees of chromosome 
abnormalities covering a range from somewhere near to the normal 
human diploid karyotype, to the multiple complex abnormalities 
found in many solid tumours. This certainly is not the finding 
in this study, where although there are many common features 
present in the cells studied within each tumour, all the cells 
are grossly abnormal compared with the normal human diploid 
karyotype. The sub-populations representing the earlier 
chromosome changes have been lost, probably because of selective 
advantages for survival and proliferation gained by the later 
sub-populations as the clone has evolved, leaving only the 
sub-populations towards the apex of the tree pattern shown in 
fig.IV.2.
In the system represented in fig.IV.3 the mechanisms of the 
chromosome changes are the same, but a more branched pattern of 
evolutionary development results because each sub-population tends 
to be the precursor of more than one new sub-population which is 
also capable of producing multiple new sub-populations. So the 
clone develops through an increasingly complex branching system 
involving considerably more sub-populations of cells than with 
the apical pattern of development. Again, many of the chromosomally 
different cells will be lethal and so unable to foster new 
sub-populations. Assuming that most of the earlier sub-populations 
die out before a late stage of malignancy is reached there will 
again be no karyotypes, in a late stage analysis, representing a 
sequence from near normal diploid to gross chromosomal abnormalities. 
The degree of heterogeneity will be much more marked with this 
branched system of clonal evolution than with the apical system 
of development, the different karyotypes being represented by the 
sub-populations towards the periphery of the tree in fig.IV.3*
These models imply that karyotypically, the predominant cell 
type is changing continually and is dependent upon a time factor 
and rate of developmental change. Correspondingly, the relative 
proportions of cells in the different sub-populations may be in 
a state of constant change. Some solid tumours reach dimensions 
of several centimetres, and it is possible that environmental 
conditions in one part of the tumour tissue differ from those 
in another part to such a degree as to promote the proliferation 
of chromosomally different sub-populations in the different 
regions of tumour tissue. (This could be tested by processing 
different parts of the same tumour separately.) In this type 
of situation a more heterogeneous tumour cell population would 
result, similar to that illustrated in fig.IV.3* Once the clone
of tumour cells has evolved beyond the initial stages it is 
difficult to know which sub-populations of cells is exerting 
the most influence within the tumour. For example, in fig.IV.3 
assuming the tumour has evolved to level If with the previous 
levels having either already died out or being overgrown by the 
newer sub-populations, if sub-population 5B (with proliferative 
advantages over IfA) arises from IfA and begins to outgrow IfA before 
IfA gives rise to 5A, then, in this part of the tree at least, 5B 
would comprise more cells than either 3A or If A , suggesting that 
it was tne most important of these three sub-populations. However, 
it is possible that the cells of 5A have a considerably greater 
proliferative advantage over the cells of both 5B and IfA and in 
a relatively short time would outgrow these two sub-populations, 
with IfA dying out and 5B giving rise to only lethal chromosome 
variants. A chromosome analysis performed at the time when all 
three of these sub-populations were in existence and 5B contained 
considerably more cells than either of the other two would suggest 
that the cells of 3B were the most important cells of these three 
sub-populations and according to the popular understanding of the 
term stemline (ISCN 1978) would be thought of as representing the 
stemline of the tumour, when the cells of 5A were the cells which 
would produce the next sequential event in the clonal evolution 
of the tumour, the cells of 5B dying out before producing any 
new sub-populations. It follows that it could be misleading to 
assign the term stemline to the most numerous cell type of a tumour. 
The cells In sub-population 5B could persist whilst the tumour 
progresses through 5A to 6A and 6B and then perhaps to a seventh 
level. Assuming that the ability to metastasise is not achieved 
until level 6 then the cells of 5B are probably providing an 
insignificant contribution to the progression of the tumour,
the cells of 5A being much more important in this respect. Any 
cell which is capable of dividing could be termed a stem cell and 
so it seems reasonable to assume that a population of similar 
stem cells could be termed a stemline. Kraemer £t al (1971) 
suggest that a tumour comprising several chromosomally different 
sub-populations of cells contains a number of stemlines, each 
corresponding to a different sub-population. This use of the 
term stemline is more literal in that it refers to each group of 
cells providing a common base from which other variant cells can 
arise, rather than to the group with the highest number of cells. 
If this use of the term was adopted then it could be substituted 
for the term sub-population in tumours, and one could refer to 
several stemlines of a tumour, and the predominant stemline of 
a tumour. However, it certainly appears that the term stemline 
needs to be redefined and used more consistently.
The findings for the 32 tumours analysed in this study 
correspond better to the system represented by the apical pattern 
of development (fig.IV.2), each case showing grossly abnormal 
karyotypes with several common features. It is possible that 
the sizes of the samples analysed are too small to give an 
accurate representation of the different sub-populations 
existing in the total tumour cell populations, and that there 
are other small sub-populations with more diverse karyotypes 
also present. If this were the case hov/ever, one would have 
expected to find some evidence of this in at least one of the 
52 cases studied.
A hypothesis of clonal evolution proposed by Nowell (1976) 
falls somewhere between the two systems outlined here. According 
to Nowell, chronic myeloid leukaemia and diploid acute leukaemias 
would be represented by the levels 1 in figs.IV.2 and IV.3
(i.e. an early stage of clonal evolution). Cases of acute 
leukaemia with one or two additional chromosome abnormalities 
would be represented by levels 2 and perhaps 3 . Early solid 
tumours would be represented by levels if, and human macroscopic 
malignant solid tumours would be represented by the higher levels 
(e.g. 6 upwards) where the sub-populations have developed such 
properties as drug resistance and ability to metastasise.
IY#9. Significance of chromosomal changes in tumours
Since Boveri (191*f) proposed that chromosome anomalies were 
fundamental in the aetiology of cancer much data has been 
collected concerning the nature of these anomalies in various 
tumours, but his hypothesis has been neither universally accepted 
or rejected. Whether chromosome abnormalities found in tumours 
are causal or merely insignificant epiphenomena in the neoplastic 
process is still debatable.
The important discovery by Nowell and Hungerford (i9 6 0) of an 
association between chronic myeloid leukaemia and the presence of 
the Philadelphia chromosome added weight to Boveri*s hypothesis, 
and it was thought that other similar associations would soon 
emerge. However, this was not generally the case and there vias 
a tendency to regard chronic myeloid leukaemia and its 
Philadelphia chromosome as an interesting exception in the field 
of cancer cytogenetics.
As mentioned in the introduction, the development of chromosome 
banding techniques which allowed for an accurate identification 
of the different chromosomes comprising the human karyotype 
brought much interest back to the study of chromosomes in cancer. 
Consequently, considerable information has been accumulated
concerning chromosome changes associated with cancer, and an 
understanding of the significance of these changes becomes a 
possibility. Work carried out prior to the development of banding 
techniques is of limited significance in the study of chromosome 
abnormalities in tumours and such results should be discarded or 
else the studies repeated using banding techniques. For example, 
Granberg (1971) observed what she thought to be a non random 
pattern of chromosome abnormalities in a study of carcinoma of 
the cervix, but without using banding techniques to identify such 
chromosomes in rearrangements, such an assumption is invalid.
Although no other findings as specific as the Philadelphia 
chromosome in cnronic myeloid leukaemia has been found, several 
consistent karyotypic patterns, particularly with regard to marker 
chromosomes, have been observed in a number of human tumours.
Atkin (197If) and Harnden (1977b) have reviewed many of these 
findings, which together with the collection of published data, 
on banded karyotypes, by Mitelman and Levan (1978) strongly suggest 
that the chromosome abnormalities found in human tumours involve 
the different chromosomes in a selective fashion. The majority of
this work was carried out on lymphoproliferative and
myeloproliferative disorders, where the chromosome abnormalities 
deviate less from the normal human diploid karyotype than those 
found in solid tumours. The studies on carcinomas comprise an 
extremely small proportion of the total data, but even so a 
differential pattern of chromosome involvement in the 
abnormalities is suggested. This selectivity is supported by the 
findings reported in this study where although the karyotypes are
grossly abnormal and most of the different chromosomes
participate in aberrations, the involvement of the different 
chromosomes certainly appears to be different. Mitelman and Levan
(1978) interpreted this selectivity as an indication that the 
chromosomes most often affected in the aberrations carry genetic 
material which is important in the regulation of cell proliferation 
and that the imbalance of this material caused by the chromosome 
abnormalities results in a dysfunction of cell proliferation, and 
is an essential factor in malignant transformation.
It could however be suggested that the chromosomes mainly 
carrying genes unimportant to cell viability and proliferation 
would be involved more often in aberrations, as because of their 
relative unimportance, a variation in these chromosomes would 
not be harmful to the cell. If this were so, then it would be 
expected that the same chromosomes would be involved in high 
rates of chromosome loss, chromosome gain and chromosome 
rearrangements, but this is clearly not the finding in this study.
In collected data by Mark and Levan (1976) and Mitelman (1977)* 
chromosomes l,8,llf and 22 were found particularly to be involved 
in chromosome abnormalities of malignancies taken as a whole. 
However, most of the data were concerned with the 
myeloproliferative disorders. In a collection of h~b carcinomas 
compiled by Mitelman and Levan (1978) selective involvement of 
chromosomes 1,3*5*7 and 8 was discernible. This is in keeping 
with the findings in this study. However, a distinction between 
the different types of chromosome abnormality was not made by 
Mitelman and Levan. In this study the selective involvement of 
various chromosomes in the anomalies found might suggest that these 
chromosomes are important in the development and progression of 
human lung tumours. However, because of the involvement of a 
relatively high number of different chromosomes it is difficult to 
make an analogy with for example, the Philadelphia chromosome in 
chronic myeloid leukaemia or chromosome 13 involvement in
retinoblastoma. It could be that in the progression of the lung 
tumours, abnormalities are occurring in a random manner but some 
of these resultant abnormalities are lethal, and it is only those 
which survive which have been detected in this study. This 
hypothesis would also allow for the development and continual 
evolution of abnormalities which endowed the tumour cells with a 
greater proliferative capacity. Alternatively the abnormalities 
could be occurring non-randomly but have no important function in 
the malignant process (e.g. preferential translocations could 
occur because of the proximity of specific chromosomes during 
interphase, or because of the existence of homologous regions of 
DNA on different chromosomes). If this were the case however, one 
would expect an increased frequency of this type of rearrangement 
as a constitutional chromosome abnormality, but this is not so.
In any event, it seems unlikely that the multiple chromosome 
anomalies found in these late lung tumours are all significant 
features of the tumours development. It is much more likely that 
most are insignificant epiphenomena but that a few are necessary 
and fundamental in the development and progression of the tumour 
cell population.
It is possible that the chromosomes involved mostly in the 
abnormalities are not the important factors in the development 
and progression of a tumour cell population. Perhaps they are 
irrelevant side events or play only a minor role in tumour 
progression. Maybe the important factor is the balance between 
the genes on other specific chromosomes, perhaps as suggested by 
the relative non-involvement in aberrations of these chromosomes; 
for example, chromosomes and 6 in this study. More light 
would be thrown on this idea by combining enzyme studies with 
established gene mapping of these chromosomes. The balance of
various genes on these chromosomes could be an important factor, 
with an imbalance resulting in non-viability. An alternative 
reason for the relative non-involvement of chromosomes Z,l\ and 6 
in the chromosome aberrations found in these lung tumours could be 
that they are highly stable chromosomes. Chromosome 15 was often 
found to be monosomic in this study. Perhaps the genes on this 
chromosome are not important to lung tumour cells. Conversely, 
chromosomes 7 and 8 were never found to be missing after 
allowance had been made for inclusion of the marker chromosomes, 
and chromosome if was found in a monosomic form only twice in the 
whole study. This suggests that certain genes on these chromosomes 
are essential to the survival of human lung tumours.
Cancer includes many varied diseases with diverse origins and 
biological functions and it seems unreasonable therefore necessarily 
to expect that a single common mechanism or series of mechanisms 
exists in the development of neoplasia. There is considerable 
evidence to demonstrate that a high proportion of human tumours 
comprise cells with chromosome anomalies. As shown in this study, 
the cells of a tumour usually exhibit several common chromosome 
abnormalities suggesting a clonal pattern of development. A process 
of clonal evolution has been proposed by de Grouchy and Turleau 
(197lf) and by Nowell (1976). Fialkow et al (1977) demonstrated 
the single cell origin of leukaemic clones by showing that chronic 
myeloid leukaemic cells from female heterozygotes for 
glucose-6-phosphate dehydrogenase isoenzymes types have only one 
type of enzyme in their leukaemic cells but both types in their 
non-leukaemic cells. This evidence is suggestive of a significant 
role played by chromosome change in the aetiology of a tumour cell 
population, but it is still possible that the chromosome changes 
occurred subsequent to the neoplastic transformation of the original
progenitor cell. The appearance of chromosome abnormalities in 
precancerous lesions is often an indication of an impending 
malignant change. Aneuploidy has been demonstrated in premalignant 
lesions of the uterine cervix by Spriggs et al (1962) who has also 
summarised collected data on chromosome anomalies In severe 
dysplasia and carcinomas in situ (Spriggs 1974)* Mark has 
demonstrated aneuploid cells to be present in benign pituitary 
tumours (Mark 1969* Mark 1971)* Also, as discussed in the 
introduction, carcinogenic agents such as Ionising radiation, 
chemical carcinogens and viruses also cause chromosome damage.
It seems unreasonable therefore to preclude the possibility that 
observed chromosome anomalies play a significant role in the 
neoplastic process. Indeed, the evidence cited above suggests 
that these anomalies play some part in the aetiology of malignancy.
On the other hand, some tumours, even when studied using 
chromosome banding techniques, sho?/ apparently normal karyotypes 
(Mitelman et al 1975* Mitelman and Levan 1976), thus indicating 
that visible chromosome change is not necessarily a causal factor 
in neoplasia or even a necessary feature of neoplasia. Although 
there is clearly a non-random component to the chromosome 
abnormalities found in tumours, apart from a relatively few 
conditions such as the Philadelphia chromosome in chronic myeloid 
leukaemia, generally there is no significant degree of specificity. 
The results of this study on lung tumours indicate that although 
the chromosomes are differentially involved in the anomalies, most 
of the chromosomes take part in some type of aberration. If the 
chromosome changes are really significant in the aetiology of the 
tumours, one would expect a more consistent pattern to emerge, or 
else one has to assume that the same tumour phenotype can arise 
from several different genotypic abnormalities.
It seems more likely that the chromosome abnormalities found in 
tumours have occurred subsequent to neoplastic transformation, 
particularly in the case of carcinomas whose karyotypes tend to be 
grossly abnormal. It could be that the cells of the chromosomally 
abnormal premalignant lesions mentioned earlier have already been 
triggered for malignant transformation at an earlier stage of their 
life. It is difficult to envisage the process as a single step or 
to think of malignant transformation as a starting point. There 
are probably at least two steps in the initial triggering off of 
the cell on its pathway to forming a malignant tumour, with 
malignant transformation, endowing the tumour cells with invasive 
and metastatic qualities, occurring some way from the start of this 
pathway. Such a system would allow for the development of 
chromosome abnormalities before or after malignant transformation, 
and although these abnormalities are probably not an essential 
feature of this pathway, it could be suggested that they play an 
important role in the progression of the tumour. Through an 
active process of selection they confer a greater proliferative 
capacity upon the tumour cell population and an increasing degree 
of malignancy, by endowing the affected cells with such properties 
as a reduced level of differentiation, and an increased ability to 
invade and metastasise.
The considerable heterogeneity which exists in the tumour cell 
populations studied is probably beneficial to the population as a 
whole in that although some sub-populations may be-deficient in for 
example certain enzymes, there could be other groups of cells 
which produce these enzymes and make their metabolic products 
available to the deficient cells. The rearrangements and extra 
chromosomes present could also result in new gene combinations 
which are capable of recompensing the deficiencies. In such a
way, the different sub-populations of the tumour could carry on a 
sort of symbiotic relationship. This type of mechanism could allow 
for deficiences in cells of a tumour cell population whereas they 
are generally not viable, except for the sex chromosomes, in the 
whole human organism.
Tumour cells depend upon their proliferation capacity for their 
success. One tumour cell divides to form two daughter cells which 
are also endowed with the neoplastic properties of the parent cell. 
It follows that there must be some change in the genetic material 
of the parent cell which is passed on to the daughter cells, and 
it seems reasonable to assume that such a change occurring in a 
normal cell could be the triggering factor in .the aetiology of 
neoplasia. As briefly discussed by Harnden and Taylor (1979) 
such a change must either be regulatory or mutational. A 
regulatory change is an alteration in the control of the expression 
of DNA rather than in its structure. Harnden and Taylor suggest 
that a switch in a differentiation pathway is a possible mechanism 
for producing a tumour cell population. A few workers have shown 
that cells with neoplastic properties can be brought back under 
regulatory control and that no structural genetic change is 
involved in the initiation of the neoplasm (McKinnell e_t al 1969* 
Mintz and Illmensee 1975* Illmensee and Mintz 1976). This would 
allow for the existence of neoplastic cells with normal karyotypes 
which were mentioned earlier. However, there are only a few 
instances y/hen a regulatory change is suggested. Most of the 
evidence suggests a structural genetic change as important in the 
development of neoplasia. As mentioned earlier, physical, chemical 
and viral agents that are carcinogenic are also usually capable of 
causing damage to chromosomes, and it is possible that the ty,ro 
actions are associated. For example, there is increased
predisposition to radiation induced chromosome damage in the 
chromosome instability syndromes with the production of clones 
as a result (Harnden 1977a). Involvement of viruses in 
activating malignant potential or producing tumours may 
also be associated with specific chromosomes. Adenovirus 12 attacks 
chromosome 17 at the position where the gene for thymidine kinase 
is located (McDougall 1971)* This enzyme is required by the virus 
for replication. The gene controlling the SV-AO T-antigen has 
been located on human chromosome number 7 which is consistently 
retained in tumours produced by mouse-human hybrid SV-ifO 
transformed cells (Croce and Koprowski 1974* Croce 1975). Rowley 
(197*f) has suggested that individual carcinogenic agents may 
produce specific patterns of chromosomal change.
These structural genetic changes or mutations could involve 
chromosomal translocations detectable by chromosomal banding 
techniques (e.g. the translocation involved in the formation of the 
Philadelphia chromosome in chronic myeloid leukaemia could cause 
damage to specific genes at the break point on the number 22 
chromosome) or they could occur without causing any noticeable 
chromosomal change. Indeed, it is also unlikely that damage at a 
single point along a D M  strand is a sufficient cause of neoplasia, 
otherwise an affected cell should immediately become the progenitor 
of a neoplastic clone of cells, and most neoplastic diseases have a 
significant period of induction. Knudson (1971*1977) suggested 
that t?/o mutations are essential to the initiation of the neoplastic 
process. The initial mutation could predispose the cell to 
further mutation or to the occurrence of chromosomal aberrations.
A progression of at least two steps, each being under separate 
genetic control was postulated by Stanbridge e_t al. (1976, 1978,1981, 
1982) as a model for the progression of a normal cell to a
neoplastic cell. The key difference between the transformed 
non-tumorigenic cells and their tumorigenic segregants is their 
response to growth regulatory signals in the intact animal.
It appears therefore, that as far as chromosomal changes are 
concerned in the neoplastic process, at least one of the essential 
steps in the aetiology of this process concerns genetic mutatation 
which may or may not involve chromosomal rearrangements which are 
observable using chromosome banding techniques; and that the gross 
chromosomal changes found in many highly malignant tumours (and in 
the lung tumours studied here) are the results of relatively minor 
secondary events that occur after malignant transformation but 
which nonetheless play a role in the progression of the tumour.
A similar proposal was made by Cairns (1981) who suggested that the 
cellular environment within any growing cancer is very abnormal 
and applies strong selection pressure for very unusual phenotypes, 
and that these are most easily generated by large-scale 
rearrangements of the genome.
IV.10. Future studies
Before the use of the high resolution chromosome banding 
techniques referred to in the introduction, 30°% of the cases of 
acute non lymphocytic leukaemia were thought to have a normal 
karyotype. Yunis £t al (1 9 8 2) suggest that this assumption is 
incorrect and that all cases of this disease may have a chromosomal 
defect. It should be mentioned that this suggestion is based on 
the study of only 20 cases, but some of the defects were only 
visible in finely banded elongated chromosomes. These techniques 
have recently been further developed to make possible the 
visualisation of the fine banding pattern of late prophase and
midprophase chromosomes exhibiting between 1200 and 2000 bands per 
haploid chromosome set (Yunis I98I). Perhaps optimistically, Yunis 
suggests that since humans are believed to have approximately 
30,000 genes per haploid genome, and the bands of propnase 
chromosomes have 10-1** basic substructures when visualised by 
electron microscopy, then the future chromosome analysis of 
neoplasias and other diseases will soon be carried close to gene 
level. The continued use and further development of these 
techniques will undoubtedly uncover more minute chromosomal defects, 
perhaps with some specificity, and could prove useful in subdividing 
certain diseases which show varied responses to therapy and also 
have different prognoses." They may also be useful in detecting 
carriers of subtle chromosomal defects which confer a relatively 
high disposition to developing neoplasias. Such carriers could be 
monitored closely and so treated in the early stages of the disease 
if it does appear.
With regard to the study of human lung tumours, future studies 
must overcome several problems if progress is to made. It is 
usually cosiderably more difficult to obtain suitable chromosome 
preparations from solid tumours than from either leukaemias or 
effusions. In recent years several short-term culture techniques 
have been developed (Lasfargues 1975* Liebovitz 1975* Kusyk e_t al 
1979* Wake jet al I98I), but ideally direct preparations should be 
used in order to reduce the possibility of anomalies arising in 
culture. Lung tumours are usually diagnosed in a late stage of 
malignancy when they have multiple complex chromosome abnormalities. 
Data need to be collected from many more tumours and a greater 
number of cells should be karyotyped for each tumour, with 
separate analyses being performed on different regions of the same 
tumour where possible. It may then be possible to be more specific
concerning the non-random involvement of the chromosomes in the 
abnormalities. Probably only a few of the abnormalities are 
important in the early progression of the tumours. Studies could 
also be performed on premalignant lesions and metaplastic bronchial 
mucosae which could subsequently give rise to malignancy, in order 
to gain an insight into the early chromosomal changes in this type 
of disease. High resolution banding techniques could prove useful 
in this respect.
Whang-Peng e_t al (1982) have recently reported a specific, 
acquired chromosomal anomaly associated with human small cell 
carcinoma of the lung. They found a deletion of the short arms 
in at least one chromosome 3 in nil the metaphases analysed in .
12 cell lines cultured from human small cell lung carcinoma tissue, 
and in short-term cultures of similar tissue. Although the amount 
of chromosomal material deleted varied from case to case, the 
region 3p(l*f-23) was missing in all cases. This abnormality 
was not seen in any 5 cell lines derived from different types of 
lung cancer tissue. Even though most of these analyses were 
performed on cell lines, the fact that all metaphases in all 
cases of small cell carcinoma of the lung and no metaphases in 
different lung cancer cell lines exhibited this deletion suggests 
that this specific defect is associated with human small cell 
carcinoma. Particular attention should be paid to this abnormality 
in any future studies on lung tumours.
APPENDIX A
Sex, age, histological type and blood group of each of the 52 cases 
used in the study.
Case No. Sex(M or F) Age(In yrs.) Histological type Blood Group
of carcinoma (ABO and Rh)
1 M 55 Epidermoid 0 pos.
2 F 63 Oat cell A pos.
3 M 51 Epidermoid A pos.
k M 68 Anaplastic small 
cell
A pos.
5 M 63 Undifferentiated 0 pos.
6 F 61 Undifferentiated A neg.
7 F 57 Undifferentiated 0 pos.
8 F 71 Squamous cell 0 neg.
11 M 66 Undifferentiated 0 pos.
12 M 68 Epidermoid B pos.
13 M 70 Undifferentiated A neg.
l*f F 55 Undifferentiated A pos.
15 M 63 Epidermoid AB pos
16 F 55 . Squamous 0 pos.
17 M 53 Epidermoid A pos.
18 M if8 Epidermoid A pos.
19 M 3k Adenocarcinoma A pos.
20 M 69 Epidermoid 0 neg.
21 M 38 Adenocarcinoma A pos.
22 M 66 Epidermoid 0 pos.
23 M 65 Epidermoid B pos.
2 if M 50 Epidermoid 0 pos.
25 M 68 Epidermoid 0 pos.
APPENDIX A (contd.)
Case No. Sex(M or F) Age(in yrs.) Histological type Blood Group
of carcinoma (ABO and Rh)
26 M 67 Squamous A pos.
27 F 60 Squamous AB pos.
28 F 54 Undifferentiated A neg.
29 F 66 Epidermoid A pos.
30 F 72 Epidermoid A pos.
31 F 34 Adenocarcinoma 0 pos.
32 M 55 Undifferentiated A pos •
33 M 63 Epidermoid A pos.
34 M 68 Epidermoid A pos.
35 M 68 Epidermoid 0 pos.
36 F 71 Adenocarcinoma 0 pos.
37 M 66 Epidermoid 0 pos.
38 M 56 Epidermoid A pos.
40 M 62 Undifferentiated A pos.
41 M 68 Anaplastic small 
cell
A pos.
42 M 47 Squamous 0 pos.
43 M 64 Squamous 0 neg.
44 M 62 Epidermoid 0 pos.
45 M 66 Epidermoid A pos.
46 F 66 Adenocarcinoma A pos.
47 M 58 Epidermoid A pos.
48 F 57 Undif ferentiated 0 neg.
49 F 75 Squamous 0 pos.
APPENDIX A (contd.)
Case No. Sex(M or F) Age(in yrs.) Histological type Blood Group
of carcinoma (ABO and Rh)
50 • M 63 Epidermoid 0 pos.
52 M 66 Epidermoid A pos.
53 F 67 Adenocarcinoma 0 pos.
54 F 64 Undifferentiated A pos.
55 . M 60 Undifferentiated 0 pos.
56 F 59 Anaplastic small 
cell
A pos.
APPENDIX B
Details of laboratory reagents used in methodology.
Tissue culture medium.
"199" with 20mM hepes buffer (Gibco-Europe Ltd.) supplemented with 
20% foetal calf serum (Sera-Lab Ltd.)
5% pooled human AB serum.
Ampicillin in a final concentration of 100 units ml 
Streptomycin sulphate in a final concentration of lOOpgms ml 
Colchicine (B.D.H. Chemicals Ltd.).
Stock solution of 0.001% w/v.
Hypotonic solution.
A working solution of 0.5% w/v KC1 was prepared from, distilled 
water and 2% w/v KC1 (Phoenix Pharmaceuticals Ltd.).
Trypsin.
Stock solution of 37o w/v (Wellcome Reagents Ltd.)
Diluted 1:2 v/v with Dulbecco's calcium and magnesium free 
phosphate buffered saline. (P.B.S.) pH 6.8 (Gibco-Europe Ltd.) 
for detaching cells from the growing surface.
Dliuted with P.B.S. to give a 0.1% w/v solution for chromosome 
banding.
Fixative.
Carnoy’s fixative (3:1 v/v methanol:glacial acetic acid).
Stain.
10% v/v "Gurr's R66 Improved" Giemsa stain (Hopkin and Williams)
in tap water.
Culture vessels.
2
25 cms plastic tissue culture flasks (Nunc Ltd.).
Correlation coefficients(r), regression coefficients(b), and residual
2
variances(SR ) calculated and used in the construction of the scatter 
diagrams shown in Figures III.16-33.
Figure P 0 
All
i n t s f 
1>3,5,7,8
o r  c h 
2,4,6,
r o m o s o m e s
9-22
III.16 r 0.0112
b 0.9932
2
SR 240.5954
III.17 r -0.6624
b -3.3400
SR2 49.8562
III.18 r 0.6066 0.8419 0.9999 0.5903
and b 2.1351 1.9657 1.1274 0.3715
19
2SR 27.3432 4.0580 0.0004 0.2609
III.20 r -0.8878 0.8960 -0.5454
b -1.9489 7.6989 -4.6734
SR2 2.6082 36.9545 52.1681
III.21 r -0.7996
b -4.1050
SR2 33.1996
III.22 r 0.0748
b 0.6950
SR2 299.6489
III.23 r -0.6567 
b -3.7264 
SR2 63.9751
Figure P o i 
All
n t s f 
1,3,5,7,8
o r  c h 
2,4,6
r o m o s o m e s
9-22
III.24 r 0.5933 0.8826 0.9841 0.4384
and b 2.1482 2.9343 0.4792 0.5646
25 SR2 29.6708 6.2422 0.0190 1.3114
III.26 r -0.4354 0.8769 . -0.6136
b -2.1598 6.7740 -6.0608
SR2 50.9413 34.9724 61.5094
III.27 r -0.7164
b -3.9657
2SR 52.1039
III.28 r -0.0032
b -0.0301
SR2 299.8115
III.29 r -0.6276
b -3.3853
SR2 61.6000 •
III.50 r 0.6212 0.8048 0.9899 0.7296
and b 2.3188 2.6700 0.9062 0.5554
31 SR2 29.8783 9.9109 0.0427 0.3044
III.32 r -0.7563 0.8342 -0.6315
b -2.0508 6.5670 -6.2992
SR2 8.0400 47.8103 60.5086
III.33 r -0.7113
b -3.9014
SR2 51.9154
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